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Introduction 
Atropisomerism and axial chirality 
Chirality is defined as the property of a molecule which can exist in two 
forms non-superimposable, mirror image one another. This kind of 
molecules lack of symmetry elements of the second kind: a mirror plane 
(σ = S1), a centre of inversion (i = S2), a rotation-reflexion axis (S2n). 
The elements of asymmetry that can generate a chiral compound can be 
chiral centers, chiral axes or helix. All pairs of chiral molecules have 
same chemical properties, but opposite optical properties. For what 
concerns axial chirality, it can be found in molecules containing bonds 
around which the rotation could be hindered, generating conformers that 
are stable at ambient temperature. 
The most general definition of conformation is the following: “the 
conformations of a molecule (of defined constitution and configuration) 
are those arrangements in space of the atoms of the molecule which are 
not superimposable upon each other”. This definition of conformation 
was coined by Barton1 in the middle of the 20th century. In 1922, Christie 
and Kenner2 demonstrated that 2,2-dinitrodiphenyl-6,6-dicarboxylic acid 
could be separated into the two enantiomers due to the hindered rotation 
about the aryl-aryl single bond. Some years later, the term 
“atropisomerism” was proposed by Kuhn3 to define the stereoisomerism 
due to the hindered rotation about a single bond. This terminology comes 
from the greek tropos (i.e., “it turns”) with the negative prefix a, 
indicating something that “does not turn”.  
Finally in 1983, with the Oki definition,4 a pair of conformers which can 
interconvert with an half-life time greater then 1000s at 25 °C, has been 
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defined as “atropisomers”. A pair of atropisomers can be separated as 
stable compounds at ambient temperature and their racemization can be 
obtained by heating the single atropisomer. 
The configuration of these molecules is related to the dihedral angle 
generated by the chiral axis, as reported in Figure 1.5 
 
Figure 1. Dihedral angle and its nomenclature. 
In a chain of atoms a-b-c-d, the torsion angle is the dihedral between the 
plane containing the atoms a, b, c and that containing b, c, d. This system 
has two extreme conformations called anti and eclipsed. The torsion 
angle between groups a and d is then considered to be positive (absolute 
configuration is P or ∆) if the bond a-b is rotated in a clockwise direction 
in order to eclipse the bond c-d moving away from the observator. A 
negative torsion angle requires rotation in the opposite sense (absolute 
configuration is M or Λ).6 The Cahn-Ingold-Prelog priority rules to the 
substituents bonded to atoms b and c to find atoms a and d allow the 
assignment of the dihedral angle sign. 
It is important to note that the slow axial rotation along the chirality axis 
can be due not only to steric hindrance, but also to electronic factors 
(weak interactions) and that conformational stability of the stereogenic 
axis under the reaction conditions is the key requirement to obtain 
enantio-enriched products. This implies that the rotational barrier must be 
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greater than 25–26 kcal/mol or, more conveniently, greater than 30 
kcal/mol. 
The concept of axial chirality as a stereogenic source in a rotationally 
hindered compound was for many years relegated to the academic field. 
However this situation changed with the discovery of many bioactive 
natural compounds containing stereogenic chiral axes7 and with the 
discovery of many catalysts useful for asymmetric synthesis.8 
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Axial chirality in drug discovery1 
Many biomolecular interactions are based on the ligand-receptor chirality 
and this feature becomes of main importance in drug discovery. The 
biological effects of enantiomers can result not only in the curative 
effects, but also in pharmacokinetics and toxicity.2 The well-known cases 
of thalidomide3 and perhexiline,4 whose enantiomers led to unexpected 
effects in humans, emphasized the importance of addressing chirality. In 
pharmaceutical industry stereoisomers are most frequently observed as a 
result of chiral centers, but atropisomerism can be another, yet 
overlooked, source of chirality. 
The U.S. Food and Drug Administration (FDA) Policy Statement for the 
Developement of New Stereogenic Drugs,5 gives precise outlines about 
the development of chiral drugs as single enantiomers or racemic 
mixture, given the technical advances in chiral separation and 
stereochemically controlled synthesis. Anyway, these statements are 
referred to classical chiral centered molecules, whereas there are no direct 
guidelines for atropisomers.  
Atropisomerism may give rise to geometrical isomers, diastereoisomers, 
or enantiomers, all with the feature that they can be thermally 
equilibrated, involving an intramolecular dynamic process that is bond 
rotation. Moreover, bond rotation is time-dependent and half-life for 
atropisomers can vary between minutes to years, depending on the steric 
hindrance, electronic interactions, temperature and solvent. Because of 
this time-dependent feature, drug discovery campaigns can become more 
complex. 
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In order to give some guidelines to manage this time-dependent feature in 
the development of atropisomeric drugs, LaPlante, Edwards and co-
workers proposed a classification1b,c of compounds, based on barriers and 
rotation rates, reported in the following Scheme 1. 
 
Scheme 1. Qualitative, cross-discipline guide to help correlate axial 
(torsion) rotation energy barriers, t1/2, and compound classes for 
predicting development strategies. 
Class 1 compounds possess fast axial rotation rates, in the order of 
seconds or lower, with ∆Erot < 20 kcal/mol. They display no axial 
chirality and are developed as single compounds, without any analytical 
strategy implemented. On the other hand, compounds with ∆Erot > 20 
kcal/mol can generate atropisomers. 
Class 3 compounds have ∆Erot >> 30 kcal/mol, so they have very slow 
rotation rates, in the order of years. These compounds are stable over 
time and can be isolated as optically pure and have an acceptable shelf 
life. Development can proceed similarly to conventional stereoisomers 
that results from chiral centers. 
Class 2 compounds show axial interconversion with values in the range 
of minutes, days or months. Their development can be challenging, 
because stereochemical integrity can be compromised not only during 
drug production, but also in administration to patients and shelf life. In 
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some cases it may be possible to modify the structure to obtain a more 
suitable analogue for development, designing related compounds that 
have slower or faster axial rotation rates. When this is not practical, 
information on the activity of the separate atropisomer in an appropriate 
in vitro or in vivo model may help support the proposed development 
pathway. 
The decision to develop a drug candidate as a purified enantiomer or a 
racemate should be made as early as possible during the optimization 
stage. If possible, options for dealing with the atropisomeric phenomenon 
should be developed and implemented at this early drug design stage. 
For example, if the barrier to atropisomerization is high (Class 3), one 
should aim to develop the drug as a single, pure and stereochemically 
stable atropisomer. This is the case of Telenzepine 1, a selective 
muscarinic antagonist, that has found use in the treatement of peptic 
ulcers6. 
N N
N
O
S
N
O
H NN
N
O
S
N
O
H
1A 1B  
Figure 2. Slow interconversion between the atropisomers of 
Telenzepine 1A and 1B. 
If the barrier to atropisomerization of a compound is low (Class 2), then 
one should consider developing the drugas a consistent and reproducible 
interconverting mixture.7 This is the case of Sch40120 (2) , which is an 
inhibitor of 5-lipoxygenase. This compound has found use in treating 
acute inflammatory diseases such as psoriasis.8 The enantiomersof 2 can 
be observed by chiral HPLC, but they readily interconvert with a half-life 
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of only 1.6 min at physiological temperatures (37 °C). The short 
racemization rate justifies the development of this compound as a racemic 
mixture. 
 
Figure 3. Compound 2 has a fast racemization, of 1.6 min at 37 °C. 
The rotation axis is colored in red. 
In some cases compounds with atropisomeric interconversion properties 
can be too challenging to be developed as drugs, then for this purpose 
some practical options can be used to simplify the structure. For example, 
compound 3 in Figure 4 exists as a mixture of four stereoisomers, which 
have half-life of interconversion of ~5h at 37 °C. To obviate this potential 
problem, symmetrical amide analogues (4) were prepared, where 
symmetry around Ar-CO bond eliminates diastereoisomerism.9 
 
Figure 4. (Left) compound 3 existing as four diasteroisomers. (Right) 
symmetrical analogue 4. 
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A related approach to simplification is to modulate the rate of axial bond 
rotation through engineering faster bond rotation such as atropisomers no 
longer exist. In this case compounds switch from class 2 to class 1, as the 
reported example of compound 5 in Figure 5 where the removal of the 
methyl from the central ring lowers the steric hindrance enough to 
remove atropisomerism from the molecule (6).7 
 
Figure 5. Example of reduced steric hindrance from compound 5 to 
compound 6. 
Foreseeing the existence of atropisomerism in compounds of interest is 
critical at all stages of drug discovery and development. Recently, 
LaPlante and co-workers showed that a computational approach is 
suitable for this purpose.1c In this approach, a relaxed torsion scan 
simulates rotation along a sterically hindered bondand the energy is 
recorded at each increment of rotation. The method used is quantum 
mechanics, for the calculation of energy values that consider steric and 
electronic properties and will be discussed more extensively along the 
Introduction. 
The computational tool becomes useful during the drug discovery 
pathway, especially when used in combination with the compounds 
classification in Scheme 1, determining whether to develop the drug as a 
racemic mixture or as an isolated single isomer. Another application of 
the computational tool is to flag potential atropisomeric compounds from 
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drug databases. In fact this study, not only identified known 
atropisomeric drugs, but also revealed compounds with previously 
unreported atropisomeric properties. Some examples are Dicoumarol (7, 
Figure 6), used as anticoagulant,10 for which the calculated barrier 
resulted 25.5 kcal/mol. Another example is Iomeprol (8, Figure 6), 
belonging to the family of X-ray contrast reagents,11 that exists as a 
mixture of diasteroisomer, based on chiral centers and a class 3 chiral 
axis. 
 
Figure 6. Examples of drugs candidates identified from search of a 
drug datebase that employed the quantum mechanics prediction 
strategy. 
In conclusion atropisomer chirality could have a significant impact on 
drug discovery and so must be managed appropriately. The first step in 
dealing with this phenomenon would be to recognize its existence for 
compounds of interest. Strategies for detecting and computationally 
revealing atropisomers are discussed above. Once identified, there are 
multiple options that range from avoiding atropisomerism to design 
compounds that rotate more quickly or more slowly. A categorization 
scheme is proposed as a guide to help the early drug discovery stages. 
 
 
7, calc ΔE
rot
 = 25.5 kcal/mol 8, calc ΔE
rot
 = 38.9 kcal/mol
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Atropisomerism in catalysis and atroposelective 
synthesis 
Natural products bearing a rotationally hindered biaryl axis are far more 
widespread and structurally diverse than initially assumed. The 
configuration at a biarylaxis can be a decisive factor in governing the 
pharmacological properties of a bioactive compound and axial chirality is 
the fundamental basis for useful reagents and catalysts in asymmetric 
synthesis.1 
Axially chiral biarylic auxiliaries and catalysts exhibit excellent chirality 
transfer properties. The most known example of an axially chiral ligand is 
the diphosphine 2,2’-bis(diphenylphosphino)-1,1’-binaphthyl (BINAP) 1 
(Figure 7), a C2-symmetric triaryldiphosphine,2 which synthesis and first 
applications were reported by Noyori and Takaya in 1980.3 BINAP is the 
ligand of choice in Ru(II) and Rh(I) catalyzed asymmetric 
hydrogenations of C=C or C=O bonds as α,β-unsaturated carboxylic 
acids,4 N-acylaminoacrylic acids,5 allylic alchols6 (see Scheme 2) and 
more examples. The reported examples, and many others, reveal the high 
level success of BINAP in inducing asymmetry, so that the design of 
other atropisomeric diphosphines have become an active area of research 
since 1980. Some other examples, as well reported in Figure 7, are a 
series of BINAP analogues, containing the bis-arylphosphine group (15)7 
and a series of biphenyl phosphines (16)8. 
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15 Ar = 3-MeC6H4;
4-MeOC6H4;
4-ClC6H4;
4-FC6H4
PPh2
PPh2
R
R
16 R = H (BIPHEMP);
Me; NMe2
 
Figure 7. BINAP and modified analogues used as asymmetric 
catalysts. 
 
 
Scheme 2. Example reactions with Ru(II)-BINAP as ligand. 
Reduction of N-acylaminoacrylic acids.5
Reduction of α,β-unsaturated carboxylic acids.4
Reduction of allylic alchols.6
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Some other examples of more complex biaryl systems are reported in 
Figure 8. The epoxidation catalyst 17 possesses two axially chiral 
binaphthyl subunits embedded in a sterically demanding backbone.9 More 
recently, attention has been focused on non-C2-symmetric biaryl 
compounds such as the tertiary aminophenol 18, which catalyzes the 
enantioselective addition of diethylzinc to aldehydes.10 The isoquinoline-
containing phosphine quinap (19) is an example of an axially chiral 
heteroaromatic biaryl; it has been used as a ligand in Pd-catalyzed 
asymmetric allylic alkylation reactions.11 
 
Figure 8. Examples of axially chiral ligands and catalysts. 
Given the importance of axially chiral biaryl compounds, a variety of 
excellent methods for their atroposelective synthesis have been 
developed. Three fundamental strategies can be outlined:12 
1. Biaryl formation in a single step by C-C coupling, with 
simultaneous asymmetric induction.13 
2. Atroposelective transformation of an existing, but 
stereochemically not yet defined, biaryl system.14 Within this 
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two-step approach, a non-stereoselective coupling step precedes 
the introduction of the stereochemical information at the axis. 
3. A C-C bond formation between an arene and a precursor 
substituent, followed by the transformation into a chiral biaryl 
axis by construction of an aromatic ring, usually with a central-
to-axial chirality transfer. 
The first approach is a direct, atroposelective aryl-aryl coupling step, as 
in the case of two aryl units pre-fixed through a chiral bridge. The 
pioneering work is done by Myano et al., employing diester-bridged 
systems, as the example reported in Scheme 3.15 This reported approach 
is of the kind in which the chiral inductive part is an artificial auxiliary, 
that has to be eliminated at the end. There are other approaches in which 
the chiral moieties are part of the intended product.12 
 
Scheme 3. Atroposelective preparation of biaryl diacids 22, by 
Ullmann coupling. 
The second kind of approach is based on the desymmetrization of an 
existing biaryl system. Many examples of this strategy are based on 
stereochemically labile lactone-bridged biaryls, as key intermediates.14 
This approach separates the aryl–aryl bond formation from the 
introduction of the stereochemical information at the biaryl axis, thus 
avoiding a direct asymmetric biaryl-coupling step. As reported by 
Bringmann et al.14a,b the first step is the pre-fixation of ortho-
bromobenzoic acids and phenols to obtain bromoesters 23, which give the 
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configurationally unstable biaryl lactones 24, by PdII catalyzed aryl–aryl 
coupling (see Scheme 4). The second step requires the atroposelective 
transformation of the lactones 24 into configurationally stable biaryl 
compounds, which can be achieved simply by cleavage of the bridge with 
chiral O, N, or H nucleophiles.14b 
 
Scheme 4. Preparation of the biaryl lactones 24. 
Examples of nucleophiles reported are potassium (S)-1-phenyl-
ethylamide and sodium (R)-menthoxide,16 (R)-8-phenylmenth-oxide,17 
(P)-binal-H or with borane in the presence of the (S)-CBS.18 From a 
stereochemical point of view, the transformation of the lactones into 
axially chiral biaryl compounds can be considered as a dynamic kinetic 
resolution.19 The chiral nucleophile selectively attacks only one of the 
two conformational enantiomers of 24, say (M)-24, which is steadily 
resupplied with the remaining enantiomer (P)-24 through the rapid (M)-
24 ↔ (P)-24 equilibrium, thus allowing conversion of the entire racemic 
material of 24 into a stereochemically homogeneous product of either 
configurations. 
The third concept for the preparation of asymmetric biaryl compounds is 
based on a preformed aryl-C single bond, then transformed 
atroposelectively into the aryl axis. The chirality transfer to the axis 
results form a stereogenic center of by enantioselective catalysis. An 
example for this strategy is given by Gutnov, Heller and co-workers who 
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synthesized chiral aryl pyridines by catalytic asymmetric [2+2+2] 
cycloaddition.20 Independently, Shibata et al. reported iridium-catalyzed 
[2+2+2] cycloadditions of dyines 25 and alkyne 26 to construct the two-
fold axially chiral teraryls 27.21 
 
Scheme 5. Construction of teraryls 27, by iridium catalyzed [2+2+2] 
cycloaddition. 
There are more examples of the conversion of C centrochirality approach, 
like the Lewis-acid promoted benzanellation22, diastereoselective addition 
of a naphthyl Grignard, followed by oxidation with DDQ23. This 
synthetic strategy for the construction of chiral biaryl compounds is 
highly innovative. At this time is still at the beginning, and not much has 
been done yet, so that the scope is largely limited in terms of functional-
group compatibility and substitution patterns accessible.24 
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Conformational analysis and metodologies 
Stereochemistry embraces a broad variety of static and dynamic aspects 
that are all related to the three-dimensional structure of molecules. While 
static stereochemistry deals with the spatial arrangement of atoms in 
molecules and the corresponding chemical and physical properties, 
dynamic stereochemistry emphasizes structural change and comprises 
asymmetric reactions as well as interconversion of configurational and 
conformational isomers. The dynamic stereochemistry plays a 
fundamental role in modern chemistry, spanning multiple disciplines 
from asymmetric synthesis and drug discovery to material sciences. 
In the middle of the1930s, Kemp and Pitzer1 came to the fundamental 
conclusion that the discrepancy in the measurements of ethane entropy 
could be interpreted considering the restricted rotation about the carbon-
carbon single bond, and that the ground state of ethane corresponded to a 
staggered conformation instead of an eclipsed one,2 with a rotational 
barrier of about 3 kcal/mol. The concept of staggered conformation of an 
alkyl chain was finally confirmed by Hassel et al.,3 who established that 
the chair conformation of cyclohexane is normally the preferred one, 
where all the carbon-carbon bonds have a dihedral angle of 60°. Finally, 
in the middle of the 1950s, Winstein and Holness4 and Eliel et al5 laid the 
foundations for the modern conformational analysis. Subsequently, 
Barton and Hassel were awarded the 1969 Nobel Prize in chemistry. 
With the advent of sophisticated analytical techniques and with the 
support of the raising power of computational chemistry, the research 
field of conformational analysis grew in importance and gained 
reliability.6 
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The main methodologies used in the dynamic stereochemistry studies are 
listed below, and further explained within this section: 
• Dynamic NMR 
• Optical techniques (ECD, VCD) 
• Dynamic HPLC 
• Theoretical conformational analysis (MM, DFT) 
Dynamic NMR 
Variable-temperature NMR spectroscopy, often called dynamic NMR 
(DNMR), is a powerful tool for investigating stereodynamic processes.7 
As a first example we can consider the molecule in Figure 9: 
dimethylformamide (DMF).8 
 
Figure 9. DMF is a two-site exchange example. 
When the rotation about the C-N bond is frozen the two methyl groups 
are different (A and B), and they have distinct NMR signals.  
The resonance frequency of a nucleus is given by its specific magnetic 
environment. If nuclei change quickly the magnetic environment, on 
NMR timescale, only an averaged NMR spectrum is visible, on the other 
hand when nuclei exchange slowly, individual environments can be seen. 
This is the case when: 
݇ = 	1ݐ ≪ ߨ
∆ν
√2 
Where: 
k = the interconversion rate constant (s-1) 
t = interconversion time (s) 
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∆ν = NMR shift separation of the signal (Hz) at low temperature at which 
exchange does not occur. 
 
This equation indicates that different positions of the same nucleus can 
show distinct signals when the chemical shift difference (∆ν) corresponds 
to a time spent by the nuclei in different positions longer than the 
interconversion time t. 
As the difference of the signals, in Hz, is proportional to the strength of 
the applied magnetic field, a higher magnetic field NMR spectrometer 
can distinguish two conformations that are not distinguishable by a low 
field NMR spectrometer at the same temperature. This is important when 
the shift separations are very small or when it is necessary to perform 
spectra at very low temperatures, where the solvent viscosity broadens 
the signals or the products are not very soluble. 
 
Figure 10. Variable-temperature NMR spectra of an uncoupled 
dynamic two-site system. 
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The blue line in Figure 10, taken at relatively low temperature, shows this 
splitting. However, the two methyl groups can exchange themselves by 
rotation about the bond between the nitrogen and the aldehyde group. As 
the temperature of the sample is raised, the methyl signals broaden as the 
exchange rate becomes faster in the the NMR timescale. The two signals 
reach coalescence (yellow line in Figure 10) and eventually merge to 
yield a single averaged sharp line when the rotation is very fast (red line 
in Figure 10). 
Variable-temperature NMR spectroscopy has been applied extensively in 
the conformational analyses and kinetic studies of stereodynamic 
processes with energy barriers between 4.5 and 31 kcal/mol. The energy 
range covered by DNMR is limited by the NMR timescale, spectral 
resolution and the practical NMR temperature range, from -180 °C to 
+160 °C, limits determined by the solvents and by the probe design. For 
the high-temperature range, DMSO-d6 (b.p. +210 °C) or C2D2Cl4 (b.p. 
+146 °C) are usually employed. Solvents without any hydrogen atom, 
such as tetrachloroethylene (b.p. +121 °C), hexachloroacetone (b.p. +70 
°C/6 mm Hg) or hexachlorobutadiene (b.p. +210 °C) can also be used.  
Variable-temperature experiments down to –100 °C are usually recorded 
in CD2Cl2 (m.p. –97 °C), THF-d8 (m.p. –118 °C) or CD3OD (m.p. –95 
°C). Quite a wide temperature range is accessible with toluene-d8 (from –
95 °C to +110 °C).6b If the temperature has to be decreased well below –
100 °C, the samples have to be prepared in a more sophisticated way, 
with use of liquefied gases such as Me2O,9 vinyl chloride,10 propane,11 
propene,12 Freons® or mixture of these. 
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Coalescence Method 
In the absence of any coupling, the first-order interconversion rate 
constant at the coalescence temperature can be calculated as: 
்݇஼ = 	ߨ
∆ν
√2 
kTC = rate constant (s-1); 
TC = coalescence temperature (K); 
∆ν = difference in the chemical shifts (Hz) of the two signals without exchange. 
 
Further increasing the temperature, the exchange rate is too fast and only 
a single averaged signal is observed (red line in Figure 10). By weighted 
average the chemical shift can be calculated: 
ߥ஺,஻ = ߥ஺߯஺ + ߥ஻߯஻ 
νA,B = chemical shift (Hz) of the signal with exchange 
νA = chemical shift (Hz) of the signal at low field without exchange 
νB = chemical shift (Hz) of the signal at high field without exchange 
χA = molecular fraction of the signal at low field without exchange 
χB = molecular fraction of the signal at high field without exchange. 
 
From the k values, the free energy of activation (∆G≠ in kcal/mol) can be 
extracted by application of the Eyring equation,13 where T is the absolute 
temperature and k is the rate constant in s-1: 
݇ = 	ߢ ݇஻ ∙ ܶℎ ݁
ି∆ಸಯೃ೅  
h = Planck’s constant (1.584·10-34cal·s) 
kB = Boltzmann constant (3.2998·10-24cal/K) 
R = universal gas constant (1.9872 cal/K·mol) 
κ = transmission coefficient (can be considered equal to 1) 
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Solving for ∆G≠ (in kcal/mol): 
∆ܩஷ = 4.574 ∙ 10ିଷ ∙ ܶ ∙ (݈݋݃ ܶ݇ + 10.318) 
The determination of the exact temperature inside the sample is crucial 
for the determination of the thermodynamic parameters. An error of ±2 
°C in the temperature causes an error in ∆G≠ of 0.15 to 0.2 kcal/mol, and 
this is usually the main source of errors in the DNMR technique. 
The NMR spectrometer always shows a “dial temperature” determined by 
a thermocouple underneath the NMR tube. The temperature of the sample 
giving rise to the observed NMR signals (i.e., in the region of the RF 
coils) is usually different, and can be correlated to the “dial temperature” 
by a calibration curve. 
The most common samples used for temperature calibration are 
isopentane or methanol (for low temperature range) and DMSO-d6 or 
ethylene glycol (for high temperature range). The real temperature inside 
the sample in the coil region is determined by a tiny Cu-Ni thermocouple 
connected to an high precision digital thermometer. From the 
experimentally measured temperatures and dial temperatures, a 
calibration curve can be derived. The uncertainty in subsequent 
temperature measurements with such a calibration curve can be estimated 
as ±1°C or less. 
The simplicity of the coalescence method, for the simpletwo-site case, 
has certainly contributed to its widespread use. However, this method is 
not applicable neither to interconversion of species with different 
thermodynamic stability, nor to compounds that show complicate NMR 
spectra with multiple coupling patterns. In these cases, the rate constants, 
at the different temperatures, are better obtained by NMR line shape 
analysis with customized programs. 
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Line Shape Simulation 
The rate constants involved in conformation processes detectable by 
dynamic NMR cover approximately the rangefrom 102 to 106 s–1. 
When two nuclei A and B are exchanged in a dynamic process with a 
kinetic constant k, the corresponding lines broaden, reach the coalescence 
point and eventually yield an average signal when the exchange rate 
constant becomes large. The presence of more than two signals and more 
than a single rate constant can complicate this situation; nevertheless the 
whole system can be mathematically simulated. With the use of 
increasing calculation power it is possible to handle mathematical models 
that can simulate second-order spectra and quite complex spin systems 
(up to 11 nuclei).14 Once a good spectral simulation is obtained at the 
temperature where all the dynamic processes are frozen (i.e. k = 0), the 
line shape at higher temperatures can be simulated by changing the values 
of the rate constants. Corrections are needed if chemical shifts, J 
couplings and conformer ratios are also temperature-dependent. Through 
the matching of simulated and experimentally measured spectra, the 
kinetic constant (k value) is obtained at each given temperature and the 
free energy of activation (ΔG≠) can then be derived by means of Eyring 
equation. 
An example of how a complex spectral pattern can be reproduced is 
displayed in Figure 11. 
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Figure 11. Example of line-shape simulation. (Left) experimental 
spectra. (Right) line shape simulation obtained with the rate 
constants indicated. 
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Optical techniques 
Chirooptical techniques such as electronic circular dichroism (ECD) have 
been used for many years for the conformational analysis of organic 
molecules, following the landmark observations of Djerassi and co-
workers15 in the early 1960s. By this technique, the conformational 
preference of a variety of cyclohexanones, bicyclic and polycyclic 
ketones, and biaryls and helicenes have been studied. This topic has been 
summarized by Lightner and Gurst16 and more recently reviewed by 
Pescitelli et al.17 ECD can be successfully used in conformational 
analysis when the conformations are different in the relative disposition 
of the chromophoric parts because this implies either different patterns of 
the ECD spectra or a very different Δε at the same wavelengths. For 
example, ECD spectra have been widely used to analyze the 
conformations of many binaphthyl derivatives, where the splitting of the 
exciton coupling is strongly related to the dihedral angle between the two 
aryl rings.18 
The infrared counterpart of ECD, the vibrational circular dichroism 
(VCD) technique works in the same way of ECD. The main advantages 
of the VCD technique, with respect to ECD, are the large number of 
infrared (IR) bands that are more sensitive to any conformational change 
and the availability of these information regardless the lack of any UV 
chromophoric group. VCD spectroscopy has been recently applied to the 
conformational analysis of some complex molecules such as baccatine 
III19 and (R)-thalidomide.20 
Dynamic HPLC 
In recent years enantioselective HPLC has been extended to the 
investigation of stereolabile compounds. Dynamic HPLC (DHPLC) can 
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be applied in the form of variable temperature, or variable flow 
chromatography and is employed to determine the enantiomerization 
barrier of chiral stereolabile species, when their interconversion takes 
place at the time scale of this technique.21 The HPLC time scale extends 
from seconds, in the case of fast HPLC on short columns, to hours, when 
long columns and low flow rates of the columns are used. Peak shape 
characteristic of an on-column interconversion are usually observed as a 
profile between the two resolved peaks, that don’t reach the baseline 
(Figure 12). 
 
Figure 12. Temperature-dependent chromatograms of an aryl 
coumarine on an enantioselective HPLC column. (Left) Experimental 
profiles with the time scale in minutes. (Right) profiles calculated on 
the basis of the best fit rate constants (k, in s-1) for enantiomerization. 
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The resulting peak shapes contain the necessary information to extract 
kinetic parameters related to the exchange process between the two 
species. Several methods have been used to extract kinetic data from 
experimental eluition profiles, such as the theoretical plate model,22 the 
stochastic model,23 the continuous flow model,24 peak deconvolution 
methods,23b approximation functions23b and unified equation.21b 
Considering the time scale of these experiments, DHPLC is 
complementary to DNMR in that it can reveal the existence of the 
exchange phenomena, and yield the corresponding exchange rates. 
Moreover, the physical separation of the interconverting species can be 
exploited to proceed with their characterization by chirooptical methods.  
Theoretical approach 
Up to the end of the 1990s, conformational calculations of organic 
molecules were mainly performed by molecular mechanics (MM3,25 
MMX,26 MMFF,27 Amber28 etc.). These calculationswere reasonably 
simple and could be completed in short times on standard desktop PCs 
without the need for super-computers. The results obtained were often 
quite accurate, at least for the calculation of the ground-state 
conformations. For the calculation of transition states, these methods 
have intrinsic limitations. Usually the interconversion barriers were 
calculated by moving the relative parts of the molecule in fixed steps and 
optimizing the remaining parts. Otherwise, a “handmade” transition state 
was assumed, and the geometry was optimized within certain constraints. 
As a result of these approximations, the computed barriers were prone to 
relatively large errors, and there was no guarantee that a real transition 
state had been located. 
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The development of computing hardware allowed the theoretical 
chemists to find solutions of the wave equations for complex atomic 
systems. The first Hartree–Fock (HF) calculations were performed in the 
middle of the 1950s. Since the HF methods suffered from low power of 
calculation of the first digital computers, a semi-empirical approach was 
developed to partially solve this problem.29 
Finally, in the middle of the 1960s, Hohenberg and Kohn30 demonstrated 
that the molecular energy can be calculated from the electron density, 
given the knowledge of the correct functional. It was also demonstrated 
that the electron density follows the variational theorem, and some years 
later.the mathematical approach to the calculation of the energy was 
proposed.31 That was the beginning of the Density Functional Theory 
(DFT). The ability to manage large molecules at an affordable 
computational cost, and the possibility to calculate a variety of chemical 
and physical properties focused the attention of a huge number of 
researchers and justified the 1998 Nobel Prize in Chemistry to Pople and 
Kohn.32 DFT has the great advantage of taking account of electronic 
correlation at a reasonable computational cost.33 In recent years, the 
availability of inexpensive high-performance servers and manageable 
software (Gaussian 09,34 Turbomole,35 Spartan36 and NWChem37) has 
allowed high-level calculations to be performed in a reasonable amount 
of time for molecules containing up to 50 – 60 atoms. 
DFT calculations are very interesting for dynamic NMR because they can 
be applied both to obtain the conformations of ground states and to find 
the correct geometries and energies of transition states. The confirmation 
that the correct transition state has been unambiguously identified is done 
by vibrational analysis. 
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Ground States 
There is some uncertainty in determining the relative energy of possible 
ground states and in recent times many papers addressing performance of 
various funcionals have appeared.38 In our experience, the popular 
B3LYP functional,39 together with 6-31G(d) or the larger 6-
311++G(2d,p) basis sets, is usually a good compromise between accuracy 
and computational cost. Geometries obtained by calculations can in many 
cases be checked by X-ray diffraction data, and the relative energies of 
conformations can be compared with the results of variable-temperature 
NMR spectroscopy. Although such a calculation usually refers to an 
isolated molecule, DFT structures compare very well with experimental 
observations and the relative energies of possible conformations are 
correctly calculated. 
Transition States 
As addressed by D. Young,40 a transition state (or saddle point) structure 
is mathematically defined as “the geometry that has zero derivative of 
energy with respect to moving every one of the nuclei, and has positive 
second derivative energy for all but one geometric movement”.There are 
several algorithms that can be used to find a transition structure and the 
optimization procedure can find the saddle point only if the starting 
geometry is sufficiently close (Figure 13). Once the stationary point is 
found, the first way to verify whether it corresponds to a transition state is 
to compute the vibrational frequencies. A transition state must have only 
one negative (imaginary) frequency, and the vibrational motion 
associated with this frequency corresponds to the motion going towards 
reagents in one direction, and toward the products in the other, being 
“reagents” and “products” two different conformations.  
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Figure 13. MM computed energy surface for a conformational 
exchange.41 
Many modelling packages can visualize an animation of the molecular 
displacements corresponding to the calculated frequencies, clarifying 
whether the correct transition state has been found.42 The reliability and 
performance of the DFT calculations to predict the energy barrier of a 
conformational process can be checked by comparison with the 
experimental activation energies obtained by spectroscopic methods such 
as DNMR or by dynamic high performance liquid chromatography43 and 
standard kinetic measurements. 
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Application of conformational analysis to the absolute 
configuration determination 
In recent years an increasing number of papers describing the Absolute 
Configuration (AC) assignment by chirooptical methods have been 
presented.1 This approach is particularly important in the cases that the 
anomalous dispersion X-ray diffraction technique can’t be used.2 This 
can happen when a compound does not contain a suitable heavy atom (Z 
> Si) or, even if containing, it can’t be crystallized. Thus the simulation 
of one or more chiroptical properties represents a good alternative for the 
AC assignment. The theoretical background for the calculation of the 
optical properties such as optical rotation (OR),3 optical rotatory 
dispersion, VCD,4 and ECD methods has been coded and refined between 
1970s and 1990s. With the implementation of DFT and TD-DFT5 
methods into affordable software, all optical properties have become 
relatively simple to calculate. 
Electronic Circular Dichroism (ECD)6 
Many theoretical models have been applied to the calculations of the 
ECD spectra with the TD-DFT method. Simulations can be performed 
with the hybrid functionals BH&HLYP7 and M06-2X,8 ωB97XD that 
includes empirical dispersion,9 and CAM-B3LYP that includes long 
range correction using the Coulomb Attenuating Method.10 The 
calculations employed the 6-311++G(2d,p) basis set that proved to be 
sufficiently accurate at a reasonable computational cost.11 
Although the theoretical simulations have shown to be highly reliable 
when dealing with rigid molecules selected to validate the methodology,12 
the critic point of this technique is due to the conformational freedom of 
the major part of the organic molecules, and the main risk is to overlook a 
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populated conformation. For this reason, before calculating any optical 
property or spectra, an accurate conformational analysis must be always 
performed because the experimental spectrum is the average of the 
spectra corresponding to all the populated conformations weighted by 
Boltzmann distribution. In this case, the resulting spectrum is not 
averaged on the timescale, as in NMR spectra,because the optical 
techniques have a temporal resolution of picoseconds. 
The conformational search starts from a simple calculation based on an 
MM force field and a systematic or a Monte Carlo approach for the 
determination ofthe starting geometries of all the possible conformations. 
This step usually provides a large number of MM minimized geometries 
and an energy cutoff of 5–10 kcal/mol is usually applied to reduce the 
number of energy minima to be subsequently refined. After this step the 
structures are subjected to a more sophisticated minimization, based on 
DFT with a moderate basis set. The simulation of the chirooptical 
property of each populated conformation is then obtained by the 
appropriate method (DFT or TD-DFT) using a larger basis set, as 6-
311++G(2d,p), or Dunning-type orbitals (aug-cc-PVDZ and aug-cc-
PVTZ).13 The simulated ECD spectrum, weighted on the Boltzmann 
population distribution is then superimposed with the experimental one, 
and the matching of the peaks validates the AC. 
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Figure 14. (Top) calculated ECD spectra for the four conformations 
of the reported compound (S absolute configuration) using the 
geometries obtained by gas-phase calculations. TD-DFT calculations 
were performed at the CAM-B3LYP/6-311++G(2d,p) and 
BH&HLYP/6-311++G(2d,p) level. (Bottom), superimposition between 
the experimental trace (black) and the two simulated spectra.11c 
Vibrational Circular Dichroism (VCD) 
The assignment of the AC of organic molecules by VCD has been very 
recently reviewed in its different aspects.14 The prediction of the Absolute 
Configuration of a chiral molecule from its experimental VCD spectrum 
requires a methodology analogue to the determination via ECD. As first 
step the experimental spectrum of the solution of an enantiomer is 
acquired, in the mid-IR spectral region. Then the simulation of the 
spectrum is performed via DFT calculations, by means of prediction of 
the harmonic vibrational frequencies, dipole strength and rotational 
strength of the fundamental transitions of all populated conformations. 
The predicted VCD spectrum, weighted on the population distribution of 
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the conformations is compared with the experimental spectrum to define 
the Absolute Configuration. 
 
Figure 15. (Left) comparison of the measured VCD and IR spectra of 
baccatin III with the predicted spectra. (Right) the optimized 
geometries of the three conformations [B3LYP/6-31G(d)].1 
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Research objectives 
The research work reported in this Thesis was held along two main lines 
of research. The first and main line of research is about the synthesis of 
heteroaromatic compounds with increasing steric hindrance, with the aim 
of preparing stable atropisomers. The main tools used for the study of 
these dynamic systems, as described in the Introduction, are DNMR, 
coupled with line shape simulation and DFT calculations, aimed to the 
conformational analysis for the prediction of the geometries and energy 
barriers to the trasition states. This techniques have been applied to the 
research projects about: 
• atropisomers of arylmaleimides; 
• atropisomers of 4-arylpyrazolo[3,4-b]pyridines; 
• study of the intramolecular NO2/CO interaction in solution; 
• study on 2-arylpyridines. 
Parallel to the main project, in collaboration with other groups, the 
research line about determination of the absolute configuration was 
followed. The products, deriving form organocatalytic reactions, in many 
cases couldn’t be analyzed by means of X-Ray diffraction, making 
necessary the development of a protocol based on spectroscopic 
methodologies: NMR, circular dichroism and computational tools (DFT, 
TD-DFT) have been implemented in this scope. In this Thesis are 
reported the determination of the absolute configuration of: 
• substituted 1,2,3,4-tetrahydroquinolines; 
• compounds from enantioselective Friedel-Crafts alkylation-
acetalization cascade of naphthols with α,β-unsaturated cyclic 
ketones; 
• substituted 3,4-annulated indoles. 
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Results and discussion 
Synthesis and conformational analysis of atropisomeric 
systems 
Atropisomers of arylmaleimides1 
Molecules containing stereogenical axes usually have a planar framework 
with one or more substituents linked in the key sites. Depending on the 
hindrance of the substituents and the geometry of the planar scaffold, the 
resulting conformational enantiomers can be stereolabile or 
configurationally stable, generating atropisomers. In this work we 
synthetized a series of benzyl maleimides bearing in position 3,4 
variously ortho-substituted aromatic groups which adopt tilted 
conformations relative to the planar scaffold. The compounds have been 
prepared with a modified Suzuki coupling, under milder conditions, as 
reported in Scheme 6. 
Scheme 6. Preparation of compounds 3a-f, 4a-f. 
3,4-bisaryl N-benzyl maleimide 
When equal aryl substituents are linked in position 3,4 of the maleimide 
(4), syn/anti conformers are formed. The substituents on the aryl ring can 
stay either on the same (syn) or on the opposite side (anti). As showed in 
Scheme 7, their interconversion corresponds to a 180° rotation and 
requires a passage through a transition state in which one ring is coplanar 
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to the scaffold, individuating a steric barrier.2 The second process pointed 
out in Scheme 7 correspond to a flipping process, in which the two rings 
adopt a twisted disposition, originating a pair of enantiomers that 
interconvert through a transition state where the rings are orthogonal to 
the scaffold (π-barrier)2. However the π-barrier is very low and its value 
decreases with the increasing of the steric barrier, so in this case is not 
possible to detect it by dynamic NMR. 
We theoretically analyzed the stereodynamic pathway performing DFT 
optimization of the ground states and the available transition states, at the 
B3LYP/6-31G(d) level of theory. For compound 4a calculated energy 
value of the π-barrier resulted 3.8 kcal/mol, thus the syn and the anti 
conformations can be considered as the average of the limiting structures. 
When ortho substituents of the aryl rings are on the same side of the 
maleimide scaffold the conformation has an average Cs symmetry and 
corresponds to a meso form. If the ortho substituents are arranged in the 
anti configuration the resulting symmetry is C2 and implies a pair of 
conformational enantiomers. The interconversion between syn and anti 
conformations can be reached through two transition states: TS1 in which 
the o-aryl substituent crosses on the carbonyl group, TS2 corresponds to 
the internal crossing on the second aryl ring. 
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Scheme 7. Stereodynamic network for 3,4-bisaryl-N-
benzylmaleimide. 
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In order to detect these conformations the hindrance caused by the ortho 
substituents must generate rotational energy barrier detectable within the 
dynamic NMR range (4.5 – 22 kcal/mol). Moreover when the 
interconversion is frozen on the NMR timescale the conformational 
diastereoisomers can be observed, but the assignment to the meso or 
racemic form can be performed only in presence of a chirality probe.3 For 
this reason the benzyl moiety was linked to the nitrogen of maleimide. It 
contains an uncoupled CH2 group that displays different multiplicity 
depending on molecular symmetry, acting as chirality probe. 
In the left part of Figure 16 is reported the variable-temperature NMR 
spectra for the CH2 signal in compound 4d (Ar = 2-isopropylphenyl). At 
room temperature the signal of CH2 is very broad and unresolved, at 0°C 
the signals of syn and anti conformers can be distinguished, as the 
process becomes slow on the NMR timescale. The singlet at 4.826 ppm 
(cyan) corresponds to the syn conformation, with 49% of population, the 
AB system (red) corresponds to the anti conformers (51%), as the CH2 
becomes diastereotopic. On the right in Figure 16 the line shape 
simulation is reported, considering the coupling constant of the AB spin 
system and the exchange of the AB lines with the singlet of the syn form. 
It’s important to point out that the racemization of the anti conformers 
corresponds to a two-step mechanism with the syn conformation as 
intermediate, thus the experimental free energy measured by dynamic 
NMR corresponds to the transition state anti-to-syn process. The 
experimental energy barrier obtained by line shape simulation for 4d was 
15.5 ± 0.1 kcal/mol and the ΔG≠ values are almost invariant with the 
temperature, implying that the activation entropy is very small or 
negligible. This is quite usual for rotational processes.4 
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Figure 16. (Left) Temperature dependence of the 1H benzylic CH2 
signal of 4d (600 MHz in C2D2Cl4). (Right) Line shape simulation 
obtained with the rate constants reported. 
The energy barriers obtained for compounds 4a−f, reported inTable 1, 
suggest that the barrier is controlled only by steric factors and the DFT 
computed energies matched well the relative stability of the two 
conformational diastereoisomers, as well as the energy barriers for their 
interconversion.  
In the case of compound 4f (Ar = 2-methylnaphthyl) DFT calculation for 
TS1 and TS2 yielded 23.5 and 25.1 kcal/mol respectively, implying the 
presence of thermally stable atropisomeric forms. This has been validated 
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by experimental results: the 1H NMR recorded at room temperature 
showed two sets of signals, supporting the existence of stable 
diastereomeric forms and on heating the sample up to 120°C in C2D2Cl4 
no evidence of dynamic exchange has been detected. 
Table 1. DFT-Computed and experimental energies of 3,4-bisaryl-N-
benzylmaleimides 4a−fa 
a All energy barriers are reported in kcal/mol. b This value corresponds to 
the syn/anti interconversion, derived from line shape simulations. c 
Determined by NMR integration at appropriate temperature. 
The three stereoisomers have been then resolved with enantioselective 
HPLC (Figure 17), cellulose based enantioselective column, eluent 90:10 
hexane:isopropanol) and 1H NMR spectra of the collected fractions 
confirmed the assignment of the chromatographic peaks. 
The experimental energy barrier for the interconversion in compound 4f 
has been determined by a kinetic study. A sample of the syn 
diastereoisomer in CDCl3 was kept at 46 °C and a set of spectra were 
recorded at fixed intervals (180 s) until the equilibrium composition was 
reached. At equilibrium a syn/anti ratio of 51/49 was observed. The 
kinetic process was analyzed at three different temperatures (46, 51 and 
61 °C, Figure 18) and from the equilibrium ratio and the slope of the 
Entry GS1 (syn) 
GS2 
(anti) 
TS1 
(ext) 
TS2 
(int) ∆Gexp
≠ b syn/antic 
4a 0.28 0.00 11.55 12.43 12.9 55/45 
4b 0.47 0.00 12.86 13.44 13.9 54/46 
4c 0.16 0.00 13.93 14.56 14.9 55/45 
4d 1.33 0.00 14.43 15.93 15.5 49/51 
4e 0.00 0.00 12.88 12.98 14.0 45/55 
4f 0.00 0.21 23.52 25.12 24.5 51/49 
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regression lines a ΔG≠ = 24.5 kcal/mol was derived. This energy barrier 
corresponds to a half-life time of 128 h at 25 °C. 
 
Figure 17. Chromatogram of 4f on enantioselective HPLC column. 
 
 
Figure 18. Kinetic data for the syn/anti interconversion of 4f. 
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3-Bromo-4-arylmaleimides 
In this work 3-Bromo-4-arylmaleimides have been studied as well 
(compounds 3a-f, Scheme 8). This compounds have a single stereogenic 
axis, so it can generate only enantiomeric conformations, due to the 
skewed disposition of the o-substituted aryl ring. As for compounds 4, 
there are two available transitions states: TS1 in which the o-aryl 
substituent crosses on the carbonyl group, TS2 corresponds to the internal 
crossing towards the bromine. 
 
Scheme 8. Stereodynamic network for 3-Bromo-4-aryl-N- 
benzylmaleimide. 
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As reported in Table 2, DFT calculations suggest that the preferred 
transition state pathway is TS1 and the experimental energy barriers, 
determined by dynamic-NMR, for compounds 3 are higher than those of 
compounds 4 (∆∆G≠ in Table 2). This difference can be related to the 
steric hindrance caused by the spherical bromine in the transition state, 
while in the ground state its effect is negligible.5 The difference in 
experimental free energy of activation is similar for each entry, with 
values is between 1 and 2 kcal/mol, except for compounds 3f and 4f, 
where it’s about 4 kcal/mol. This can be related to the steric hindrance on 
both sides of the rotating aryl ring. 
Table 2. DFT-Computed  and experimental energy barriers of 3-
Aryl-4-bromo-N-benzylmaleimides 3a−fa 
Entry TS1 (ext) TS2 (int) ∆Gexp≠ ∆∆G≠ b 
3a 11.23 12.65 14.3 1.4 
3b 13.63 14.55 15.3 1.4 
3c 14.21 15.24 16.6 1.7 
3d 15.01 15.58 17.3 1.8 
3e 13.16 14.83 15.7 1.7 
3f 25.88 28.19 28.6c 4.1 
a All energy barriers are reported in kcal/mol, as the difference with the 
corresponding 3,4-bisaryl-N-benzylmaleimide energy barrier (ΔΔG≠ in 
kcal/mol) are also reported. b This value was obtained by considering the 
racemization barrier of the corresponding compound 4. c Derived from 
HPLC analysis. 
Compound 3f resulted having free energy of activation up to 28.6 
kcal/mol and the atropisomers were separation by AD-H enantioselective 
HPLC column (90:10 hexane:isopropanol). 
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Absolute configuration of 4f 
The reference method to assign the absolute configuration relies on the 
X-ray anomalous scattering (the “Bijovet method”). However, this 
approach requires the preparation of enantiopure single crystals and the 
presence of an heavy atom in the molecule (usually Z > Si). In this case 
compound 4f does not contain any heavy atom and the assignment by X-
ray crystallography is unfeasible. In the present case the determination of 
the absolute configuration of atropisomers has been performed with the 
chirooptical technique ofe lectronic circular dichroism (ECD) coupled 
with the theoretical calculation of the spectra, performed via TD-DFT. In 
order to correctly simulate the experimental ECD spectrum all the 
possible conformations of the anti diastereoisomer should be considered, 
the experimental spectrum resulting from the weighted sum of the 
populated conformations. 
The conformational search performed on the M,M atropisomer suggested 
that two conformations are available for the two naphthyl rings: one with 
the methyl groups pointing toward the five-membered ring (anti-in) and 
the other in which they are directed toward the two carbonyl oxygens 
(anti-out). The theoretical ECD spectrum of both conformations was 
obtained with the TD-DFT method at CAM-B3LYP/6-311+G(d,p) level. 
The electronic excitation energies and rotational strengths were 
calculated in the gas phase using TD-DFT with four different functionals 
to explore whether different types of calculations provide different shapes 
of the simulated spectra. Simulations were performed on the previously 
optimized geometries using four different funcionals: the hybrid 
functionals BH&HLYP6 and M06-2X,7 the long-range correlated 
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ωB97XD that includes empirical dispersion,8 and CAM-B3LYP that 
includes long-range correction using the Coulomb Attenuating Method.9 
 
Figure 19. (Left) Theoretical ECD spectra of the two conformations 
of M,M-4f obtained with the TD-DFT method with four different 
theoretical methods and the 6-311+G(d,p) basis set. All the spectra 
were obtained by applying Gaussian shapes (line width = 0.25 eV) to 
the discrete transitions. The vertical scale has been reduced by a 
factor of 20 with respect to the calculated value. (Right) are reported 
the two optimized structures (relative ZPE-corrected free energies in 
kcal/mol, distances in Å). 
As shown in Figure 19 the simulations obtained for the two 
conformations have nearly opposite spectrum. For this reason the correct 
population ratio of the two conformations is required to obtain a correct 
ECD spectrum simulation. Direct method to the determination of the 
population can’t be used, being the π-barrirer inaccessible for dynamic-
NMR technique, for this reason NOE spectrum (in CD3CN) of the second 
eluted atropisomer (Figure 17) was used. In both conformations, the 
methyl group of each naphthyl ring is spatially close to the hydrogen in 
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position 3 of the same ring and to the H-8 of the other naphthyl ring.The 
distances from the 2-methyl to H-3 and H-8 are different, depending on 
the conformation considered. In the anti-in conformation this ratio is 
calculated as 0.89, while inanti-out conformation this ratio is 1.03 (Figure 
19). The observed NOE corresponds to a 60:40 ratio of the two 
conformations (anti-in:anti-out). This result is in agreement with the 
59:41 ratio based on the computed free energies of the two conformations 
(0.00 and 0.21 kcal/mol for the anti-in and anti-out, respectively). The 
second eluted atropisomer (EN2) resulted having M,M absolute 
configuration. 
 
Figure 20. Computed ECD spectra of 4f considering a ratio of 59:41 
of the two conformations, using four different functionals. All the 
calculations employed the 6-311+G(d,p) basis set. Black line: 
experimental ECD spectrum of the second eluted atropisomer of 4f. 
Absolute configuration of 3f 
In the case of compound 3f, atropisomers separation was obtained by 
AD-H enantioselective HPLC column (90:10 hexane:iso-propanol as 
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eluent) as reported in Figure 21). Using the same approach of compound 
4f the absolute conformations of the enantiomers have been obtained by 
ECD spectra. From the preliminary conformational search by MM four 
different conformations were found to be populated, which correspond to 
the two dispositions of the naphthyl ring, combined with the two 
available dispositions of the benzyl ring. Simulation of the ECD spectrum 
is obtained assuming Boltzmann population distribution of the four 
conformations (30:26:24:21 ratio, using ZPE corrected free energies). 
The first eluted atropisomer (EN1) resulted having M absolute 
configuration. 
 
Figure 21. (Top) Chromatogram, with retention times, in AD-H 
enantioselective HPLC column, 90:10 hexane/isopropanol. (Bottom) 9 
nm shifted finally computed M spectrum (purple line) and 
experimental ECD spectrum of EN1 (red line) 
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Conclusions 
Stable atropisomers can be generated when hindered aryl rings occupy 
the 3,4 positions of the benzyl maleimide. DFT calculation, at B3LYP/6-
31G(d) level, were able to well predict the energy barrier of the 
racemization in the case of compound 4f, which have been confirmed 
with experimental data. 3-bromo-4aryl maleimides can generate 
atropisomers as well, as in the case of compound 3f. Absolute 
configuration of the atropisomers obtained has been determined by 
theoretical simulation of the ECD spectrum, by means of TD-DFT 
calculation, supported by NMR conformational analysis. 
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Atropisomers of 4-arylpyrazolo[3,4-b]pyridines1 
The pyrazolo[3,4-b]pyridine ring system has emerged as a privileged 
substructure in the pharmaceutical industry because of its occurrence in 
various biologically active compounds exhibiting medicinal properties,2,3 
among which as HIV reverse transcriptase inhibitors4 and as effective 
candidate in the treatment of Alzheimer’s disease (BAY 41-2272)5. 
Furthermore, pyrazolo[3,4-b]pyridines cartazolate, etazolate, and 
tracazolate (Figure 22), are well-established anxiolytic drugs.6 In addition 
to their pharmacological importance this scaffold possess a high 
structural resemblance to purine bases, essential constituents of DNA and 
RNA nucleosides,7 which adds further significance to the synthesis and 
study of this moiety. 
 
Figure 22. Pyrazolopyridine-embedded drugs and 
bioactivecompounds. 
The aim of this section is a thorough investigation of the stereodynamics 
of a class of pyrazolo[3,4-b]pyridines (Figure 23) and an evaluation of 
the steric requirements needed to produce stable heteroaromatic 
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atropisomers. Many bioactive natural compounds contain stereogenic 
axes, thus Clayden, LaPlante and co-workers have recently begun to 
address pharmaceutical implications of atropisomerism in drug 
discovery.8 As an additional feature of interest these compounds bear a 
fluorinated substituent on the heterocyclic scaffold. Over the years, great 
attention has been focused on the design and synthesis of fluorinated 
organic compounds because of their chemical and biological properties.9 
 
Figure 23. Chemical structure of compounds 1 – 6. 
The pyrazolo[3,4-b]pyridine scaffold of compounds 1 − 6 (Figure 23) 
bears a methyl group in position 3 and a trifluoromethyl group in position 
6. Because of the presence of these sterically demanding substituents, 
these compounds bear two single bonds around which the rotation could 
be hindered: the aryl group in position 4 and the benzoyl group in 
position 5. From a stereochemical point of view, compounds 1 and 2 bear 
a single stereogenic axis corresponding to the bond in position 5 and 
when in this rotation is frozen in the NMR timescale a pair of 
conformational enantiomers is generated. (Scheme 9). 
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Scheme 9. The two enantiomeric conformations of 1 and 2 (the grey 
rectangle stands for the p-substituted phenyl moiety, the white stands 
for the heterocyclic scaffold) 
Whereas the p-anisole (1) and the p-tolyl (2) aryl in position 4 is 
symmetrically substituted thus is not generating a stereogenical axis. 
When optimized at the B3LYP/6-31G(d) level, the ground-state 
structures showed that the p-substituted ring was almost perpendicular to 
the pyrazolo[3,4-b]pyridine ring and the benzoyl moiety was disposed in 
a skewed conformation, too. In its ground-state geometry, compounds 1 
and 2 belong to the C1 symmetry point group. These calculated structures 
fully agree with the known X-ray structure of compound 2.10 
In compound 1 two transition states (TS1 and TS2 in Figure 24) should 
be considered to achieve racemization by the 180° rotation of the benzoyl 
moiety. In TS1 the carbonyl oxygen crosses the pyrazolo pyridine plane 
on CF3 group side, while in TS2 the oxygen is close to the p-anisole 
group. According to DFT calculations, the transition state with the lower 
energy is TS1, with a ΔH≠ of 15.1 kcal/mol, while TS2 has a ΔH≠ of 15.6 
kcal/mol. The computed transition state for anisole rotation corresponds 
to a coplanar conformation (TS3 in Figure 24) and its energy was 
calculated as 17.1 kcal/mol. 
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Figure 24. Calculated transition states for compound 1 at the 
B3LYP/6-31G(d) level. The reported energy values (relative tothe 
ground state) are thermal corrected enthalpies, in kcal/mol. 
The room temperature NMR spectrum of 1 showed broad peaks in the 
aromatic region, corresponding to the signals of the p-anisole ring. On 
raising the temperature above +25 °C, broad signals sharpened at +93 °C 
into the expected AA′BB′ spectrum. On lowering the temperature these 
signals sharpened and eventually split at −22 °C into two sets of signals 
in a 50:50 ratio (see Figure 25). The same behavior was observed in the 
case of compound 2. The experimental energy barriers were determined 
by line-shape simulations as 14.3 ± 0.2 kcal/mol and 14.1 ± 0.2 for 1 and 
TS3 
17.1 
TS2
15.6
TS1
15.1
GS
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2, respectively. If the rotation of anisole is frozen and the benzoyl 
rotation is still fast in the NMR time scale, the two sides of anisole are 
enantiotopic, thus their hydrogens are not anisochronous. If the benzoyl 
rotation is frozen and the anisole rotation is fast, the two sides of anisole 
are exchanged by rotation (homomerization) and again no splitting is 
observed in the NMR spectrum. When both rotations are frozen, 
nevertheless, the two sides of the aromatic ring belong to different 
magnetic environments, giving the observed splitting. For these reasons, 
the experimental energy barrier must be assigned to the lower calculated 
barrier for the two stereodynamic pathways, i.e., that for the benzoyl 
group rotation (15.1 kcal/mol). The barrier for the anisole (tosyl) rotation 
can’t be determined. 
To get information about the stereodynamics of the aryl ring in position 4 
we prepared compounds 3 and 4, bearing a m-ethylphenyl and a m-
isopropylphenyl ring, respectively. The presence of a substituent in the 
meta position does not alter to a great extent the heteroaryl−aryl 
rotational barrier, nevertheless, the aromatic ring loses its local C2 
symmetry and a new stereogenic axis is generated when its rotation is 
frozen. For these compounds when both barriers are frozen we should 
take into consideration four possible conformations, as reported in Figure 
26. 
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Figure 25. (Left) temperature dependence of the 1H aromatic signals 
of 1 (600 MHz in C2D2Cl4). (Right) line-shape simulations obtained 
with the rate constants reported. Blue dots indicate the hydrogens 
ortho to the methoxy group, and red dots indicate the hydrogens 
meta to the methoxy. 
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Figure 26. Stereochemical pathways for compounds 3 – 6. The black 
spheres correspond to the benzoyl moiety. The blue spheres 
correspond to the meta substituent on the aryl ring in position 4 of 
the pyrazolopyridine ring. 
When the dynamic process with the higher barrier is frozen, a pair of 
conformational enantiomers is generated, whereas when rotation around 
the second stereogenic axis is restricted, two pairs of conformational 
diastereoisomers are formed. Using M, P descriptors,11 the syn 
diasteroismer corresponds to 4M*,5M* and the anti to the 4M*,5P* 
relative configuration. The ethyl and isopropyl groups were chosen 
because they act as stereochemical probes by showing diastereotopic 
signals in the NMR spectra.12 
Compound 3 crystals were obtained from a hexane/ethyl acetate 4:1 v:v 
solution, as a racemate of the P-1 point group. X-ray structure showed 
that the m-ethylphenyl and the CO moieties are skewed with respect to 
the pyrazolo[3,4-b]pyridine ring, with 61.7° and 71.6° angles, 
respectively. Moreover in the solid state the two groups adopt the syn 
disposition, see Figure 27. 
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Figure 27. X-ray structure and DFT calculated structures for the two 
diastereoisomers of compound 3. The reported energy values are 
thermal-corrected enthalpies, in kcal/mol. 
DFT calculations were performed to evaluate the energies of the two 
diastereoisomers of 3, which have been found to be very similar. The syn 
conformer was the more stable by only 0.16 kcal/mol when the internal 
energy was considered, and by even less (0.10 kcal/mol) when the 
thermal-corrected enthalpy was taken into account (Figure 27). The four 
possible transition states connecting the four conformations were 
calculated at the same level of theory. There are two possible transition 
states for each moiety: for the benzoyl group, in which the CO is coplanar 
with the heterocyclic scaffold, it can be close either to the aryl ring in 
position 4 or to the CF3 group in position 6 (TS1 and TS2 in Figure 28), 
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and for the m-ethylphenyl ring where the ethyl group points to either the 
methyl in position 3 of the pyrazolo[3,4-b]pyridine or to the benzoyl 
group in position 5 (TS3 and TS4 in Figure 28). For each rotational 
pathway, the lowest calculated energy barrier is the one to be considered 
for the comparison with experimental data. Calculated energies suggested 
that the rotation of the m-ethylphenylgroup was higher than that of the 
benzoyl group (18.1 and 14.9 kcal/mol, respectively). 
 
Figure 28. Calculated transition states for compound 3 at the 
B3LYP/6-31G(d) level. The reported energy values (relative to the 
ground state) are thermal-corrected enthalpies, in kcal/mol. 
The NMR spectrum of compound 3 recorded at room temperature 
showed broad peaks for both the CH2 and CH3 signals of the ethyl group. 
On lowering the temperature of a C2D2Cl4 solution of 3, the signals of the 
CH2 decoalesced and eventually split into two quartets with 55:45 
relative ratio at -22 °C. The unbalanced ratio confirmed that the two 
conformational diastereoisomers were present, thus both rotational 
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barriers must be frozen in the NMR time scale. The lack of 
diastereotopicity on the CH2 signals is due to a negligible chemical shift 
difference between the diastereotopic protons. On switching the solvent 
to acetonitrile-d3, the same signals did show diasterotopicity at -22 °C, 
but the low boiling point of this solvent did not allow the measurement of 
the higher of the two barriers. The diastereomerization barrier, assigned 
to the benzoyl rotation was conveniently measured by line-shape 
simulation of the methyl signal in C2D2Cl4 (Figure 29), yielding a barrier 
of 13.9 ± 0.15 kcal/mol, in agreement with the one found for 1 and 2. 
 
Figure 29. (Left) temperature dependence of the1H methyl signals of 
3 (600 MHz in C2D2Cl4). (Right) Lineshape simulation obtained with 
the rate constants reported.  
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The measurement of the rotational barrier of the second stereogenic axis 
was accomplished with compound 4 (C2D2Cl4 sample), bearing a m-
isopropylphenyl group. At room temperature the methyl groups show a 
broad signal, then on lowering the temperature, the methyl signal split at 
−20 °C into three signals with 36:32:32 ratio (bottom trace of Figure 30) 
where the low field triplet is ascribable to the partial overlap of two 
doublets with the same intensity. Integration of the isopropyl CH signal 
confirmed the 64:36 ratio of the two conformational diastereoisomers. 
On raising the temperature, the broad signal observed at room 
temperature sharpened and two separated signals (Δν = 21 Hz) were 
observed at +81 °C (top left trace of Figure 30). The two observed 
spectral lines correspond to the diastereotopic signals of the isopropyl 
group when the dynamic process with the lower barrier is fast in the 
NMR time scale, and the higher barrier process is still frozen (the 
coupling constant with the CH is hidden within the line width). On 
further raising the temperature, the two signals reached coalescence at 
+102 °C and a doublet due to the coupling with CH was eventually 
visible at +133 °C (right section of Figure 30). Two different sets of rate 
constants must be considered in the simulations. The first set accounts for 
the exchange between the pair of methyl signals of one diastereomeric 
conformation with the pair of methyl signals of the other one 
(diastereomerization barrier). The second set of rate constants must 
exchange the two diastereotopic methyl signals within the same 
diastereoisomer. The energy barrier derived from the simulationof the 
first set of rate constants was 14.3 ± 0.15 kcal/mol, in good agreement 
with the values obtained for compounds 1 − 3. The energy barrier derived 
for the higher energy process was 19.2 ± 0.2 kcal/mol. The experimental 
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values have to be compared with the values of 15.6 and 18.4 kcal/mol 
provided by the calculations for the benzoyl and m-isopropylphenyl 
rotation, respectively. 
 
 
Figure 30. Temperature dependence of the 1H NMR isopropyl methyl 
signal of 4 (600 MHz in C2D2Cl4). (Left) low-temperature part and 
corresponding line-shape simulations obtained with the rate 
constants reported. (Right) high temperature spectra and line-shape 
simulations. Italicized rate constants are relative to the higher energy 
barrier, whereas the other rate constants are those for the lower 
barrier. The spectrum at +81 °C of the left side is the same at the 
bottom of the right side, where the chemical shift scale was expanded 
by a factor of 3. 
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Table 3. Experimental 1H NMR (600 MHz, CD2Cl2 -67 °C) and 
calculated chemical shifts of the two diastereoisomeric conformers of 
compound 3. 
Experimental chemical 
shifts (ppm) 
Calculated chemical 
shifts (ppm) 
Major Minor Anti Syn 
3-Me 2.07 2.10 2.20 2.23 
Ethyl CH2 2.36 2.57 2.65 2.67 
Ethyl CH3 0.82 1.16 0.87 1.25 
H2’ 6.75 7.08 7.34 7.69 
H6’ 7.05 6.80 7.55 7.35 
 
Table4. Experimental 1H NMR (600 MHz, CD2Cl2 -67 °C) and 
calculated chemical shifts of the two diastereoisomeric conformers of 
compound 4. 
Experimental chemical 
shifts (ppm) 
Calculated chemical 
shifts (ppm) 
Major Minor Anti Syn 
3-Me 2.05 2.09 2.20 2.26 
CH3 0.82 1.12 1.01 1.20 
CH3 0.95 1.14 1.32 1.24 
i-PrCH 2.65 2.81 2.78 2.96 
H2’ 6.86 7.09 7.28 7.43 
H6’ 7.01 6.90 7.62 7.33 
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To determine the structure of the more populated conformer of 
compounds 3 and 4, NOE spectra were acquired. The spectra had to be 
recorded at a temperature (−67 °C) in which the rotation of the benzoyl 
was calculated to have negligible rate, to avoid saturation transfer effects 
arising from the irradiated peak. Unfortunately, at this temperature the 
signals of the benzoyl moiety were heavily broadened by a third dynamic 
process, thus the NOE analysis was inapplicable. In order to perform this 
determination we calculated NMR chemical shifts of the two 
diasteromeric conformations for both compound 3 and 4. The GIAO 
method was used at the B3LYP/6-311++G(2d,p)//B3LYP/631G(d) level 
and calculations for both products 3 and 4 are reported in Table 3 and 
Table4, respectively. 
For both compounds calculations suggested that the major isomer has the 
anti conformation. The experimental diastereomeric ratio of 3 is 55:45 
anti/syn (−22 °C in C2D2Cl4), whereas for 4 is more unbalanced, being 
64:36 anti/syn (−22 °C in C2D2Cl4). From DFT ground state optimization, 
in compound 3 the syn conformer was calculated to be slightly more 
stable than the anti conformer, in the case of 4 the anti conformational 
isomer was calculated as more stable than the syn conformational isomer, 
probably because of the larger steric hindrance of the isopropyl with 
respect to the ethyl group. This is therefore in agreement with the 
experimental trend. 
As previously mentioned, in compound 4 below −60 °C the aromatic 
signals of the benzoyl moiety were heavily broadened by a third dynamic 
process. On lowering the temperature below −80 °C, the signal of the 
ortho hydrogens of the phenyl-CO ring reached coalescence and 
eventually split at −118 °C into two separated sets of signals in a 50:50 
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ratio (sample in CDFCl2). This third dynamic process has to be assigned 
to the restricted rotation of the phenyl ring around the Cipso−CO bond. 
Due to the crowding of the aromatic region and to the large chemical shift 
spread, a complete line-shape simulation was not workable. For this 
reason compound 5 has been prepared, where the phenyl moiety was 
substituted with a 3,5-dimethylphenyl group. For this compound the 
barriers for the rotation of the m-isopropylphenyl ring and the benzoyl 
were found to be identical to those of compound 4 (19.2 kcal/mol and 
14.3 kcal/mol respectively). On lowering the temperature below −80°C 
the two unbalance signals (63:37 at −22°C) of the two CH3 of the 3,5-
dimethylphenyl group, split in four separated peaks at −118°C. Line 
shape simulations yelded two different rotational barriers (9.6 ± 0.2 and 
9.4 ± 0.2 kcal/mol)13, with the major distereoisomer (anti) having the 
higher rotational barrier. Experimental values of the energy barriers 
measured for all the studied compounds are reported in the following 
table. 
Table 5. Summary of the syn:anti ratio and of the experimental 
energy barriers for 4-aryl rotation and 5-benzoyl rotation a 
Compound Experimental syn:anti ratio 4-aryl rotation 
5-benzoyl 
rotation 
1 - - (17.1) 14.3 (15.1)b 
2 - - (17.5) 14.1 (14.8)b 
3 44:56 (-22°C) -(18.1)b 13.9 (14.9)b 
4 36:64 (-22°C) 19.2 (18.0)b 14.3 (14.7)b 
5 37:63 (-22°C) 19.2 (18.1)b 14.3 (14.9)b 
6 38:62 (-35°C) >35 (36.4)b 13.0 (14.2)b 
a in parentheses are reported the DFT calculated values at the B3LYP/6-
31G(d) level, as thermal-corrected enthalpies. All values are in kcal/mol. b 
the reported energy value is that of the lower energy transition state. 
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Atropisomers separation and absolute configuration 
The torsional barrier found for the meta-aryl substituted compounds 3 
and 4 were very high, due to steric constraints. For this reason we 
prepared compound 6, in which the aryl ring is substituted in ortho 
position, in order to provide a torsional barrier sufficiently high to allow a 
physical resolution of the atropisomeric pair. In particular compound 6 is 
substituted with a 1-naphthyl ring, because DFT calculation suggested a 
rotational barrier higher than 36 kcal/mol (see Table 5). 
We achieved the separation of the atropisomers by means of 
enantioselective HPLC, with a amylose-based stationary phase 
(Chiralpack AD-H). Then by means of ECD the spectra of the separated 
compounds were recorded, showing opposite trace (Figure 31).  
We determined the experimental racemization barrier by keeping an 
enantiopure sample of 6 at +120 °C for 24 hours in 1,1,2,2-
tetrachloroethane. Subsequent HPLC analysis did not show the presence 
of the second atropisomer. Assuming the second atropisomer being 
present less than 1 %, the lower limit to racemization barrier is about 35 
kcal/mol, in good agreement with the DFT calculated value. This value 
corresponds to a “class 3” atropisomer in LaPlante’s scheme8b,c, with half 
life of more than 2 × 105 years at ambient temperature. 
By means of dynamic NMR, the barrier for the benzoyl rotation has been 
determined, being 13.0 ± 0.2 kcal/mol, a value close to that determined 
for all other compounds 1 – 5. 
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Figure 31. (Top) HPLC chromatogram of 6 on chiral stationary phase 
(Chiralpak AD-H). (Bottom) ECD spectra of the two atropisomers taken in 
acetonitrile solution. 
Having in hand the two separated atropisomers of compound 6, we 
pursued the determination of their absolute configuration. The reference 
method to assign the absolute configuration (AC) relies on the X-ray 
anomalous scattering14 that in the present case would require high-quality 
single crystals and the use of a Cu − Kα X-ray source.15,16 Nevertheless, 
the determination of the AC ofchiral molecules by chiro-optical 
techniques such as optical rotation (OR), vibrational circular dichroism 
(VCD), and electronic circular dichroism (ECD) has recently gained 
feasibility and reliability thanks to the development of the time-dependent 
density functional theory approach (TD-DFT).17 
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The experimental ECD spectrum of compound 6 shows a rather complex 
pattern. The typical features of the 1-naphthyl chromophore are found in 
the weak band at 285 nm and in the strong band at 225 nm.18 The ECD 
spectrum also shows two Cotton eﬀects at 266 and 308 nm and a weak 
band at 355 nm. The two bands related to the two transitions of 
acetophenone are found at 266 and 195 nm.19 
 
Figure 32. UV and ECD spectrum of the first eluted atropisomer of 6. 
For the simulation of the ECD spectrum the electronic excitation energies 
and rotational strengths were calculated for the two conformational 
diastereoisomers in the gas phase using the geometries optimized at the 
B3LYP/6-31G(d) level and using TD-DFT with four diﬀerent functionals 
to explore whether diﬀerent theoretical models provide diﬀerent shapes 
of the simulated spectra. Simulations were performed by means of the 
functional: BH&HLYP,20 M06-2X,21 ωB97XD,22 and CAM-B3LYP.23 
The simulated ECD spectra for the anti and syn conformers of the M 
atropisomer are very similar within the same conformation, but shown 
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early opposite trend for the two conformations. The averaged ECD 
spectrum will be therefore extremely sensitive to the population ratio.24 
Being the experimental ECD spectrum the weighted sum of the spectra of 
the diastereoisomers, the correct population ratio must be used to average 
the simulations. The 1H NMR spectra taken at −30 °C in C2D2Cl4 showed 
a ratio of 59:41 for the two conformational diastereoisomers.25 
Unfortunately the syn:anti attribution can’t be gained by NOE spectra, 
being again thwarted by the slow rotation of the benzoyl moiety at the 
low temperatures. However, the X-ray structure of racemic 6 showed that 
the conformation present in the solid state was anti. In Figure 33 are 
reported the weighted ECD spectra and the resulting spectrum is in very 
good agreement with the experimental one of the second eluted 
atropisomer of compound 6, to which M absolute configuration can be 
assigned. 
 
Figure 33. Colored lines: computed ECD spectra of the M 
atropisomer of 6 using diﬀerent functionals and considering a 58:42 
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ratio of the two conformations (anti/syn). All the calculations 
employed the 6-311++G(2d,p) basis set. Black line: experimental 
ECD spectrum of the second eluted atropisomer of 6. 
Conclusions 
In this section we have analyzed the stereodynamic behavior of a series 
of 4-aryl-5-benzoyl-6-(trifluoromethyl)pyrazolo[3,4-b]pyridines. The 
restricted rotations of the aryl substituent in position 4 of the 
heteroaromatic ring and of the benzoyl group in position 5 generate 
conformational enantiomers or conformational diastereoisomers 
depending on the local symmetry of the aryl ring in position 4. The 
energy barriers for the rotation of the benzoyl group and for the aromatic 
ring were measured by dynamic NMR and rationalized by DFT 
calculations. In all the analyzed compounds the 4-aryl rotation was found 
to have a larger barrier than the benzoyl rotation, and its value was found 
to be quite large, despite the absence of any ortho substituent on the 
aromatic ring. At very low temperatures (i.e., < −80 °C), a third dynamic 
process due to rotation around the phenyl − CO bond was observed. 
When the 4-aryl ring was the 1-naphthyl (compound 6), the arene − 
heterocyclic ring rotational barrier was larger than 35 kcal/mol, and the 
atropisomeric pair was resolved by means of enantioselective HPLC. 
Also in this case the restricted rotation of the benzoyl group yielded two 
conformational diastereoisomers detectable with dynamic NMR. Using 
the experimentally determined ratio of the two conformational 
diastereoisomers, the absolute configuration of the atropisomers was 
determined by simulating the electronic circular dichroism spectra using 
TD-DFT calculations. The synthesis and the chemistry of the 
pyrazolopyridine derivatives has attracted much attention in view of their 
importance as the core structure of numerous biologically active 
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compounds. However, they are not intrinsically chiral, and classical sp3 
stereocenters can be added only far away from the heterocycle. The 
availability and synthetic feasibility of thermally stable heteroaryl − aryl 
atropisomers could spread and enhance the biological activity of these 
compounds thanks to the newly added stereogenic moiety, directly 
connected to the pyrazolopyridine core. 
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Study of the intramolecular NO2/CO interaction in solution1 
Weak chemical interactions play a key role in chemistry. They are 
effective in many biological systems and they can be employed to design 
supramolecular assemblies and scaffolds.2 Recently, it was shown that 
noncovalent interactions can modulate the conformational preferences 
and stereoselectivity of some organocatalysts.3 A weak bond due to the 
electrostatic interaction between nitrogen and oxygen has been shown to 
be responsible for the stabilization of the crystal structure of N,N-
dipicrylamine4. The intermolecular N–O interaction was one of the 
driving interactions for the self-assembly of N-oxalyl-2,4-dinitroanilide in 
the solid state.5 Through-space interactions were also observed in the 
solid state for a series of bipyridine N-oxides.6 Ab initio calculations had 
suggested that the energy involved in the N–O interaction was about 13 
kJ/mol.7 
The weak interaction between a nitro and a carbonyl group could 
compete with other weak interactions in the solid state, as well as in 
solution, in the stabilization of preferred molecular conformations, 
provided the correct geometries of the two acting partners are met. 
In this section we studied chemical systems in which the following 
features are present: 
• carbonyl and nitro group are linked to scaffolds that can move at 
a great amplitude without significant variation of the overall 
conformational energy 
• biaryl systems in which the energy minima are quite flat 
• they generate two different conformations that can be observed 
by dynamic-NMR spectroscopy 
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Figure 34. Structure of the compounds used in this study. (Bn = 
benzyl) 
In order to perform this studies we synthesized compounds reported in 
Figure 34, in which the ortho-substituted aryl rings, carring the nitro 
group, generate a rotational barrier that can be detected by dynamic-
NMR, fulfilling the required features for us to study the intramolecular 
NO2/CO interaction. 
Bisarylmaleimides 
In the previous work8 a series of 3,4 substituted benzyl maleimides have 
been prepared, bearing ortho-substituted aromatic groups which adopt 
tilted conformations relative to the planar scaffold. DFT computational 
studies and dynamic NMR spectroscopic data showed that the energies of 
the syn and anti conformers were very similar when aliphatic ortho-aryl 
substituents were employed. On the other hand, in the case of compound 
1, the anti conformer was more stable than the syn conformer by more 
than 4 kcal/mol, at the B3LYP/6-31G(d) level. This implies that in 
compound 1 only the anti conformer should be populated. From a steric 
point of view, the nitro group is very similar to methyl group9, thus steric 
considerations can’t explain the large stabilization of the anti 
conformation. 
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Optimized structures showed that on each side of the maleimide ring an 
electrostatic interaction can take place between the electron-rich oxygen 
atom of the carbonyl group and the nitrogen atom of the nitro group. A 
second electrostatic interaction was present, with reverse polarity, 
between one of the oxygen atoms of the nitro group and the electron-poor 
carbon atom of the carbonyl group (Figure 35). Calculated distance 
between the oxygen atom of the carbonyl group and the nitrogen atom 
was very similar to that observed for N-oxalyldinitroanilide (2.85Å)5. 
This interaction can take place in the syn conformer as well, but in this 
case only one can be effective: the second interaction would drive the 
opposite sides of the phenyl rings close to each other, generating a 
destabilizing steric clash. As a further investigation, compound 1 was 
crystallized form a solution of acetonitrile and the presence of only the 
anti conformer has been confirmed. Both nitro groups interact with the 
two carbonyl groups, in particular we see an electrostatic interaction of 
the electron-rich oxygen atom with the electron-poor nitrogen, as well as 
the interaction of one oxygen of the nitro group with the carbon atom of 
the carbonyl group. The N–O and O–C distances were very similar to 
those reported.4 The calculated skew angles of the two o-nitrophenyl 
rings were -57 °C, whereas the experimentally found angles were -49 °C 
and -55 °C. 
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Figure 35. (Top) X-ray crystal structure of compound 1. (Bottom) 
calculated structures of anti and syn conformers at ωB97XD/6-
311++G(2d,p) level. Distances in Å. 
To experimentally observe this interaction in solution we acquired 
variable-temperature NMR spectra. As shown in Figure 36, a sample of 
compound 1 in CDCl3 was cooled to -24 °C, the signal of the benzylic 
CH2 group split in an AB system, corresponding to the anti conformer 
(C2 symmetry). As previously predicted by the ground state energy 
calculated by DFT, no signal of the syn conformer was present. So the 
rotational energy barrier corresponds to the racemization and its 
experimental value was derived by line shape simulation, as 14.2 ± 0.2 
kcal/mol, matching very well the one found by DFT calculation (14.3 
kcal/mol). In order to check whether there was a solvent effect, 
experiments with CD2Cl2 and CD3OD as solvents have been done and the 
same result has been achieved. 
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Figure 36. Variable-temperature 1H NMR spectra of 1 (600 MHz in 
CDCl3). (Left) Experimental spectra. (Right) Simulated spectra with 
the relative rate constants. 
Because of the absence of the syn conformer we obtained suitable 
information about the stabilization energy involved in the electrostatic 
interactions. If a 99.5:0.5 ratio at -24 °C is taken into account,10 the 
corresponding energy difference (∆G°) is 2.6 kcal/mol. This value is the 
lower limit for the stabilization of the anti conformation because the syn 
conformer was not detectable at all. As one NO2/CO interaction is 
available in both conformations, the value should be considered a direct 
measurement of the strength of the electrostatic interaction. The value 
matches the DFT-predicted value (2.6 ± 4.1 kcal/mol). 
From a geometric point of view in the ground state the electrostatic 
NO2/CO interaction shrinks the angle between the maleimide plane and 
the o-nitrophenyl nearer the transition state geometry. In the transition 
state the motion of one o-nitrophenyl forces the second ring to become 
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perpendicular with the maleimide plane, to minimize the steric interaction 
between the two rings. For this reason the observed energy barrier is the 
result of two contributions: 
• the steric clash between the rotating ring and the maleimide plane 
• partial loss of the NO2/CO stabilization for the second ring. 
Naphthoquinones and benzoquinones. 
We prepared more compounds in which we can perform a quantitative 
evaluation of the energetic contribution of the NO2/CO interaction. For 
example we studied compound 2, that bears one o-nitrophenyl and one o-
tolyl ring. Whereas the nitro group can be involved in the NO2/CO 
interaction, the disposition of the o-tolyl ring is due only to steric factors. 
Low temperature 1H-NMR spectrum showed that both conformations 
were populated, with syn/anti 71:29 and NOE spectra showed that syn 
conformer was the most populated. 1H methyl signal is split only when 
the two conformers are generated, thus it indicates the smaller of the two 
rotational barriers. On the other hand, the CH2 group is a chirality probe 
that indicates the formation of the enantiomeric pair generated by the 
frozen rotation of the ring with the higher rotational barrier. The 
simulation of the methyl signal provided a value of 12.6 ± 0.2 kcal/mol 
for the syn/anti interconversion and the energy barrier derived from the 
simulation of the benzylic CH2 group was 12.9 ± 0.2 kcal/mol. This 
values are very similar, confirming that methyl and nitro group are 
isosteric and a reliable assignment of the two measured barriers is 
impossible.9,11 
Both barriers are significantly lower than that of compound 1, thus 
confirming a substantial stabilization of the ground-state in the case of 1. 
Similarly, we found for compound 3 a syn/anti ratio of 55:45, equivalent 
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to ∆G° = 0.09 kcal/mol. All results of the calculations for compounds 1 – 
3 are reported in Table 6. 
Table 6. Summary of calculations. 
Compd. Level of calculation ΔH° a anti/syn 
1 B3LYP/6-31G(d) 4.1 >99.5:0.5 
1 B3LYP/def2-TZVP 4.0  
1 B97D/def2-TZVP 2.6  
1 ωB97XD/6-311++G(2d,p) 3.0  
1 ωB97XD/def2-TZVP 3.3  
2 ωB97XD/6-311++G(2d,p) -0.6b 21:79c 
3 ωB97XD/6-311++G(2d,p) -0.2b 45:55d 
a All calculated energies are ZPE-corrected enthalpies, reported in kcal/mol. 
b A negative value means that the syn conformation is calculated to be more 
stable than the anti conformation. c The ratio was determined from NOE 
NMR spectrum. d Ref. [8]. 
Having in hands the experimental energy barriers for 1 - 3, the evaluation 
of the electrostatic interaction can be done considering these compounds 
as components of a double-mutant-cycle (DMC).12 As reported in 
Scheme 10, compounds 2 and 3 are respectively the single and double 
mutant, with respect to compound 1. By using this approach we 
calculated that the stabilization due to the electrostatic interaction 
corresponds to 3.35 kcal/mol. 
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Figure 37. Variable temperature 1H spectra of compound 2 (600 
MHz in C2D2Cl4). (Left) Signal of the benzylic CH2. (Right) Signal of 
the methyl group. The signal marked with × is an impurity of the 
solvent. 
OO
NO2
NO2
OO
NO2
Me
O O
NO2
Me
O O
Me
Me
> 2.6 -0.42
-0.42 -0.09  
Scheme 10. DMC cycle for compounds 1 – 3. Indicated values (in 
kcal/mol) are the energy differences (∆G°) between anti and syn 
conformers as measured by NMR spectroscopy at -40 °C. Negative 
values indicate that the syn conformation is more stable than the anti. 
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To check whether the NO2/CO interaction was restricted to the geometric 
constraints of the pentatomic scaffold of maleimide, we prepared 
compounds 4 – 6 (Figure 34) containing the 1,4-naphthoquinone scaffold. 
Within this series, the anti conformer of compound 4 should gain 
stabilization from two NO2/CO interactions, whereas in compounds 5 and 
6 both conformers should be populated. DFT calculations at the 
B3LYP/def2-TZVP, ωB97XD/def2-TZVP, and ωB97XD/6-
311++G(2d,p) levels, reported in Table 7 suggested that in the case of 
compound 4, the anti conformer was more stable than the syn conformer 
by at least 4.0 kcal/mol, in fact the 1H NMR spectrum of 4 at +25 °C 
showed a single set of signals. The calculated o-nitrophenyl rotational 
energy barrier was determined to be 22.7 kcal/mol. 
Table 7. Summary of calculations. 
Comp. Level of calculation ΔH°a anti/syn 
4 B3LYP/def2-TZVP 4.6 >99.5:0.5 
4 ωB97XD/6-311++G(2d,p) 4.0  
4 ωB97D/def2-TZVP 4.0  
5 ωB97XD/6-311++G(2d,p) 1.1 68:32b 
6 ωB97XD/6-311++G(2d,p) 0.4 59:41b 
a All calculated energies are ZPE-corrected enthalpies, reported in kcal/mol. 
b The ratio was determined from NOE NMR spectrum. 
For compounds 5 and 6, the two conformers were calculated to be very 
close in energy and their 1H NMR spectra revealed the presence of both 
the conformers in a 68:32 and 59:41 ratio, respectively. The anti 
conformation was confirmed to be the more abundant on the basis of 
NOE spectra. The energy barrier for the o-nitrophenyl rotation were 
calculated in compound 5 to be 22.3 kcal/mol and for the o-tolyl rotation 
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in 6 resulted 21.0 kcal/mol. As they are inaccessible for the dynamic 
NMR spectroscopic technique, the energy barriers for compounds 5 and 6 
were determined by 1D EXSY, which yielded barriers of 21.0 ± 0.2 and 
20.7 ± 0.2 kcal/mol, respectively. 
In the case of 4, the ambient-temperature NMR spectrum should display 
the presence of a second conformation, if it were populated. The absence 
of a suitable chirality probe did not allow the determination of whether 
the single conformer observed corresponded to the anti or to the syn 
conformer. X-ray diffraction showed that only the anti conformer was 
present in the solid state, with NO2/CO distances and geometries very 
similar to those in compound 1 (see Figure 38). 
 
Figure 38. X-ray crystal structure of compound 4. Distances in Å. 
Compound 4 was analyzed by enantioselective HPLC, which showed two 
peaks undergoing dynamic exchange at +25 °C. At 0 °C, the two 
chromatographic peaks were well-resolved and electronic circular 
dichroism (ECD) at 280 nm showed that they had opposite sign (Figure 
39), confirming the presence of only the enantiomeric pair of the anti 
conformer. 
2.8
2.9
2.8
2.7
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Figure 39. Chromatograms of compound 4 on an enantioselective 
(R,R)-Whelk-O1 HPLC column, recorded at 0 °C. (Bottom) UV 
detector. (Top) ECD detector at 280 nm. 
By means of dynamic HPLC we evaluated the racemization barrier as 
20.5 ± 0.3 kcal/mol.13 Applying the same approach used for 1 to the case 
of compound 4, we determined that the stabilization energy of the anti 
conformation has to be larger than 2.6 kcal/mol. The application of the 
DMC approach (compounds 4 – 6) then yielded a lower limit of 1.9 
kcal/mol for the stabilization energy. 
As a final attempt to experimentally measure the electrostatic interaction 
without any interference caused by the proximity of the aryl rings, we 
prepared compounds 7 and 8. The 1,4-benzoquinone scaffold of 
compound 7 bears two o-nitrophenyl rings in the 2,5-positions and their 
rotations are completely independent, but two NO2/CO interactions can 
be effective and the ground state of both the syn and anti conformers can 
be stabilized in the same way by the electrostatic interaction. Compound 
CD @ 280 nm 
UV @ 280 nm 
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8 shares the same situation, but the rotational barrier is now driven only 
by steric effects. As the nitro and methyl moieties are isosteric, the barrier 
for rotation is mainly due to the stabilization of the ground state.The 
calculated values are reported in Table 8. 
Table 8. Summary of calculations. 
Compd. Level of calculation ΔH° a anti/syn 
7 ωB97XD/6-311++G(2d,p) 0.9 67:33b 
8 ωB97XD/6-311++G(2d,p) 0.7 58:42b 
a All calculated energies are ZPE-corrected enthalpies, reported in kcal/mol. 
b The ratio was assigned on the basis of calculations. 
The rotational energy difference for the syn/anti interconversion between 
7 and 8 has to be assigned to the stabilization due to a single NO2/CO 
interaction. At -65 °C, the 1H NMR spectrum of 7 showed that both 
conformations were populated in a 67:33 ratio, whereas the spectrum of 8 
at -118 °C showed a 58:42 ratio. The energy barrier for the syn/anti 
interconversion of 7 was found to be 12.0 ± 0.2 kcal/mol and the barrier 
for 8 was found to be 9.1 ± 0.2 kcal/mol. Thus, the stabilization due to a 
single NO2/CO interaction was evaluated to be 2.9 kcal/mol, in 
agreement with the previous considerations. 
Conclusions 
We have documented the observation of the weak NO2/CO electrostatic 
interaction in solution. In order to evaluate the entity of the interaction we 
prepared suitable compounds, with maleimide, naphotquinone and 
benzoquinone scaffolds. The energetic contributions were studied by 
means of DFT calculations, dynamic NMR spectroscopy and by the use 
of the DMC approach. The stabilization due to a single NO2/CO 
interaction was evaluated to be from 2.6 to 3.35 kcal/mol. 
101 
 
References 
                                                     
1 Chiarucci, M.; Ciogli, A.; Mancinelli, M.; Ranieri, S.; Mazzanti, A. Angew. 
Chem. Int. Ed. 2014, 53, 5405 − 5409. 
2 Ward, M. D.; Raithby, P. R. Chem. Soc. Rev. 2013, 42, 1619 – 1636, and 
references therein. 
3 Holland, M. C.; Paul, S.; Schweizer, W. B.; Bergander, K.; Mück - Lichtenfeld, 
C.; Lakhdar, S.; Mayr, H.; Gilmour, R. Angew. Chem. Int. Ed. 2013, 52, 7967 – 
7971. 
4 Yin, Z.; Jiang, L.; Hea, J.; Cheng, J. - P. Chem. Commun. 2003, 2326 – 2327. 
5a) Steiner, T. Chem. Commun. 1997, 727 – 734. b) Desiraju, G. R.; Steiner, T.; 
The Hydrogen Bond in Structural Chemistry and Biology, Oxford University 
Press, Oxford, 1999. 
6 O’ Learly, J.; Wallis, J. D. CrystEngComm 2007, 9, 941 – 950. 
7 Platts, J. A.; Howard, S. T.; Wozniak, K.; Chem. Phys. Lett. 1995, 232, 479 – 
485. 
8 Ambrogi, M.; Ciogli, A.; Mancinelli, M.; Ranieri, S.; Mazzanti, A. J. Org. 
Chem., 2013, 78, 3709 – 3719. 
9 Lunazzi, L.; Mancinelli, M.; Mazzanti, A.; Lepri, S.; Ruzziconi, R.; Schlosser, 
M. Org. Biomol. Chem. 2012, 10, 1847 – 1855. 
10 Lunazzi, L.; Mazzanti,A.; Casarini, D.; De Lucchi, O.; Fabris, F. J. Org. 
Chem. 2000, 65, 883 – 888. 
11 Ruzziconi, R.; Spizzichino,S.; Lunazzi, L.; Mazzanti, A.; Schlosser, M. Chem. 
Eur. J. 2009, 15, 2645 – 2652. 
12 a) Yang, L.; Adam, C.; Nichol, G. S.;Cockroft, S. L. Nat. Chem. 2013, 5, 1006 
– 1010. b) Cockroft, S. L.; Hunter, C. A. Chem. Soc. Rev. 2007, 36, 172 – 188. 
13 a) Wolf, C. Chem. Soc. Rev. 2005, 34, 595 – 608. b) D’Acquarica, I.; 
Gasparrini, F.; Pierini, M.; Villani, C.; Zappia, G. J. Sep. Sci. 2006, 29, 1508 – 
1516. c) Piron, F.; Vanthuyne, N.; Joulin, B.; Naubron, J. -V.; Cismaş, C.; Terec, 
A.; Varga, R. A., Roussel, C.; Roncali, J.; Grosu, I. J. Org. Chem. 2009, 74, 
9062 – 9070. 

103 
 
Long range bonding/non-bonding interactions: study on 2-
arylpyridines 
All standard criteria based on the steric effects suggest that a 
methoxymethyl group should be bigger than a methyl group. The 
Charton’s “effective” upsilon parameter,1 derived from the Van der 
Waals radii, puts the following scale: methyl (ʋ = 0.52), ethyl (ʋ = 0.56), 
methoxymethyl (ʋ = 0.63), propyl (ʋ = 0.68). Wintestein’s A values2 
ranks methoxymethyl (A = 1.72) at the same level of methyl (A = 1.74). 
The B scale3, based on the torsional angle of biphenyls with one ortho 
substituent R, puts methoxymethyl (B = 8.6) ex aequo with ethyl (B = 
8.7), on top of methyl (B = 7.4). 
On the other hand this order of bulkiness has been found reversed, 
switching from 2-alkylbiphenyls to the 2-aza-analogous. A library of 2-
(2’-alkylphenyl)pyridines4 has been prepared, reported in Table 9, finding 
the torsional barriers smaller up to 4 kcal/mol difference, because of the 
compressibility of the nitrogen lone pair. 
The CH2 signal of 2-(2-etylphenyl)pyridine 1 did show decoalescence 
below -160°C (∆G≠ = 5.9 kcal/mol), but in the case of 2-(o-
tolyl)pyridine5 2 and 2-(2-(methoxymethyl)phenyl)pyridine 3 neither 
decoalescence, nor line-broadening of the diastereotopic signals was 
observed at temperatures as low as –173 °C (100 K). This means the 
barriers were too small to allow an experimental determination by 
dynamic NMR measurements.6 These barriers were then evaluated by 
quantum chemical calculation. The geometries of the stationary points on 
the aryl-aryl rotation pathway of 1 - 3 were optimized at the B3LYP/6-
31+G(d) and ωB97XD/6-31+G(d) levels of theory.  
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In the Ground State the pyridine ring and the 2-subsituted aryl adopt a 
skewed disposition in order to minimize the steric hindrance. In the 
Transition State the rings adopt a coplanar disposition and all optimized 
TS showed that the lower energy transition state corresponds to the 
crossing of the CH2-X group on the pyridine nitrogen (the alternative TS 
is higher in energy because of the steric hindrance due to the hydrogen in 
position 3 of pyridine).7 
Both theoretical models suggested the energy barrier for 3 (X = OMe) 
was smaller than that of 1 and 2. The calculated barrier for compound 4, 
bearing the NMe2 moiety, was found to be in the middle. The trend of 
calculations was then confirmed by the experimental barrier found, being 
4.8 kcal/mol (coalescence found at -140 °C). This outcome could be due 
to a wrong estimation of the contribution due to the pyridine lone pair in 
the transition state.8 For this reason we calculated the single-point 
energies at the CCSD(T)/6-31+G(d)//ωB97XD/6-31+G(d) level. 
Table 9. Experimental and calculated torsional barriers for 
arylpyridines. Calculations at the CCSD(T)/6-31+G(d)//ωB97XD/6-
31+G(d) level.a 
aAll values are in kcal/mol. b Ref. [4]. c For this compound there is only one 
TS. d This compound has not been prepared, but a theoretical evaluation of 
the barrier has been performed. 
 
 
PlanarTS Skewed TS Exp. value 
1 X = Me 8.4 6.2 5.9b 
2 X = H 5.9c 5.9c - 
3 X = OMe 4.9 6.7 - 
4 X = NMe2 8.5 8.3 4.8 
5d X = F 2.2 5.1 - 
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The value suggested for the rotational barrier of 2-(2-ethylphenyl)-
pyridine 1 (6.2 kcal/mol) confirmed the reliability of these calculations. 
Nevertheless, at the CCSD(T) level of theory the activation energy for 
aryl-aryl rotation of 3 was again found to be smaller than that of 1 and 2. 
 
Figure 40. The two available transition states for aryl-aryl rotation of 
compounds 1 and 3. Energies (in kcal/mol) were calculated at the 
CCSD(T)/6-31+G(d)//ωB97XD/6-31+G(d) level and they are relative 
to the ground states. 
A close examination of the transitions state geometries, as reported in 
Figure 40, showed that the conformation assumed by the ethyl group in 
the TS is substantially different from that of metoxymethyl. In the first 
the methyl group has a dihedral angle of 80° (Me-CH2-C2-C1) with the 
phenyl plane, whereas the same angle is exactly 180° for the CH2OMe 
group (O-CH2-C2-C1 angle). When the alternative TS (i.e. Me at 180° and 
OMe at ≈ 74°) were calculated, their energy were higher than the 
previous ones by 2.2 and 1.8 kcal/mol. 
The energy mismatch between the planar and the skewed transition states 
in compounds 1 and 3 can be explained considering the stabilizing 
interaction due to the lone pair of the pyridine nitrogen. In fact, provided 
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the correct geometry, the nitrogen may share its lone pair with an electron 
deficient center in its closeness. In analogy with the anomeric effect9 and 
neighboring group participations10 this assistance becomes effective if the 
nitrogen donor and the acceptor site are part of germinal or vicinal 
bonding patterns. What makes unique the situation met with α-
heterosubstituted 2-arylpyridines is the distance between the nitrogen 
atom and the heterosubstituted α-carbon: the two centers are separated by 
four interposed bonds and no conjugative electron transmission chain is 
available. Moreover, the amplitude of the barrier–lowering donor–
acceptor interaction is modulated by the nature of the heteroelement. In 
this way the long-range resonance interaction manifests itself as an 
adjustable blend of bonding (A) and nonbonding (B) limiting structures. 
For reasons of proximity, only the coplanar transition state of the 
torsional motion can benefit from this electron-density leveling 
interaction. 
 
Scheme 11. Donor-acceptor interaction between pyridine nitrogen 
and the sp3 carbon. In the transition state the coplanar disposititon of 
the Cα resembles a SN2 type reaction. 
The resonance extending from the pyridine nitrogen through the benzylic 
α-carbon to the heterosubstituent X is accompanied by a respectable gain 
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of energy. If we consider that all 2'-CH2X substituents exert the same 
steric hindrance, the non-classical long-range interaction lowers the 
torsional barriers at an extent corresponding to the stabilization of the 
transition state, where this interaction can be effective. This trend was 
confirmed with the calculation of the energy barrier to rotation of 2-(o-
fluoromethylphenyl)-pyridine 5, where the calculated barrier was well 
lower than that of 3 and 4 (Table 9). 
Within this framework it can be discussed also the behavior of the 
compound bearing a 2’-CH2Br group. The reaction of 2-
bromobenzylbromide with 2-pyridineboronic acid led to the prompt 
cyclization to 6H-pyrido[2,1-a]isoindol-5-ium bromide. The same result 
was found also when (2-(bromomethyl)phenyl)boronic acid was reacted 
with 2-bromopyridine, or when 2-(2-(hydroxymethyl)phenyl)-pyridine 
was treated in the Appel conditions11 with CBr4. The same results were 
obtained when using the 2’ CH2Cl group. These outcomes are in 
agreement with a strong interaction of the pyridine lone pair with the 2’ 
carbon, leading to prompt cyclization when a good leaving group such as 
chloride or bromine is present. 
From an alternative point of view, this interaction could also be 
rationalized as a pre-transition state complex for the SN2 reaction, where 
the correct approach of the nucleophilic lone pair of the nitrogen can be 
achieved only in the TS planar geometry and the X substituent acts as a 
“leaving group” (see Scheme 11). 
To further proof the validity of the CCSD(T) computational results, we 
prepared a series of compounds manageable to the dynamic NMR 
technique, reported in Figure 41. Compounds 6 – 8 bear two methyl 
groups in 3 and 5 position of the pyridine ring, compounds 9 and 10, one 
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methyl in position 3 and compounds 11 - 14 bear two ethyl groups in 
position 3 and 5, to make the torsional barrier more hindered, without 
interfering with the electronic interaction of our interest. 
 
Figure 41. List of prepared pyridine type compounds. 
For convenience of synthesis,the model compounds 6 – 8 were prepared 
by a Ziegler-type addition12 of 2-ethylphenyllithium, [2-
(dimethylamino)methyl]-phenyllithium and 2-(methoxymethyl) 
phenyllithium13 onto 3,5-dimethylpyridine followed by spontaneous 
lithium hydride elimination at ambient temperature. Compounds 9 - 10 
were obtained by Suzuki-Miyaura cross coupling between 2-bromo-3-
methylpyridine and suitable 2’-substituted phenylboronic acids. 2',3,5-
Trimethyl-2-phenylpyridine lacks diastereotopic nuclei and is hence 
unsuitable for dynamic NMR spectroscopy. To remedy this shortcoming 
another set of model compounds (11 – 14) was designed and prepared by 
adding the suitable aryllithium onto the 2-position of 3,5-diethylpyridine 
and to rely again on thermal rearomatization. 
As proven by the identity, within the experimental error, of the rotational 
barriers of compounds 8 and 9, the methyl in the 5 position of pyridine 
does not influence the torsional barrier by inductive contribution in the 
TS geometry. The torsional barriers of the model compounds, as 
determined by line shape analysis of NMR spectra recorded at variable 
temperature (example in Figure 42), convey an unequivocal message: 
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electronegative substituents (N, O, F) lower the activation energy for the 
rotation about the 2-pyridyl–aryl axis substantially (Table 10).  
 
 
Figure 42. (Left) Temperature dependence of the 1H benzylic CH2 
signal of compound 9 (600 MHz in CD3CN). (Right) Line shape 
simulation obtained with the rate constants reported. 
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Table 10. Experimental and calculated torsional barriers. 
Calculations at the CCSD(T)/6-31+G(d)//ωB97XD/6-31G(d) level. 
Compound X Exp. Barrier Calcd. 
6 Me 13.1 13.1 
7 NMe2 12.8 15.0 
8 OMe 11.1 - 
9 OMe 10.9 14.2 
10 F 8.8 10.5 
11 H 13.7 - 
12 Me 14.4 - 
13 NMe2 14.7 - 
14 OMe 12.6 - 
 
The key role played by the pyridine lone pair in the stabilization of the 
coplanar transition state can be confirmed by preparing the analogous 
biphenyls 15 – 18 (Figure 43) where the methoxy group was installed in 
the 2’ position of phenyl to tune the rotational barriers to values similar to 
that of compounds 6 – 14. In this series of compound the oxygen lone 
pairs does not influence the rotational barrier because the preferred 
transition state is that with the CH2X group anti to the OMe group. 
 
Figure 43. List of prepared biphenyl compounds. 
DFT calculations suggested that in this series of compounds the rotational 
barrier were very similar on varying the X substituent. Between the two 
feasible TS, the preferred one corresponds to a C2-C1-C1’-C2’ dihedral 
angle close to 180° to reduce the steric clash between the methoxy and 
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CH2X. Within this series of compounds, the preferred conformation of 
the CH2X group in the best transition state was always the skewed one. 
The experimental rotational barriers of these biphenyls were indeed found 
to be clustered in a very small range (less than 1 kcal/mol, see Table 11), 
thus confirming that all the CH2-X groups have almost identical steric 
barriers.  
Table 11. Experimental and Calculated Torsional Barriers. 
Calculations at the CCSD(T)/6-31+G(d)//ωB97XD/6-31G(d) level. 
Compound X Exp. Barrier Calcd.
14 Me 15.9 - 
15 NMe2 15.5 - 
16 OMe 15.1 - 
17 F 15.1 - 
 
The concept of long-range resonance interactions opens new 
perspectives. For example, it will be intriguing to compare the loosening 
of carbon–heteroatom bonds as experienced in the model compounds 
with Mayr's nucleofugality parameters.14 
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Application of conformational analysis to the absolute 
configuration determinantion 
Absolute configuration of substituted 1,2,3,4-
tetrahydroquinolines1 
The 1,2,3,4-tetrahydroquinoline skeleton is the core of a variety of 
biologically active compounds (natural and synthetic), making it a key 
structural element in medicinal chemistry.2 Among the diﬀerent methods 
for the preparation of these compounds, the inverse electron demand aza 
Diels–Alder reaction between olefins and N-aryl imines (Povarov 
reaction)3 is one of the most eﬃcient, versatile and atom-economical. 
Recently, the catalytic asymmetric version of this reaction has gained 
great progress.4 Bernardi and co-workers, taking advantage of thier 
experience in chiral phosphoric acid catalyzed cycloaddition reactions,4d,5 
focused their work in developing the enantioselective vinylogous 
Povarov reaction, known that the non-enantioselective counterpart has 
been reported.6 
The reaction has been developed from enecarbamantes 2, and first 
screening of reaction conditions lead to the choice of 4 as catalyst, 
operating at room temperature with toluene as solvent. (See Scheme 12) 
Then a broad scope for the reaction has been developed, with great yields 
and enantioselectivities. 
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Scheme 12. Vinylogous Povarov reaction. 
Compound 3k was selected as representative compound for the 
determination of the relative and absolute configuration by a combination 
of conformational analysis and theoretical simulations of chiro-optical 
spectra. 
3k 
The relative stereochemistry was determined by means of NMR 
spectroscopy. Full assignment of the 1H and 13C spectra was preliminarily 
achieved by bi-dimensional experiments (COSY, gHSQC and gHMBC, 
taken in CDCl3 solutions). The two diastereotopic hydrogens belonging 
to C-3 were found at 1.89 and 2.11 ppm. The COSY spectrum showed 
they are coupled with the hydrogens at 3.66 and 4.49 ppm. The hydrogen 
at 3.66 ppm showed additional coupling with the signal at 4.93 ppm (H-
1). This allowed us to assign the signal at 3.66 ppm to H-4 and the signal 
at 4.49 ppm to H-2. The proton at 4.93 ppm, that is coupled with the 
signal at 6.64 ppm with a coupling constant of 14.1 Hz provided evidence 
of the E-geometry of the exocyclic double bond. The signals of the 
tetrahydroquinoline NH at 3.42 ppm and of the carbamate NH (6.45 ppm, 
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doublet, J = 10.8 Hz) were assigned by the lack of correlation in the 13C-
1H HSQC spectrum. One of the signals of the two diastereotopic protons 
at C-3 appears as a pseudo-quartet, with a large coupling constant (J = 
12.4 Hz, H-3b in Figure 44). This implies that this proton is coupled with 
three hydrogens with similar and large coupling constants, which are 
consistent with the geminal coupling with H-3a and trans-diaxial 
couplings with H-2 and H-4, due to a dihedral angle close to 180°.7 This 
clearly indicates that both H-2 and H-4 are in pseudo-axial position on 
the tetrahydroquinoline ring, whereas the phenyl and the ene-carbamate 
moiety occupy the pseudo-equatorial positions. As a confirm, the signal 
of H-3a (the second diastereotopic hydrogen of C-3) exhibits the same 
large geminal constant (12.4 Hz) and two small coupling constants due to 
the equatorial-axial coupling, where the dihedral angle is close to 90°. 
 
Figure 44. Expansion of the 1H spectrum (600 MHz in CDCl3) of 3k 
showing the signals of the two diastereotopic hydrogens of C-3. 
Mono-dimensional DPFGSE-NOE experiments8 were acquired in order 
to confirm the relative stereochemistry at C-2 and C-4. On saturation of 
the vinylic hydrogen H-1’ (trace a in Figure 45), NOE enhancement was 
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observed for one proton at C-3 (H-3b, in pseudo-axial position) and no 
enhancement was observed for the other ene-carbamate proton H-2’. This 
confirms the E geometry of the double bond. The large NOE on H-3b 
suggests that H-1’ is anti to H-4. On saturation of H-4, NOE are observed 
on H-2 (trace c inFigure 45) and on the signal of H-3a (in pseudo-
equatorial position). On saturation of H-2 (trace b in Figure 45), NOE are 
observed for H-4 and for H-3a, thus confirming the 1-3 diaxial 
relationship of H-2 and H-4, already deduced from the analysis of the J-
couplings of the 1H NMR spectrum. NMR analysis thus confirms the cis 
relative configuration of the two asymmetric centres of the 1,2,3,4-
tetrahydroquinoline skeleton (thus 2R*,4S*), and the E-geometry of the 
exocyclic double bond. Having in hand the relative configuration and 
suitable information about the preferred conformation, the assignment of 
the absolute configuration was tackled by chiro-optical methods. 
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Figure 45. DPFGSE-NOE spectra of 3k (600 MHz in CDCl3). 
(Bottom) 1H-NMR control spectrum; trace a) saturation of H-1’; trace 
b) saturation of H-2; trace c) saturation of H-4. 
The theoretical calculation of the electronic circular dichroism spectra 
(ECD) was selected for the absolute configuration assignment. Although 
the rigidity of the 1,2,3,4-tetrahydroquinoline core of compound 3k helps 
in the reduction of the number of conformations to be considered,9 the 
conformational freedom of the exocyclic ene-carbamate moiety represent 
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a challenging issue for the conformational analysis step. As the first 
stage, we performed a conformational search on a model compound 
where all the ene-carbamate moiety (CH=CH-NH-Cbz) was reduced to a 
methyl group (model compound Me-3k). 
 
All the conformations found by MM search within a 10 kcal/mol window 
(Monte Carlo searching together with the MMFF94 molecular mechanics 
force field as implemented in Titan 1.0.5, Wavefunction inc.) were then 
optimized using DFT at the B3LYP/6-31G(d) level. The harmonic 
vibrational frequencies of each conformation were calculated at the same 
level to confirm their stability (no imaginary frequencies were observed) 
and to evaluate the free energy of each conformation. After DFT 
minimization, only two conformations were found to be enclosed in the 
10 kcal/mol window, and one of them (conformation a in Figure 46) was 
much more stable than the other (conformation b). Conformation b 
differs from a because of the different shape of the six-membered ring, 
that corresponds to a pseudo-boat conformation where the phenyl ring 
and the methyl occupy a pseudo-axial position. The energy gain (3.25 
kcal/mol as internal energy difference, 3.71 kcal/mol as ZPE-corrected 
free energy) suggest that a should be the only populated conformer in 
solution. (Figure 46). 
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Figure 46. 3D view of the two conformations of the model compound 
Me-3k with a methyl group in position 4. Reported energies are in 
kcal/mol. 
The electronic excitation energies and rotational strengths have been 
calculated for the isolated molecule in the gas phase for the best 
conformation of Me-3k using TD-DFT with four different methods 
(functionals), to ascertain if different computational approaches provide 
different shapes of the simulated spectra. Simulations were performed 
with the hybrid functionals BH&HLYP and M06-2X, the Long-range 
Correlated LC-ωB97XD that includes empirical dispersion, and CAM-
B3LYP that includes long range correction using the Coulomb 
Attenuating Method. The calculations employed the 6-311++G(2d,p) 
basis set that proved to be sufficiently accurate at a reasonable 
computational cost. Rotational strengths were calculated in both length 
and velocity representation, the resulting values being very similar (RMS 
differences < 5%). For this reason the errors due to basis set 
incompleteness should be very small, or negligible.  
As shown in Figure 47, the simulated spectra match the Cotton effects at 
190 nm and 203 when the 2S, 4S absolute configuration is assumed in the 
calculations. However, the lower energy Cotton effect at 229 nm is not 
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reproduced by the calculations. This means that the contribution of the 
ene-carbamate moiety on the ECD spectrum cannot be ruled out. Thus 
the simulation of the ECD spectra must be performed on the whole 
structure of 3k. 
 
Figure 47. Black line: experimental ECD spectrum of 3k. Colored 
lines: TD-DFT simulated spectra calculated for Me-3k. All the 
simulated spectra were red-shifted by 15 nm to match the 
experimental maximum at 203 nm. 
Starting from the best conformation of Me-3k, a new conformational 
search was the performed on 3k. After DFT optimization, two 
conformations were found to be very close in energy. Both exibit the 
pseudo-chair conformation of the tetrahydroquinoline ring and they are 
different because of the E/Z rotational isomerism of the amidic part of the 
carbamate. If the internal energy is considered, the Z conformation is 
favoured by 1.18 kcal/mol. On the contrary, the E conformation is more 
stable by 0.38 kcal/mol when the free energies obtained by 
thermochemistry corrections are applied. 
Apart from the E/Z rotational isomerism, the calculated geometry of 
conformations 3k-a and 3k-b are in good agreement with the 
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experimental NOE data, whereas one of the two hydrogens belonging to 
C-3 (H-3b) has dihedral angles close to 180° with H-2 and H-4 (179° and 
168°, respectively). Also the position of H-1’ corresponds to the distance 
constraints extracted by NOE data, with an anti-relationship with H-4.  
 
Figure 48. 3D view of the two most stable conformation of 3k, 
calculated at the B3LYP/6-31G(d) level. Energy differences are in 
kcal/mol and represent ZPE–corrected free energy in standard 
conditions (G°) or uncorrected internal energies (E). 
Variable temperature NMR spectra, taken down to -15°C in CD3CN , 
showed that the E/Z interconversion due to rotation of the carbamate 
could be frozen in the NMR timescale. The ratio of the two 
conformations due to E/Z isomerism was 90:10, corresponding to a ∆G° 
= 1.1 kcal/mol. at +25°C. Unfortunately, NOE spectra can’t ascertain 
whether the Z or the E rotamer was the more populated conformation. 
DFT calculations of the chemicals shifts at the B3LYP/6-311++G(2d,p) 
level (GIAO approach ) suggested that the chemical shift of the NH-Cbz 
hydrogen in the E-conformer is shielded by 0.35 ppm in the E-rotamer 
with respect to the NH of the Z-conformer. Since the upfield signal 
experimentally corresponds to the most populated conformer, this 
theoretical result agrees well with the calculations based on the free 
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energies and it assigns the E-conformation (b in Figure 48) as the more 
stable rotamer in solution. 
The electronic excitation energies and rotational strengths were 
calculated in the gas phase for the two conformation of 3k using TD-DFT 
with the same four different methods (functionals) and basis sets used for 
Me-3k (BH&HLYP, M06-2X, LC-ωB97XD, and CAM-B3LYP with 6-
311++G(2d,p) basis set). All the calculations were performed supposing 
2S, 4R Absolute Configuration, with the results shown in Figure 49. 
 
Figure 49. TD-DFT simulated spectra calculated for 3k. The reddish 
set of lines correspond to conformation a (Z-rotamer). The bluish set 
correspond to conformation b (E-rotamer). 
As shown in Figure 49, the simulated spectra are similar within the same 
conformation, but the two conformations show quite different spectra. In 
particular, they show opposite phase in the high energy region between 
200 and 180 nm. However, the experimental ratio to be used to get the 
averaged spectrum was provided by low-temperature NMR. The 
simulated spectra were then obtained by using a 86:14 ratio, 
corresponding to a ∆G° = 1.1 kcal/mol at +25°C. (Figure 50). It should be 
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stressed that if the opposite ratio of the rotamers is used the agreement is 
still acceptable, but the wavelength of the highest energy Cotton does not 
match to the experimental value. From an alternative point of view, the 
ECD spectrum confirms the conformational preference toward the Z-
rotamer of the ene-carbamate.  
 
Figure 50. Simulations of the experimental ECD spectrum of 3k 
(black traces). obtained with different methods of calculation. Each 
simulated spectrum (red, blue, green and purple lines) was obtained 
starting from the spectra obtained for the two conformations 
weighted using the experimental NMR data (86:14). The 
experimental spectrum of 3k was obtained in acetonitrile solution 
(5.5 10-5 M, 0.2 cm path length). Δε are expressed in Mol L-1 cm-1. The 
simulated spectra were vertically scaled to match the experimental 
maximum at 203 nm (0.35, 0.40, 0.43 and 0.20 for CAM-B3LYP, 
BH&HLYP, M06-2X and LC-ωB97XD, respectively) and red shifted 
(by 15, 20,15 and 15 nm, respectively). 
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The best simulation was obtained by the M06-2X functional, but all the 
simulated spectra now show a good agreement with the experimental one, 
also in the 230 nm region. Thus the absolute configuration could be 
reliably assigned as 2S,4R, which is in agreement with the proposed 
reaction mechanism. 
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Absolute configuration of compounds from enantioselective 
Friedel-Crafts alkylation-acetalization cascade of naphthols 
with α,β-unsaturated cyclic ketones1 
The Friedel–Crafts (F–C) reaction represents one of the most well known 
ways for the generation of a new C–C bond between an electron-rich 
aromatic system and a suitable electrophile.2 During the last few years 
this reaction has been performed in enantioselective fashion, via 
organocatalysis.3 Organocatalytic F–C alkylation has been intensively 
explored under diﬀerent activation modes and using a large number of 
chiral catalysts: Brønsted acid,4 thiourea,5 base catalyzed reactions6 and 
aminocatalytic strategy mainly based on chiral seconday amines.7 
Exploiting the capability of primary amine catalysts, in particular based 
on the Cinchona alkaloid structure,8 Bencivenni and co-workers 
developed a new asymmetric organocascade9 reaction of F–C alkylation, 
followed by acetalization, between naphthols and α,β-unsaturated 
ketones. (Scheme 13) 
 
Scheme 13. F-C alkylation acetalization cascade. 
The reaction between cyclohexenone 1a and β-naphthol 2a was chosen as 
model and after the screening of different primary amines, they found 
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that amino(9-deoxy)epi-quinine (10) in combination with 5-nitrosalicylic 
acid (5-NO2-SA) was able to catalyze the reaction in toluene at 40 °C 
giving 3aa as a single diastereoisomer in 88% yield and 81% ee after 72 
hours. Then a broad scope for this reaction has been prepared, with 
different enones and a series of variously decorated α and β-naphthols, 
with good yields and enantioselectivities. (For all reaction details and 
substituents on the reagents, see reported paper in Ref[1]). 
Finally the reactivity of 1H-inden-1-ones (7a-d) have been explored, 
using ent-10 as catalyst (see Scheme 14). Given the severe steric 
hindrance10 of these substrates, the desired compounds 8aa – 9dc were 
isolated in high yields and enantioselectivities. 
 
Scheme 14. F–C alkylation of 1H-inden-1-ones with α- and β-
naphthols. 
The absolute configuration was found for compound 8de by means of X-
ray analysis and for compounds 8aa and 9bb, as well as for compounds 
5da – 3ab, by means of TD-DFT ECD simulation. 
Compounds 8 
Good crystals suitable for X-ray diffraction were obtained for compound 
8de by slow evaporation of a methanol solution. The anomalous 
scattering determination of the absolute configuration was possible 
thanks to the presence of the chlorine atom. The S configuration was 
129 
 
determined for the selected crystal and its relationship to the major 
enantiomer obtained with ent-10 catalyst was confirmed by means of 
enantioselective HPLC analysis of the very same crystal used for X-ray 
analysis (this was not straightforward, since the crystals were obtained 
from a 81% ee mixture of enantiomers).The crystal cell contained two 
conformations of the S enantiomers, that were different in the orientation 
of the OMe group on the naphthalene ring. 
 
Figure 51. X‐Ray structure of 8de. Two different conformations with 
the same S absolute configuration represent the asymmetric unity. 
Since the prepared compounds belong to four different classes, a straight 
relationship of the stereochemical course of the reaction is likely, but in 
principle it cannot be safely assumed. However, despite many attempts, 
enantiopure crystals of other compounds containing a suitable heavy 
atom cannot be obtained. In the remaining cases, the X-ray analysis 
cannot determine the absolute configuration. For these reason we 
switched to a different approach based on conformational analysis and 
chirooptical methods (ECD). 
From a conformational point of view, the rigidity of the scaffold of 
compounds 3, 5, 8 and 9 reduces the number of conformations to be 
considered and simplify the conformational analysis. In addition to this, 
the configuration assignment by chirooptical methods of a sample 
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compound of the 8 series can provide information on the reliability of this 
method applied to the present compounds. 
A preliminary conformational search on 8aa was carried out using Monte 
Carlo method together with the MMFF94 molecular mechanics force 
field (as implemented in Titan 1.0.5, Wavefunctioninc.). All the 
conformations within a 10 kcal/mol window were then optimized using 
DFT at the B3LYP/6-31G(d) level , the harmonic vibrational frequencies 
of each conformation were calculated at the same level to confirm their 
stability (no imaginary frequencies were observed) and to evaluate the 
free energy of each conformation. 
O
OH
8aa  
Figure 52. 3D view of the two most stable conformations of 8aa, 
calculated at the B3LYP/6‐31G(d) level. Energy differences are in 
kcal/mol and represent ZPE–corrected free energies in standard 
conditions. 
After DFT minimization only two conformations were found to be 
enclosed in the 10 kcal/mol window (Figure 52). These correspond to two 
conformational diastereoisomers due to the rotation on the indane ring 
that is almost perpendicular to the naphthol ring in the ground states. The 
electronic excitation energies and rotational strengths have been 
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calculated in the gas phase for the two conformations of 8aa using TD-
DFT with four different methods (functionals) to ascertain if different 
calculations provide different shapes of the simulated spectra. The 
simulation were performed with the functionals BH&HLYP, M06-2X, 
LC-ωB97XD and CAM-B3LYP. All the calculations employed the 6-
311++G(2d,p) basis set, that proved to be sufficiently accurate at a 
reasonable computational cost. 
 
Figure 53. ECD simulations for the two conformations of 8aa, 
obtained with the four different functionals and the same 
6‐311++G(2d,p) basis set. 
The rotational strengths were calculated in both length and velocity 
representation with the resulting values being very similar. For this 
reason the errors due to basis set incompleteness should be considered 
very small, or negligible.11 All the calculations were performed supposing 
S Absolute Configuration, with the results shown in Figure 53. The eight 
simulated spectra are divided into two set of opposite shaped spectra 
(reddish lines and bluish/greenish lines), each one corresponding to one 
of the two conformations of 8aa. The opposite pattern can be attributed to 
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the excitonic coupling12 to the two chromophores, i.e. the naphtyl and the 
indane ring, that have opposite helicity in the two conformations (R*M* 
in conformation a and R*P* in conformation b). Therefore the shape of 
the simulated spectrum that should be compared with the experimental 
one strongly depends on the population ratio employed. Unfortunately, 
the calculated energies of the two conformations are very similar (∆G° = 
0.12 kcal/mol), thus a correct evaluation of the populations13 is 
completely unreliable. This imply that the AC assignment is unfeasible 
without further experimental data. 
 
Figure 54. Variable temperature spectra (1H-NMR at 400 MHz in 
DMSO‐d6) of compound 8aa. The signal of the CH of the indanone 
ring is showed. The asterisk marks a solvent impurity. 
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However, the conformational analysis of 8aa showed that the indane ring 
is forced to be perpendicular to the naphthol ring by the steric hindrance 
exerted by the OH and the peri hydrogen (H-8). If the interconversion 
barrier is sufficiently high, two observable conformational 
diastereoisomers could be generated. This is what actually happened. 1H 
NMR showed two sets of signals in a 69:31 ratio due to the frozen 
rotation around the Cα - CH bond. When the temperature is raised the 
two multiplets broadens and show a single peak at +120°C, when the 
rotation is fast in the NMR time scale, (Figure 54). An energy barrier of 
17.8 kcal/mol was derived at the coalescence temperature (+90°C). 
NOE spectra where then acquired to determine which conformational 
diastereoisomer is the more populated. In the a diastereoisomer the CH 
hydrogen of indane is close to the peri H-8 hydrogen of the naphthol ring 
(1.87 Å), whereas in the b conformation the CH points towards the OH 
and it is far from H-8. DPFGSE-NOE14 spectra obtained on saturation of 
the two CH signals showed that the major conformation has the CH close 
to H-8 and the minor has the CH close to OH (Figure 55). 
In the present case the integration of the NMR spectra and the NOE 
spectra provide the exact ratio of the two conformational 
diastereoisomers to be used in the simulation of the experimental ECD 
spectrum. 
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Figure 55. DPFGSE-NOE spectra of 8aa (600 MHz in DMSO-d6). 
(Bottom) control spectrum. (Middle trace) NOE obtained on 
saturation of the major CH. (Top) NOE spectrum obtained on 
saturation of the minor CH. (in both NOEs the small inverted peak 
of the second diastereoisomer was due to saturation transfer effects). 
The simulated ECD spectrum was thus obtained for each model of 
calculation by taking into account the 69:31 populations ratio 
experimentally determined by NMR. All the four simulations obtained 
(Figure 56) display now a good agreement with the experimental 
spectrum and the best simulation was obtained with the BH&HLYP 
functional. Provided the experimental ratio of the two conformations,15 
the ECD simulations showed to be able to tackle the absolute 
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configuration of 8aa. 
 
Figure 56. Simulations of the experimental ECD spectrum of 8aa 
(black traces) obtained with different methods of calculation 
(functionals). Each simulated spectrum (red, blue, green and purple 
lines) was obtained starting from the spectra obtained for the two 
conformations weighted using the experimental NMR data. The 
experimental spectrum of 8aa was obtained in acetonitrile solution (1 
10-4 M, 0.2 cm path length). Δε are expressed in Mol L-1 cm-1. The 
simulated spectra were vertically scaled to match the experimental 
intensity and red shifted to match the experimental peak at 238 nm. 
Compounds 9 
No compound of the 9 series could be crystallized as single crystals and 
the assignment of 9bb was performed by means of same chirooptical 
methods used for 8aa. As in the previous case, 9bb has two 
conformations found by conformational analysis and subsequent DFT 
optimizations have the CH pointing towards the OH (a conformation) and 
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the CH in position 3 (b conformation), respectively. In this case, 
however, the steric hindrance to the rotation of the indane ring is smaller 
and the 1H NMR spectrum recorded at room temperature does not show 
the signals corresponding to the two conformational diastereoisomers. 
However, since calculations estimated a very similar energy they should 
be both populated. For this reason, variable temperature NMR spectra 
were recorded down to -100°C. Below -60°C the signal of the CH 
broadened and split at -100°C into two signals with a 90:10 ratio. 
Following the trend observed for 8aa, the lower field signal (90%) can be 
attributed to the conformation in which the CH hydrogen is close to OH. 
Comfortably, this is also the lowest energy conformation and also the 
evaluation of the energy difference matched well the experimental ratio 
(calculated ∆G≠: 0.56 kcal/mol; experimental: 0.75 kcal/mol at -100°C). 
By applying Boltzmann statistics, the ratio at room temperature is 78:22. 
O
OH
F
Cl9bb  
Figure 57. 3D view of the two stable conformations of 9bb, calculated 
at the B3LYP/6-31G(d) level. Energy differences are in kcal/mol and 
represent ZPE–corrected free energies in standard conditions. 
The rotational strengths and electronic excitation energies were 
calculated in the gas phase for the two conformations of 9bb using TD-
DFT and the same four different methods used for 8aa. All the 
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calculations employed the 6-311++G(2d,p) basis set and supposing S 
Absolute Configuration (Figure 58). 
As for 8aa, the opposite helicity generated by the out-of-plane disposition 
of the indane ring yields two set of calculated ECD spectra with opposite 
pattern. However, when the final simulated spectra are obtained using the 
population ratio determined by low-temperature NMR, the agreement 
with the experimental trace is very good (Figure 59), and the S absolute 
configuration can be assigned to compound 9bb. In addition to this, the 
agreement of the four methods and the similarity of the spectra enhances 
the reliability of the assignment. 
 
Figure 58. TD-DFT simulations for the two conformations of 9bb, 
obtained with the four functionals and the 6-311++G(2d,p) basis set. 
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Figure 59. Simulations of the experimental ECD spectrum of 9bb 
(black traces) obtained with different methods of calculation. Each 
simulated spectrum (red, blue, green and purple lines) was obtained 
starting from the spectra obtained for the four conformations 
weighted using Boltzmann statistics at +25°C. The experimental 
spectrum was obtained in acetonitrile solution (1 10-4 M, 0.2 cm path 
length). Δε are expressed in Mol L-1 cm-1. The simulated spectra were 
vertically scaled to match the experimental intensity, and red shifted 
to match the experimental maxima. 
Compounds 5 
As reported in the text, compounds 5 correspond to the hemiacetalic 
form. Form a conformational point of view, these structures are 
completely blocked, and only one conformation is supposed to be 
populated. This correspond to the chair conformation of the cyclohexane 
part of the bicyclic system. Compound 5da, containing a phenyl group in 
position 4 was selected for the spectroscopic analysis because the 
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presence of a second chromophore that could couple with the naphthalene 
ring to cause a stronger ECD spectrum. 
O
HO
Ph 5da
 
Figure 60. (Left) 3D view of the optimized conformation of 5da, 
calculated at the B3LYP/6-31G(d) level. The chair-shaped 
cyclohexane ring is shaped. (Center) 1H multiplet of the CH in 
position 4 showing the trans-diaxial and axial-equatorial coupling 
constants. (Right) X-ray structure of 6da. 
The analysis of the 1H spectrum of compound 5da showed that the 
phenyl ring in position 4 occupies the equatorial position. The signal of 
benzylic CH shows a trans-diaxial coupling constant of 12.8 Hz and an 
axial-equatorial constant of 4.6 Hz. The 2R*,4S*,6S* relative 
configuration can be therefore assumed in the following discussions 
(Figure 60). It is worth to note that the second diastereoisomer produced 
by the reaction (6da) does not evolve to the hemiacetalic form because in 
this compound the phenyl ring should occupy the axial position. 
Although the absolute configuration of 6da could not be established by 
anomalous scattering, the X-ray structure confirmed that the two chiral 
carbons have opposite chirality (thus 3R*,5S*). 
To exclude the presence of other low-energy conformations, the 
conformational search by MM methods was performed as above, but no 
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other conformations were found. As in the previous cases, DFT 
optimization at the B3LYP/6-31G(d) level provided the final geometry to 
be used in the TD-DFT simulations. The rotational strengths and 
electronic excitation energies were calculated in the gas phase by TD-
DFT and the same four different methods used for 8aa and 9bb. All the 
calculations employed the 6-311++G(2d,p) basis set and supposed S 
Absolute Configuration at the reaction center. (thus 2R,4S,6S) (Figure 
61). In this case the simulation of the experimental spectrum is 
straightforward, since no conformational averaging is needed and the four 
calculated spectra are very similar. As shown in Figure 61, the 
experimental trace is well matched by all the simulation obtained for the 
2R,4S,6S absolute configuration. 
 
Figure 61. TD-DFT simulations for 5da, obtained with the four 
different functionals and the 6-311++G(2d,p) basis set. The black line 
corresponds to the experimental spectrum obtained in acetonitrile 
solution (1 10-4 M, 0.05 cm path length). Δε are expressed in Mol L-1 
cm-1. The simulated spectra were vertically scaled to match the 
experimental intensity, and red shifted to match the experimental 
maxima. 
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Compounds 3 
Compounds 3 has the same hemiacetalic scaffold of compounds 5, thus a 
second chiral carbon is generated with complete stereocontrol during the 
cyclization. With respect to the cyclohexane scaffold the two substituents 
must occupy the 1-3 diaxial positions (Figure 62). Compound 3ab was 
selected for the stereochemical assignment. 
As in the case of 5, the bicyclic structure is very rigid, and only a single 
conformation was found by MM search. In this case, however, a second 
conformation with a boat-shaped cyclohexane cannot be excluded in 
principle. When optimized by DFT, this conformation showed to be 
about 5 kcal/mol higher in energy with respect to the conformation found 
by conformational search, and it can be neglected in the ECD 
simulations. Compound 3ab lacks a second chromophore on the 
cyclohexane ring and the experimental ECD is rather weak. However, the 
TD-DFT simulations performed assuming the 1S,5R absolute 
configuration satisfactorily followed the experimental trend (Figure 63). 
It should be pointed out that the same S configuration at the reaction 
center was assigned as in the three previous cases.  
O
Br
OH
3ab  
Figure 62. 3D view of the optimized conformation of 3ab, calculated 
at the B3LYP/6-31G(d) level. 
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Figure 63. TD-DFT simulations for 3ab, obtained with the four 
different functionals and the same 6-311++G(2d,p) basis set. The 
black line corresponds to the experimental spectrum obtained in 
acetonitrile solution (5 10-5 M, 0.2 cm path length). Δε are expressed 
in Mol L-1 cm-1. The simulated spectra were vertically scaled to 
match the experimental intensity, and red shifted to match the 
experimental maxima. 
References 
                                                     
1 Paradisi, E.; Righi, P.; Mazzanti, A.; Ranieri, S., Bencivenni, G. Chem. 
Commun. 2012, 48, 11178 – 11180. 
2 a) Friedel–Crafts Chemistry, ed. G. A. Olah, Wiley, New York, 1973. b) 
Bandini, M.; Melloni, A.; Umani-Ronchi, A. Angew. Chem., Int. Ed. 2004, 43, 
550 – 556. c) Catalytic Asymmetric Friedel–Crafts Alkylations, ed. M. Bandini 
and A. Umani-Ronchi, Wiley-VCH, Weinheim, 2009. d) Bolm, C.; Hildebrand, 
J. P.; Muiñz, K.; Hermanns, N. Angew. Chem., Int. Ed. 2001, 40, 3284 – 3308. e) 
Poulsen, T. B.; Jørgensen, K. A. Chem. Rev. 2008, 108, 2903 – 2915. f) 
Dalpozzo, R.; Bartoli, G.; Bencivenni, G. Symmetry 2011, 3, 84 – 125. g) 
Chauhan, P.; Chimni, S. S. RSC Adv. 2012, 2, 6117 – 6134. 
143 
 
                                                                                                                       
3 a) Terrasson, V.; de Figueiredo, R. M.; Campagne, J. M. Eur. J. Org. Chem. 
2010, 14, 2635 – 2655. b) You, S.-L.; Cai, Q.; Zeng, M. Chem. Soc. Rev. 2009, 
38, 2190 – 2201. 
4 a) Uraguchi, D.; Sorimachi, K.; Terada, M. J. Am. Chem. Soc. 2004, 126, 
11804 – 11805. b) Seayad, J.; Seayad, A. M.; List, B. J. Am. Chem. Soc. 2006, 
128, 1086 – 1087. c) Rueping, M.; Nachtsheim, B. J.; Moreth, S. A.; Bolte, M. 
Angew. Chem., Int. Ed. 2008, 47, 593 – 596. d) Duce, S.; Pesciaioli, F.; 
Gramigna, L.; Bernardi, L.; Mazzanti, A.; Ricci, A.; Bartoli, G.; Bencivenni, G.; 
Adv. Synth. Catal. 2011, 353, 860 – 864. 
5 a) Herrera, R. P.; Sgarzani, V.; Bernardi, L.; Ricci, A. Angew. Chem., Int. Ed. 
2005, 44, 6576 – 6579. b) Taylor, M. S.; Jacobsen, E. N. J. Am. Chem. Soc. 
2004, 126, 10558 – 10559. c) Ganesh, M.; Seidel, D. J. Am. Chem. Soc. 2008, 
130, 16464 – 16465. 
6 a) Marcelli, T.; Hiemstra, H. Synthesis 2010, 8, 1229 – 1279. b) Chauhan, P.; 
Chimni, S. S. Eur. J. Org. Chem. 2011, 9, 1636 – 1640. 
7 a) Paras, N. A.; MacMillan, D. W. C. J. Am. Chem. Soc. 2001, 123, 4370 – 
4371. b) Paras, N. A.; MacMillan, D. W. C.; J. Am. Chem. Soc. 2002, 124, 7894 
– 7895. c) Chi, Y.; Scroggins, S. T.; Fréchet, J. M. J. J. Am. Chem. Soc. 2008, 
130, 6322 – 6323. d) Nicolaou, K. C.; Reingruber, R.; Sarlah, D.; Bräse, S. J. 
Am. Chem. Soc. 2009, 131, 2086 – 2087.  
8 a) Bartoli, G.; Melchiorre, P. Synlett, 2008, 12, 1759 – 1772. b) Chen, Y.-C. 
Synlett, 2008, 13, 1919 – 1930. c) Melchiorre, P. Angew. Chem., Int. Ed., 2012, 
39, 9748 – 9770.  
9 a) Grondal, C.; Jeanty, M.; Enders, D. Nat. Chem. 2010, 2, 167 – 178. c) 
Nicolaou, K. C.; Edmonds, D. J.; Bulger, P. G. Angew. Chem., Int. Ed. 2006, 45, 
7134 – 7186. 
10 De Vincentiis, F.; Bencivenni, G.; Pesciaioli, F.; Mazzanti, A.; Bartoli, G.; 
Galzerano P.; Melchiorre, P. Chem. Asian J. 2010, 5, 1652 – 1656. 
144 
 
                                                                                                                       
11 Stephens, P. J.; McCann, D. M.; Devlin, F. J.; Cheeseman, J. R.; Frisch, M. J 
J. Am. Chem. Soc. 2004, 126, 7514 – 7521. 
12 a) Harada, N.; Nakanishi, K. Acc. Chem. Res. 1972, 5, 257 – 263. b) Harada, 
N.; Nakanishi, K. Circular Dichroic Spectroscopy: Exciton Coupling  in Organic 
Stereochemistry; University Science Books: Mill Valley, CA, 1983. c) Circular 
Dichroism: Principle and Applications; Berova, N.; Nakanishi, K.; Woody, 
R.W. Eds; VCH: New York, 2000; Chapter 12, p 337. 
13 Mazzeo, G.; Giorgio, E.; Zanasi, R.; Berova, N.; Rosini, C. J. Org. Chem. 
2010, 75, 4600 – 4603. 
14 a) Stott, K.; Stonehouse, J.; Keeler, J.; Hwand, T. L.; Shaka, A. J. J. Am. 
Chem. Soc. 1995, 117, 4199 – 4200. b) Stott, K.; Keeler, J.; Van, Q. N.; Shaka, 
A. J. J. Magn. Resonance 1997, 125, 302 – 324. c) See also: High Resolution 
NMR Techniques in Organic Chemistry. Claridge, T. D. W. Pergamon: 
Amsterdam, 1999. 
15 Casarini, D.; Lunazzi, L.; Mancinelli, M.; Mazzanti, A.; Scafato. P. Chirality 
2009, 21, 16 – 23. 
145 
 
Absolute configuration of substituted 3,4-annulated indoles1 
The construction of enantioenriched carbo- and hetero-cycles by domino 
organocatalytic processes has been intensively studied in the last few 
years.2 In this context, great focus has been set on the preparation of 
various benzo-fused heterocycles, by using aromatic rings bearing 
nucleophilic and electrophilic moieties in ortho positions in combination 
with activated olefins.3 These organocatalytic sequences are generally 
initiated by a hetero-Michael4 addition of a sulphur, oxygen or nitrogen 
nucleophile, which promotes the formation of an enolate/enamine that 
adds to the ortho electrophile terminating the cascade reaction. An 
elimination step, or an additional cyclization event, eventually follows. In 
particular, the cascade of iminium ion and enamine catalyses,5 in which a 
nucleophilic enamine is formed upon the conjugated addition to an enal 
or an enone activated by an amine catalyst, has been particularly eﬀective 
in these cascade processes.2 On these grounds, we hypothesized that 4-
substituted indoles 1 could be productively engaged in organocatalytic 
iminium ion–enamine cascade reactions, giving a new synthetic route to 
3,4-annulated indoles (Scheme 15). 
 
Scheme 15. Reaction between 1 and acrolein 2 with the selected 
catalyst 4d. 
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We envisaged that the indole C-3 of polyfunctional compounds 1 could 
act as a nucleophile in an iminium ion promoted Friedel–Crafts (F–C)6 
process, triggering an intramolecular Michael addition7 of the enamine to 
the activated double bond placed at its ortho position. The resulting all-
carbon 3,4-ring fused indole core (1,3,4,5-tetrahydrobenzo[cd]indole) of 
products 3 is widespread in natural products and biologically relevant 
compounds, as exemplified by the ergot alkaloid family8 and by steroidal 
indoles.9 Bernardi and co-workers selected the indole 1a as first substrate 
and acrolein 2a as the enal partner. After the screenings, the optimal 
catalyst and all other conditions have been found and a library of 3,4-
annulated indoles 3 have been prepared. 
 
Scheme 16. Synthetic manipulations in the products 3. (Top) Pinnick 
conditions. (Bottom) Robinson annulation. 
The possibility of performing synthetic manipulations in the products 3 
was briefly explored (Scheme 16). Treatment of 3a under Pinnick 
conditions6a oxidized both the aldehyde and the indole, furnishing the 
intriguing spirocyclic lactone 5, whereas a Robinson annulation reaction10 
rendered the tetracyclic derivative 6 as a mixture of diastereoisomers, due 
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to a partial epimerisation of the chiral centre a to the aldehyde during the 
reaction.  
The absolute configuration was found for compound 3a and 3h, as well as 
for compounds 6, by means of TD-DFT ECD simulation. 
All the attempts to obtain good crystals of the prepared compounds were 
not successful. Moreover, with the exception of 3c, a suitable heavy atom 
(Z > Si using standard Mo-Kα radiation11) was not available for the 
assignment of the absolute configuration by the anomalous dispersion X-
ray method.12 For this reason the relative and absolute configuration was 
determined by a combination of conformational analysis and theoretical 
simulations of ECD spectra. Compound 3a was selected as representative 
compound. 
3a 
The relative stereochemistry of the two stereogenic centres at C-4 and C-
5 was determined by means of NMR spectroscopy. Full assignment of the 
1H and 13C spectra was preliminarily achieved by bi-dimensional 
experiments (gHSQC and gHMBC, taken in CDCl3 solutions). The two 
diastereotopic hydrogens belonging to C-3 were found at 3.00 and 3.38 
ppm whereas the two diastereotopic hydrogens belonging to C-9 were 
found at 2.77 and 2.85 ppm (by long-range correlation with the C=O). 
The latter showed an additional coupling with the signal at 4.14 ppm (H-
5). The signal of the NH (7.98 ppm) was assigned by the lack of 
correlation in the 13C-1H HSQC spectrum. DPFGSE-NOE experiments13 
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were acquired in order to assign the relative stereochemistry at C-4 and 
C-5. These carbons bear respectively the CHO and the CH2COCH3 
moieties, that can assume a cis or trans relative disposition. On saturation 
of the aldehyde hydrogen (9.54ppm , trace b) in Figure 64), NOE 
enhancement was observed for H-5 and for one of the diastereotopic 
hydrogens at C-3 (3.38 ppm, H-3a). No enhancement was observed for 
the other hydrogen H-3b, and on the two hydrogens belonging to C-9. The 
observed NOEs suggested that the aldehyde and the CH2COCH3 
substituents lie on opposite sides of the exa-atomic cycle. On saturation 
of both the diastereotopic C-9 hydrogens (trace a) in Figure 64), large 
NOEs were observed at 4.14 ppm (H-5), 2.92ppm (H-4) and 3.0 ppm (H-
3b). While the first two NOEs have to be visible independently from the 
relative configuration of the two stereogenic centres, the latter confirmed 
that the CH2COCH3 group is on the opposite side of the cycle with 
respect to the CHO. On saturation of H-5 (trace c) of Figure 64), NOEs 
were observed on the aldehyde hydrogen, on the two hydrogens at C-9, 
but no enhancement was observed on the two hydrogens at C-3. This 
confirms that H-5 is occupies a pseudo-equatorial position. Finally, on 
saturation of the COMe signal (not shown in figure), NOE were observed 
only on H-9a and H-9b, suggesting that the COMe moiety adopts a 
conformation that places the methyl far from the cycle. NMR analysis 
thus suggests the trans relationship of the two stereogenico centres (thus 
4R*,5S* relative configuration). 
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Figure 64. DPFGSE-NOE spectra of 3a (600 MHz in CDCl3). 
(Bottom) 1H-NMR control spectrum; trace a) saturation of H-9; trace 
b) saturation of CHO; trace c) saturation of H-5. 
Although the rigidity of the heterociclic core of compound 3a helps in the 
reduction of the number of conformations to be considered,14 the 
conformational degrees of freedom due to the rotation of the aldehyde 
and CH2COCH3 moieties represent a challenging issue for the 
conformational analysis step. As the first stage, we performed a 
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conformational search on compound 3a, with the 4R*,5S*relative 
configuration. The whole conformational space was explored by means 
of Monte Carlo searching together with the MMFF94 molecular 
mechanics force field as implemented in Titan 1.0.5 (Wavefunctioninc.) 
3a 
All the conformations found by MM search within a 10 kcal/mol window 
were then optimized using DFT at the B3LYP/6-31G(d) level using the 
Gaussian 09 suite of programs. The harmonic vibrational frequencies of 
each optimized conformation were calculated at the same level to confirm 
their stability (no imaginary frequencies were observed) and to evaluate 
the free energy of each conformation. After DFT minimization, five 
conformations were found to be enclosed in a 2 kcal/mol window, as 
reported in Figure 65 and Table 12. All of them exhibit the same shape of 
the six-membered ring, that corresponds to a pseudo boat conformation 
where both the aldehyde and the CH2COCH3 moiety occupies a pseudo-
axial position. Conformation b differs from a because of the different 
disposition of the ketone chain, and they both have the CH of the 
aldehyde pointing towards the H-5. Conformations c and d have a 
different orientation of the aldehyde moiety, so the CH of the aldehyde is 
pointing toward H-3a. The relative internal and free energies suggested 
that all these conformations should be populated (Figure 65). 
To check whether a different theoretical level provide different results, 
the four ground states were optimized again at the M06-2X/6-31+G(d,p) 
level obtaining similar results. Conformation a is always the most stable, 
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and d the less stable, whereas the energies of b and c are reversed on 
varying the theoretical level of calculation. 
Table 12. Relative energies of the four conformations of 3a evaluated 
using ZPE-corrected free energies and different optimization levels: 
B3LYP/6-31G(d) and M06-2X/6-31+G(d,p). Populations are 
calculated using Boltzmann distribution at 298 K. 
Conform. 
G° 
(B3LYP) 
G°  
(M06-2X) 
Pop. 
(B3LYP) 
Pop. 
(M06-2X) 
a 0.0 0.0 48 53 
b 0.80 0.46 12 25 
c 0.20 0.79 34 14 
d 1.29 1.10 6 8 
 
Albeit with different intensity, NMR spectra showed large NOE effects 
on H-5 and H-3a when the CHO signal was saturated, thus confirming 
that both conformations of the CHO are populated in solution. The 
stronger NOE enhancement observed for H-5 confirms the 
conformational preference suggested by DFT calculations for the a-type 
conformation. The CHO-H5 and CHO-H3a calculated distances in 
conformations a and c are 2.30 and 2.33 Å respectively. Being the 
expected NOE almost equivalent, the observed difference can provide a 
good estimate of the experimental ratio of the conformations. The 
experimental NOE ratio was 63:37, that is matched very well by the ratio 
suggested by calculations (60:40 by B3LYP and 78:22 by M06-2X). 
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Figure 65. 3D view of the four conformations of the model compound 
3a. 
Having in hand the relative configuration and suitable experimental data 
supporting the preferred conformations, the assignment of the absolute 
configuration was tackled by ECD. The electronic excitation energies and 
rotational strengths have been calculated for the isolated molecule in the 
gas phase for the four conformation of 3a using TD-DFT with four 
different methods (functionals), to ascertain if different computational 
approaches provide different shapes of the simulated spectra (see Figure 
66). Simulations were performed with the four functionals: BH&HLYP,15 
M06-2X,16 ωB97XD17 and CAM-B3LYP.18 The calculations employed 
the 6-311++G(2d,p) basis set that proved to be sufficiently accurate at a 
reasonable computational cost. Rotational strengths were calculated in 
both length and velocity representation, the resulting values being very 
similar (RMS differences < 5%). For this reason the errors due to basis 
set incompleteness should be very small, or negligible.19 
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Figure 66. TD-DFT simulated spectra calculated for the four 
conformations of 3a using four different functionals (CAM-B3LYP, 
BH&HLYP, M06-2X, ωB97-XD) and the same 6-311++G(2d,p) basis 
set. For each conformation the first 50 excited states were calculated, 
and the spectrum was obtained using a 0.40 eV line width at half 
height. 
Although the spectra simulated within the same functional for the four 
conformation are quite different, they are nevertheless consistent with the 
simulation of the positive Cotton effect at about 220 nm, and with the 
negative part in the 240-260 nm region. The almost coincidence of the 
simulates spectra for the same conformation on varying the functional 
represent a good proof of the simulations consistency.  
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Figure 67. Simulations of the experimental ECD spectrum of 3a 
(black traces). For each section,the black line correspond to the 
experimental spectrum (acetonitrile solution, 1.5·10-4 M, 0.2 cm path 
length Δε in Mol L-1 cm-1). The red lines correspond to the 
simulations obtained using the populations derived from B3LYP/6-
31G(d) optimization. The blue linescorrespond to the simulations 
obtained using the populations derived from M06-2X/6-31+G(d,p) 
optimization.The simulated spectra were vertically scaled and red-
shifted by 7-14 nm to get the best match with the experimental 
spectrum. All the simulations are for the 4R, 5S absolute 
configuration. 
The population-weighted spectra to be compared with the experimental 
spectrum were obtained using the percentages of Table 12. As shown in 
Figure 67, the simulated spectra match well the Cotton effects at 224 nm 
and 270 nm when the 4R,5S absolute configuration is assumed in the 
calculations. The best simulation was obtained by the ωB97-XD 
functional, but all the simulated spectra show a good agreement with the 
experimental one. It has to be noted that the simulated spectra derived 
from the conformational geometries and energies obtained with 
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B3LYP/6-31G(d) optimization have the same level of accuracy with 
respect to those obtained with the more recent and computationally 
heavier M06-2X/6-31+G(d,p) optimization level. This seems to confirm 
the good performance of B3LYP in the conformational analysis of 
organic molecules. 
Compounds 6 
Due to the epimerization process observed in the Robinson annulation of 
3a to compounds cis-6 and trans-6, the determination of their relative and 
absolute configuration was desiderable. During the reaction, only the 
stereogenic centre in position 4 of 3a could be racemized. Being more 
conformationally constrained by the tetracyclic scaffold, compounds cis-
6a and trans-6 are very rigid. This helps in the conformational analysis to 
reduce the populated conformations. 
 
Figure 68. 1H spectra of compound cis-6 (600 MHz in CD3CN). (Top) 
ambient temperature spectrum. (Bottom) spectrum recorded at -
20°C. The asterisk indicates the water signal of the solvent. 
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The two diastereoisomers cis-6a and trans-6 were separated by means of 
semi-preparative HPLC on a C18 column (Phenomenex® Synergi 
Hydro-RP) using Acetonitrile/H2O 70:30. The 1H spectra of the first 
eluted peak showed very broad lines in the aliphatic part and for the two 
vinylic hydrogens (see Figure 68, top trace). On lowering the temperature 
these lines broaden further and they eventually split at -20°C into two set 
of signals in a 55:45 ratio (Figure 68, bottom). This dynamic behaviour 
can be explained considering the optimized structures of the two 
diastereoisomers. In the case of trans-6 isomer a single conformation 
should be populated. In this conformation the two bridgehead hydrogens 
occupy the pseudo-axial positions. In the case of the cis-6 isomer, the 
same hydrogens occupy one pseudo-axial and one pseudo-equatorial 
position, thus two conformation obtained by exchanging the positions of 
these hydrogens can be envisaged (Figure 69). 
 
Figure 69. Optimized structures for the ground state conformations 
of trans-6 and cis-6. 
The conformational search found only one conformation for the trans-6 
isomer, and confirmed that both the proposed conformation of cis-6 
corresponded to energy minima. When optimized at the M06-2X/6-
31G(d) level, the two conformations of the cis isomer were found to be 
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very close in energy (0.67 kcal/mol), and the transition state for their 
interconversion was found to be 14.1 kcal/mol. This explains the dynamic 
behaviour observed in the NMR spectra of the first eluted compound, that 
can be thus assigned to the cis-6 isomer. The trans-6 isomer was 
calculated to be slightly more stable than the cis (0.33 kcal/mol). When 
the calculation of the two ground states of cis-6 were repeated using a 
larger basis set and including the solvent (acetonitrile) in the calculations 
(PCM-M06-2X/6-31+G(d,p)), the energy difference between the two 
conformations reduced to 0.05 kcal/mol, thus reproducing well also the 
experimentally observed ratio. 
 
Figure 70. TD-DFT simulated spectra calculated for the two 
conformations of cis-6 using four different functionals (CAM-
B3LYP, BH&HLYP, M06-2X, ωB97XD) and the same 6-
311++G(2d,p) basis set. For each conformation the first 50 excited 
states were calculated, and the spectrum was obtained using a 0.40 
eV line width at half height. All the simulations are for the 6aR,10aS 
absolute configuration. 
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As said before, compound cis-6 is very rigid and the exact ratio of the 
two populated conformations can be provided by low-temperature NMR. 
For this reason the simulation of the ECD spectrum is straightforward. 
Having already established the absolute configuration of 3a, a new 
assignemnet of the absolute configuration could appear an overkill, but it 
is not. Compound 3a had a considerable conformational mobility while 
6a is rigid. The stereogenic centre at C-5 of 3a should be left unchanged, 
but the reaction conditions are severe. For these reasons the independent 
assignment of the absolute configuration of cis-6 provides a validation 
about the retention of configuration at C-5. As for 3a, the electronic 
excitation energies and rotational strengths have been calculated for the 
isolated molecule in the gas phase for the two conformations of cis-6 
using TD-DFT with CAM-B3LYP, BH&HLYP, M06-2X, ωB97XD and 
the 6-311++G(2d,p) (Figure 70). Although the experimental assignment 
of the two conformationsof cis-6 is not available, the ratio is very close to 
50:50. Moreover, the spectrum simulated for the b conformation is very 
weak. For these reason the spectrum resulting from Boltzmann 
distribution does not change on reversing the conformers population. All 
the simulated spectra agree well with the 6aR,10aS absolute 
configuration. Taking into account the different numbering of cis-6, the 
10aS configuration matches the 5S configuration of the starting 
compound 3a. 
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Figure 71. Simulations of the experimental ECD spectrum of cis-6 
(black traces). For each section, the black line correspond to the 
experimental spectrum (acetonitrile solution, 1.5·10-4 M, 0.2 cm path 
length, Δε in Mol L-1 cm-1). The simulated spectra were vertically 
scaled and red-shifted by 7-18 nm to get the best match with the 
experimental spectrum. All the simulations are for the 6aR,10aS 
absolute configuration. 
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Experimental section 
Atropisomers of arylmaleimides 
Materials  
3,4-Dibromo-1H-pyrrole-2,5-dione, benzyl bromide, 1-bromo-2-
methylnaphthalene, n-butyllithium, and the boronic acids 2a−e were 
commercially available. 2-Methylnaphthylboronic acid1 and 3,4-dibromo-
1-benzylpyrrole-2,5-dione2 were prepared according to known 
procedures. Diethyl ether and THF have been dried before use by 
distillation on Na/benzophenone. Chromatography employed the 
following stationary phases: silica gel 60 F254 for the TLC and silica gel 
60 Å (230−400 mesh) for prepurification. All reactions were performed 
in dried glassware and under dry nitrogen atmosphere. Glassware was 
dried at 70 °C for at least 3 h before use. A Phenomenex Luna C18 (10 
μm, 100 Å, 250 × 21.2 mm) semipreparative column was used to purify 
the compounds using mixtures of CH3CN and H2O as eluent. 
Enantioselective HPLC columns were used to separate the stable 
atropisomers of 4f and 3f (Phenomenex LUX-cellulose-2 250 × 10 mm 
and Daicel Chiralpak AD-H 250 × 21.2 mm, respectively). Detection 
wavelength was 254 nm. NMR spectra were recorded using a 
spectrometer operating at a field of 14.4 T (600 MHz for 1H, 150.8 for 
13C). Chemical shifts are given in ppm relative to the internal standards 
                                                     
1 Joyce, R. P.; Gainor, J. A.; Weinreb, S. M. J. Org. Chem. 1987, 52, 1177 – 
1185. 
2 Thompson, W. J.; Gaudino, J. J. Org. Chem. 1984, 49, 5237 – 5243. See also: 
Pathak, R.; Nhlapo, J. M.; Govender, S.; Michael, J. P.; Van Otterlo, W. A. L.; 
De Koning, C. B. Tetrahedron 2006, 62, 2820 − 2830. 
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tetramethylsilane (1H and 13C) or relative to the residual peak of the 
solvents. The 600 MH 1H spectra were acquired using a 5 mm dual direct 
probe with a 9000Hz spectral width, 2.0 μs (20° tip angle) pulse width, 3 
s acquisition time, and 1 s delay time. A shifted sine bell weighting 
function equal to the acquisition time (i.e., 3 s) was applied before the 
Fourier transformation. The 150.8 MHz 13C spectra were acquired under 
proton decoupling conditions with a 38000 Hz spectral width, 4.2 μs (60° 
tip angle) pulse width, 1 s acquisition time and 1 s delay time. A line 
broadening function of 1−2 Hz was applied before the 
Fouriertransformation. Assignment of the carbons multiplicity were 
obtained by means of the DEPT sequences. 
General Synthetic Procedure 
1-Benzyl-3,4-dibromo-1H-pyrrole-2,5-dione (1) (1 mmol) was dissolved 
in dry THF (5 mL), and then the appropriate boronic acid (2 mmol), 
cesium carbonate (2.5 mmol), and the palladium catalyst Pd(PPh3)4 or 
Pd(OAc)2 were added. The stirred solution was kept at reflux for 2 h or at 
40 °C overnight (Table 13 summarizes the experimental conditions). 
Et2O and H2O were then added, and the extracted organic layer was dried 
(Na2SO4), filtered on silica gel, and concentrated at reduced pressure. The 
crude products were purified by semipreparative HPLC on C18 column 
to obtain analytically pure samples of 3a−f and 4a−f. 
1-Benzyl-3-bromo-4-(o-tolyl)-1H-pyrrole-2,5-dione (3a).  
Yield: 0.104 g (30%) as a white waxy solid.  
1H NMR (600 MHz, CD2Cl2, 5.33 ppm, 25 °C): δ 2.27 (s, 3 H), 4.79 (s, 2 
H), 7.22 (d, J = 7.7 Hz, 1H), 7.28−7.44 (m, 8H).  
13C NMR (150.8 MHz, CD2Cl2, 54.0 ppm, 25 °C): δ 20.6 (CH3), 43.1 
(CH2),12.3 (CH), 127.1 (Cq), 128.0 (Cq), 128.5 (CH), 128.9 (2 CH), 
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129.3 (2 CH), 129.8 (CH), 130.8 (CH), 131.3 (CH), 136.6 (Cq), 137.7 
(Cq), 144.3 (Cq), 165.7 (Cq), 168.6 (Cq).  
HPLC: CH3CN/H2O 82:18 v/v, tR = 7.78 min. HRMS (EI): m/z calcd for 
C18H14BrNO2 [M•+] 355.02079, found 355.0210.  
Table 13. Summary of the Synthetic Details 
Entry 
(yield %) 
Entry 
(yield %) catalyst temp (°C) time (h) 
3a (30) 4a (32) Pd(PPh3)4 reflux 2 
3b (37) 4b (18) Pd(OAc)2 40 overnight 
3c (35) 4c (30) Pd(OAc)2 reflux 2 
3d (27) 4d (10) Pd(PPh3)4 40 overnight 
3e (28) 4e (20) Pd(OAc)2 reflux 2 
3f (13) 4f (6) Pd(OAc)2 reflux 2 
 
1-Benzyl-3,4-di-o-tolyl-1H-pyrrole-2,5-dione (4a) 
 Yield: 0.118 g (32%) as a white amorphous solid.  
1H NMR (600 MHz, CD2Cl2, 5.33 ppm, 25 °C): δ 2.06 (s, 6 H), 4.84 (s, 2 
H), 7.09 (d, J = 7.6 Hz, 2 H), 7.17 (t, J = 7.6 Hz, 2 H), 7.21 (d, J = 7.6 
Hz, 2 H), 7.29 (td, J = 7.6, 1.1 Hz, 2 H), 7.31 - 7.35 (m, 1 H), 7.38 (t, J = 
7.43 Hz, 2 H), 7.44 (d, J = 7.1 Hz, 2 H).  
13C NMR (150.8 MHz, CD2Cl2, 54.0 ppm, 25 °C): δ 20.6 (2 CH3), 42.6 
(CH2), 126.2 (2 CH), 128.3 (CH), 128.7 (2 CH), 129.2 (2 CH), 129.4 (2 
Cq), 130.1 (2 CH), 130.6 (bs, 2 CH), 131.2 (2 CH), 137.3 (2 Cq), 137.7 
(Cq), 141.1 (2 Cq), 170.8 (2 Cq).  
HPLC: CH3CN/H2O 82:18 v/v, tR = 10.58 min. HRMS (EI): m/z calcd for 
C25H21NO2 [M•+] 367.15723, found 367.1572. 
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1-Benzyl-3-bromo-4-(2-ethylphenyl)-1H-pyrrole-2,5-dione (3b). 
Yield: 0.135 g (37%) as a white waxy solid.  
1H NMR (600 MHz, C2D2Cl4, 6.00 ppm, 25 °C): δ 1.17 (t, J = 7.5 Hz, 3 
H), 2.55 (q, J = 7.5 Hz, 2 H), 4.80 (bs, benzylic CH2), 7.18 (d, J = 7.6 Hz, 
1 H), 7.30-7.42 (m, 7 H), 7.48 (t, J = 7.6, 1 H).  
13C NMR (150.8 MHz, C2D2Cl2, 74.0 ppm, 25 °C): δ 15.25 (CH3), 26.9 
(CH2), 42.8 (CH2), 126.1 (CH), 126.6 (Cq), 126.9 (CH), 128.3 (CH), 
128.6 (CH), 129.0 (2 CH),129.4 (CH), 130.7 (Cq), 135.8 (Cq), 143.1 
(Cq), 144.2 (Cq), 165.2 (Cq), 168.4 (Cq).  
HPLC: CH3CN/H2O 82:18 v/v, tR = 9.25 min. HRMS (EI): calcd for 
C19H16BrNO2 [M•+] 369.03644, found 369.0360. 
1-Benzyl-3,4-bis(2-ethylphenyl)-1H-pyrrole-2,5-dione (4b). 
Yield: 0.070 g (18%) as a white amorphous solid.  
1H NMR (600 MHz, CD3CN, 1.96 ppm, 60 °C): δ 1.07 (t, J = 7.6 Hz, 6 
H), 2.49 (q, J = 7.6 Hz, 4 H), 4.82 (s, 2 H), 7.11 (d, J = 7.7 Hz, 2 H), 7.17 
(t, J = 7.6 Hz, 2 H), 7.30 − 7.37 (m, 5 H), 7.40 (bd, 4 H).  
13C NMR (150.8 MHz, CD3CN, 118.3 ppm, 60 °C): δ 15.2 (2 CH3), 27.3 
(2 CH2), 43.1 (CH2), 126.8 (2 CH), 128.8 (2CH), 128.9 (CH), 129.6 (2 
Cq), 129.7 (2 CH), 129.9 (2 CH), 130.9 (2 CH), 131.3 (2 CH), 138.4 
(Cq), 142.6 (2Cq), 144.5 (2 Cq), 171.9 (2 Cq).  
HPLC: CH3CN/H2O 82:18v/v, tR = 15.10 min. HRMS (EI): m/z calcd for 
C27H25NO2 [M•+]395.18853, found 395.1881. 
1-Benzyl-3-bromo-4-(2,3-dimethylphenyl)-1H-pyrrole-2,5-dione (3c). 
Yield: 0.130 g (35%) as a white waxy solid. 
1H NMR (600 MHz,C2D2Cl4, 6.00 ppm, 25 °C): δ 2.16 (s, 3 H), 2.35 (s, 3 
H), 4.78 (d, J = 14.59 Hz, 1 H), 4.82 (d, J = 14.59 Hz, 1 H), 7.09 (d, J = 
7.6 Hz, 1 H), 7.235 (t, J = 7.6 Hz, 1 H), 7.28 − 7.44 (m, 6 H).  
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13C NMR (150.8 MHz, C2D2Cl4, 74.0 ppm, 25 °C): δ 18.0 (CH3), 20.5 
(CH3), 42.7 (CH2), 125.8 (CH), 126.3 (Cq), 127.1 (CH), 128.3 (2 CH), 
129.0 (2 CH), 132.0 (Cq), 135.6 (Cq), 135.8 (Cq), 138.2 (Cq), 144.2 
(Cq), 165.3 (Cq), 168.5 (Cq).  
HPLC: CH3CN/H2O 82:18 v/v, tR = 9.20 min. HRMS (EI): m/z calcd for 
C19H16BrNO2 [M•+] 369.03644, found 369.0358. 
1-Benzyl-3,4-bis(2,3-dimethylphenyl)-1H-pyrrole-2,5-dione (4c). 
Yield: 0.118 g (30%) as a white amorphous solid.  
1H NMR (600 MHz, CDCl3, 50 °C): δ 1.96 (s, 6 H), 2.22 (s, 6 H), 4.83 (s, 
2 H), 6.88(bd, 2 H), 7.02 (bt, 2 H), 7.12 (bd, 2 H), 7.21 − 7.40 (m, 3 H), 
7.45 (bd, 2 H).  
13C NMR (150.8 MHz, CDCl3, 77.0 ppm, 50 °C): δ 17.4 (2 CH3), 20.2 (2 
CH3), 42.2 (CH2), 125.5 (2 CH), 127.8 (3 CH), 128.6 (2 CH), 128.7 (2 
CH), 128.9 (2 Cq), 131.0 (2 CH), 135.4 (2 Cq), 136.7 (Cq),137.4 (2 Cq), 
141.2 (2 Cq), 170.4 (2 Cq).  
HPLC: CH3CN/H2O 82:18 v/v, tR = 14.51 min. HRMS (EI): m/z calcd for 
C27H25NO2 [M•+] 395.18853, found 395.1880. 
1-Benzyl-3-bromo-4-(2-isopropylphenyl)-1H-pyrrole-2,5-dione (3d). 
Yield: 0.104 g (27%) as a white waxy solid.  
1H NMR (600 MHz, C2D2Cl4, 6.00 ppm, 25 °C): δ 1.18 (d, J= 6.7 Hz, 3 
H), 1.24 (d, J = 6.7 Hz, 3 H), 2.69 (sett, J = 6.7 Hz, 1 H), 4.77 (d, J = 
14.6 Hz, 1 H), 4.81 (d, J = 14.6 Hz, 1 H), 7.13 (d, J = 7.7 Hz, 1 H), 7.30 
(t, J = 7.5 Hz, 1 H), 7.32−7.42 (m, 5 H), 7.43−7.52 (m, 2 H).  
13C NMR (150.8 MHz, C2D2Cl4, 74.0 ppm, 25 °C): δ 23.9 (CH3), 24.5 
(CH3), 31.9 (CH), 42.8 (CH2), 126.0 (Cq), 126.1 (CH), 126.2 (CH), 127.1 
(Cq),128.3 (CH), 128.6 (2 CH), 129.0 (2 CH), 129.2 (CH), 130.8 (CH), 
135.8 (Cq), 144.6 (Cq), 148.0 (Cq), 165.2 (Cq), 168.5 (Cq).  
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HPLC:CH3CN/H2O 82:18 v/v, tR = 12.15 min. HRMS (EI): m/z calcd for 
C20H18BrNO2 [M•+] 383.05209, found 383.0525. 
1-Benzyl-3,4-bis(2-isopropylphenyl)-1H-pyrrole-2,5-dione (4d).  
Yield: 0.042 g (10%) as a white amorphous solid. NMR spectra showed 
the presence of the two conformations syn (49%) and anti (51%).  
1H NMR (600 MHz, CDCl3, 0 °C): δ 0.72 (d, 6 H anti, J = 6.4 Hz), 0.81 
(d, 6 H syn, J = 6.4 Hz), 1.145 (d, 6 H anti, J = 6.4 Hz), 1.22 (d, 6 H syn, 
J = 6.4 Hz), 2.65 (quint, 2 H anti, J = 6.4 Hz), 2.70 (quint, 2 H syn, J = 
6.8 Hz), 4.79 (d, 1 H anti, J= 14.5 Hz), 4.835 (s, 2 H syn), 4.88 (d, 1 H 
anti, J = 14.5 Hz), 6.99 (bt, 4 H), 7.08 − 7.16 (m, 4 H), 7.24 − 7.40 (m, 14 
H), 7.49 (bt, 4 H).  
13C NMR (150.8 MHz, CDCl3, 77.0 ppm, 0 °C): δ 23.0 (2 CH3), 23.2 (2 
CH3), 24.7 (2 CH3), 25.1 (2 CH3), 31.1 (4 CH), 42.15 (CH2), 42.2 (CH2), 
125.6 (2 CH), 125.7 (2 CH), 126.1 (2 CH), 126.4 (2 CH), 126.6 (2 Cq), 
126.7 (2 Cq), 127.8 (2 CH), 128.7 (4 CH), 128.8 (2 CH), 128.9 (2 CH), 
129.8 (2 CH), 129.9 (2 CH), 129.9 (2 CH), 130.4 (2 CH), 136.4 (2 Cq), 
136.5 (2 Cq), 140.3 (2 Cq), 140.6 (2 Cq), 147.7 (2 Cq), 148.0 (2 Cq), 
170.6 (4 Cq). 
HPLC: CH3CN/H2O 82:18 v/v, tR = 21.34 min. HRMS (EI): m/z calcd for 
C29H29NO2 [M•+] 423.21983, found 423.2192. 
1-Benzyl-3-bromo-4-(naphthalen-1-yl)-1H-pyrrole-2,5-dione (3e). 
Yield: 0.110 (28%) as a white amorphous solid.  
1H NMR (600MHz, CDCl3, 25 °C): δ 4.85 (s, 2 H), 7.29 − 7.4 (m, 3 H), 
7.46 (d, J = 7.2 Hz, 2 H), 7.48 − 7.63 (m, 5 H), 7.92 (d, J = 8.3 Hz, 1 H), 
7.995 (d, J =8.3 Hz, 1 H).  
13C NMR (150.8 MHz, CDCl3, 77.0 ppm, 25 °C): δ 42.8 (CH2), 124.9 
(CH), 125.0 (Cq), 125.5 (CH), 126.5 (CH),126.8 (CH), 127.1 (Cq), 128.2 
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(CH), 128.5 (CH), 128.81 (CH), 128.83 (2 CH), 128.9 (2 CH), 129.9 
(Cq), 131.1 (CH), 133.6 (Cq), 135.8 (Cq), 142.4 (Cq), 165.1 (Cq), 168.4 
(Cq).  
HPLC: CH3CN/H2O90:10 v/v, tR = 5.94 min. HRMS (ESI-Orbitrap): m/z 
calcd for C21H15BrNO2+ [M + H+] 392.02807, found 392.02914. 
1-Benzyl-3,4-di(naphthalen-1-yl)-1H-pyrrole-2,5-dione (4e). Yield: 
0.088 g (20%) as a white amorphous solid.  
1H NMR (600MHz, C2D2Cl4, 6.00 ppm, 60 °C): δ 4.92 (s, 2 H), 7.24 (t, J 
= 7.6 Hz, 2 H), 7.32 − 7.38 (m, 7 H), 7.40 (t, J = 7.6 Hz, 2 H), 7.50 (d, J 
= 7.6 Hz, 2 H), 7.59 (bd, 2 H), 7.74 (d, J = 8.1 Hz, 2 H), 7.78 (d, J = 7.6 
Hz, 2 H).  
13C NMR (150.8 MHz, C2D2Cl4, 74.0 ppm, 60 °C): δ 42.5 (CH2), 125.1 (2 
CH), 125.2 (2 CH), 126.1 (2 CH), 126.4 (2 CH), 126.6 (2 Cq), 127.9 
(CH), 128.4 (2 CH), 128.5 (2 CH), 128.7 (2 CH), 128.8 (2 CH), 130.3 (2 
CH), 130.7 (2 Cq), 133.4 (2 Cq), 136.5 (Cq), 140.4(2 Cq), 170.4 (2 Cq).  
HPLC: CH3CN/H2O 90:10 v/v, tR = 7.23 min. HRMS (ESI-Orbitrap): m/z 
calcd for C31H22NO2+ [M + H+] 440.16451, found 440.16529. 
1-Benzyl-3-bromo-4-(2-methylnaphthalen-1-yl)-1H-pyrrole-2,5-dione 
(3f). 
Yield: 0.053 g (13%) as white amorphous solid.  
1H NMR (600 MHz, CDCl3, 25 °C): δ 2.37 (s, 3 H), 4.87 (s, 2 H), 7.30 − 
7.36 (m, 1 H), 7.37 − 7.40 (m, 2 H), 7.41 − 7.49 (m, 6 H), 7.86 − 7.90 (m, 
2 H). 
13C NMR (150.8 MHz, CDCl3, 77.0 ppm, 25 °C): δ 20.6 (CH3), 42.8 
(CH2), 123.2 (Cq), 124.3 (CH), 125.6 (CH),127.0 (CH), 128.1 (CH), 
128.4 (CH), 128.5 (3 CH), 128.8 (2 CH), 129.2 (Cq), 130.2 (CH), 130.6 
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(Cq), 131.8 (Cq), 135.2 (Cq), 135.8 (Cq), 143.6 (Cq), 164.9 (Cq), 168.0 
(Cq).  
ChiralPak AD-H (5 μm, 250 × 20 mm, 20 mL/min, 254 nm, 25 °C) 
semipreparative HPLC column has been used for the separation of the 
atropisomers and for the kinetic study; hexane/2-propanol 90:10 v/v, tR = 
6.89 and 9.55 min. HRMS (ESI-Orbitrap): m/z calcd for C22H17BrNO2+ 
[M + H+] 406.04372, found 406.04453. 
1-Benzyl-3,4-bis(2-methylnaphthalen-1-yl)-1H-pyrrole-2,5-dione (4f). 
Total yield (as syn anti): 0.028 g (6%) as slightly yellow waxy solid.  
Syn.1H NMR (600 MHz, CDCl3, −10 °C): δ 2.24 (s, 6 H), 4.95 (s, 2 H), 
7.12 (t, J = 7.6 Hz, 2 H), 7.20 (d, J = 8.3, 2 H), 7.27 − 7.29 (m, 2 H), 7.34 
− 7.42 (m, 3 H), 7.51 (d, J = 7.0 Hz, 2 H), 7.60 (d, J = 8.6 Hz, 2 H), 7.64 
− 7.70 (m, 4 H).  
13C NMR (150.8 MHz, CDCl3, 77.00 ppm, −10 °C): δ 21.13 (CH3), 42.29 
(CH2), 124.30 (2 Cq), 124.80 (2 CH), 125.06 (2 CH), 126.11 (2 CH), 
127.86 (CH), 128.15 (2 CH), 128.45 (2 CH), 128.59 (2 CH), 128.80 (2 
CH), 129.71 (2 CH), 131.00 (2 Cq), 131.58 (2 Cq), 135.41 (2 Cq), 136.44 
(Cq), 141.92 (2 Cq), 170.13 (2 Cq).  
Anti.1H NMR (600 MHz, CDCl3, −10 °C): δ 2.03 (s, 6 H), 4.95 (AB 
system, J = 14.75 Hz, 2 H), 7.15 (d, J = 8.44 Hz, 2 H), 7.27 − 7.42 (m, 7 
H), 7.52 (d, J = 7.73 Hz, 2 H), 7.56 (d, J = 7.73 Hz, 2 H), 7.69 (d, J = 8.5 
Hz, 2 H), 7.72 − 7.76 (m, 2 H).  
13C NMR (150.8 MHz, CDCl3, 77.0 ppm, −10 °C): δ 21.5 (CH3), 42.3 
(CH2), 124.1 (2 Cq), 125.0 (2 CH), 125.2 (2 CH), 126.2 (2 CH), 127.9 
(CH), 128.3 (2 CH), 128.5 (2 CH), 128.6 (2 CH), 128.8 (2 CH), 129.7 (2 
CH), 131.0 (2 Cq), 131.7 (2 Cq), 136.0 (2 Cq), 136.4 (Cq), 142.2 (2 Cq), 
170.3 (2 Cq).  
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Lux Cellulose-2 HPLC column was used to separate the three 
stereoisomers. (5 μm, 100 Å, 250 × 10.00 mm, hexane/2-propanol 90:10 
v/v, 5 mL/min, detection at 254 nm, 25 °C); tRsyn = 15.88 min, tRanti: 
12.62 and 16.92 min. HRMS (ESI-Orbitrap): m/z calcd for C33H26NO2+ 
[M + H+] 468.19581, found 468.19726. 
 
Atropisomers of 4-arylpyrazolo[3,4-b]pyridines 
Materials 
Compounds 1 and 2 were known and compounds 3 −6 were prepared as 
reported in the literature.3  
n-Butyllithium (1.6 M in hexane), dimethylformamide, 4,4,4-
trifluoroacetoacetic acid ethylester, 3-isopropylbenzaldeyde, 3,5-
dimethylacetophenone, 5-amino-3-methyl-1-phenylpyrazole, and L-
proline were commercially available. 1-(3,5-Dimethylphenyl)-4,4,4-
trifluoro-1,3-butanedione was preparedaccording to the literature.4 
Diisopropylamine was freshly distilled from CaH2 prior to use. Et2O and 
THF were dried before use bydistillation over Na/benzophenone. CDFCl2 
was prepared accordingto a known procedure.5 
4,4,4-Trifluoro-1-(3,5-dimethylphenyl)butane-1,3-dione (7) 
Diisopropylamine (1.14 mL, 0.82 g, 8.1 mmol) was dissolved in 40 mL 
of THF. The solutionwas cooled to −20 °C, and then a solution of n-BuLi 
in hexane (1.6 M,5 mL, 8 mmol) was added dropwise. The mixture was 
                                                     
3 Gunasekaran, P.; Indumathi, S.; Perumal, S. RSC Adv.2013, 3, 8318−8325. 
4 Büttner, S.; Riahi, A.; Hussain, I.; Yawer, M. A.; Lubbe, M.;Villinger, A.; 
Reinke, H.; Fischer, C.; Langer, P. Tetrahedron 2009, 65,2124 − 2135.  
5 Siegel, J. S.; Anet, F. A. L. J. Org. Chem. 1988, 53, 2629 − 2630. 
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stirred for 30 minutes at −20 °C, and then the temperature was allowed to 
rise to +5 °C and then cooled down to −78 °C. A solution of 3,5-
dimethylacetophenone (1.00 g, 6.7 mmol) was then added dropwise to the 
solution of LDA. The reaction mixture was stirred for 30 min at −78 °C, 
and its color went from colorless to yellow. A solution of 4,4,4-
trifluoroacetoacetic acid ethyl ester (0.97 mL, 1.15 g, 8.1 mmol in 5 mL 
of THF) was added dropwise to the solution of enolate. The reaction was 
stirred at −78 °C for 1 h and then allowed to warm to ambient 
temperature overnight. Saturated NH4Cl solution was then added, and the 
mixture was extracted with diethyl ether (3 × 30 mL). The combined 
organic layers were dried (Na2SO4), filtered, and concentrated under 
reduced pressure. The residue was purified by dissolving the impurities in 
CHCl3 and by recrystallization from acetonitrile, yielding the title 
compound as a white solid (798 mg, 40%). mp +280 °C (decomp). 
1H NMR (600 MHz, CD3CN, 1.96 ppm, +25 °C): δ 2.35 (s, 6 H), 2.32 (s, 
OH), 6.23 (s, 1 H), 7.15 (s,1 H), 7.51 (s, 2 H). 
13C NMR (150.8 MHz, CD3CN, 1.79 ppm, +25 °C): δ 21.8 (CH3), 90.9 
(CH), 121.1 (q, J = 279 Hz, CF3), 126.4 (CH), 134.1 (Cq), 139.4 (CH), 
172.4 (q, J = 35 Hz, CO-CF3), 190.5 (CO). 
19F NMR (376 MHz, CD3CN, +25 °C): δ −76.3 (s). HRMS (ESI-TOF-
MS−) m/z: [M − H]−calcd for C12H10F3O2: 243.06329; found: 243.06369. 
General Procedure for the Synthesis of 3-Methyl-1-phenyl-1H-
pyrazolo[3,4-b]pyridines (3 – 6) 
A mixture of 4,4,4-trifluoro-1-phenylbutane-1,3-dione (1 mmol), the 
appropriate aromatic aldehyde(1 mmol), 3-methyl-1-phenyl-1H-pyrazol-
5-amine (1 mmol), and L-proline (0.20 mmol) in ethanol (15 mL) was 
stirred at +60 °Covernight. The reaction mixture was then extracted with 
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ethyl acetate(2 × 40 mL), and after removal of the solvent, the crude was 
chromatographed over silica gel using petroleum ether − ethyl acetate 
mixture (4:1 v/v), which aﬀorded pure compounds 3, 4, and 6.  
4,4,4-Trifluoro-1-(3,5-dimethylphenyl)butane-1,3-dione 7 (0.2 mmol), m-
isopropylbenzaldehyde (0.2 mmol), 3-methyl-1-phenyl-1H-pyrazol-5-
amine (0.2 mmol), and L-proline (0.05 mmol) in ethanol (5 mL) were 
used for the preparation of compound 5. 
4-(4-Methoxyphenyl)-(3-methyl-1-phenyl-6-(trifluoromethyl)-1 H -
pyrazolo[3,4-b]pyridine-5-yl)(phenyl)methanone (1). 
Yield: 400 mg (82%, relative to p-methoxybenzaldehyde). White solid, 
mp 150 − 151 °C. 
1H NMR (600 MHz, CD3CN, +50 °C): δ 2.11(s, 3 H), 3.77 (s, 3 H), 6.85 
(bs, 2 H), 7.17 (d, J = 8.0 Hz, 2 H), 7.37 (t, J = 7.9 Hz, 2 H), 7.43 (t, J = 
7.5 Hz, 1 H), 7.55 (t, J = 7.5 Hz, 1 H), 7.60 − 7.65 (m, 4 H), 8.32 (d, J = 
8.1 Hz, 2 H). 
13C NMR (150.8 MHz,CD3CN, +50 °C): δ 15.4 (CH3), 56.7 (OCH3), 
115.0 (CH), 118.9(Cq), 122.6 (CH), 123.4 (q, J = 275.4 Hz, CF3), 126.9 
(Cq), 128.1(CH), 128.9 (Cq), 130.1 (CH), 130.9 (CH), 130.9 (CH), 132.8 
(CH), 135.4 (CH), 139.2 (Cq), 140.6 (Cq), 144.2 (q, J = 35.1 Hz, C-CF3), 
145.7 (Cq), 147.8 (Cq), 150.7 (Cq), 162.0 (Cq), 196.0 (CO). 
19F NMR (376.3 MHz, CD3CN, +25 °C): δ −61.61 (s). HRMS(ESI-TOF-
MS+) m/z: [M + H]+ calcd for C28H21F3N3O2: 488.15859; found: 
488.15805. 
(3-Methyl-1-phenyl-4-(p-tolyl)-6-(trifluoromethyl)-1H-pyrazolo[3,4-
b]pyridine-5-yl)(phenyl)methanone (2). 
Yield:372 mg (79%, relative to p-methylbenzaldehyde). White solid, 
mp155 − 156 °C. 
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1H NMR (600 MHz, CD3CN, +50 °C): δ 2.05 (s, 3 H,CH3), 2.32 (s, 3 H, 
CH3), 7.14 (br, 4H, Ar − H), 7.38 (t, J = 8.3 Hz, 7.6Hz, 2 H), 7.42 (tt, J = 
7.5 Hz, 1.2 Hz, 1 H), 7.55 (tt, J = 7.4 Hz, 1.2 Hz,1 H), 7.63 (m, 4 H), 8.31 
(m, 2 H). 
13C NMR (150.8 MHz, CD3CN, +50 °C): δ 15.3 (CH3), 21.8 (CH3) 122.6 
(CH), 123.5 (q, J = 275.1 Hz, CF3) 128.1 (CH), 128.7 (Cq), 130.0 (CH, 
br), 130.1 (CH),130.9 (CH), 131.0 (CH), 131.2 (CH, br), 131.9 (Cq), 
135.4 (CH), 139.3 (Cq), 140.6 (Cq), 140.9 (Cq), 144.1 (J = 34.5 Hz, C-
CF3), 145.7 (Cq), 148.0 (Cq), 150.6 (Cq), 195.8 (CO). 
19F NMR (376.3 MHz, CD3CN, +25 °C): δ −61.61. HRMS (ESI-TOF-
MS+) m/z: [M + H]+ calcd for C28H21F3N3O (M + H)+: 472.16367. found: 
472.16116. 
(4-(3-Ethylphenyl)-(3-methyl-1-phenyl-6-(trifluoromethyl)-1 H -
pyrazolo[3,4-b]pyridine-5-yl)(phenyl)methanone (3)  
Yield:266 mg (55%, relative to m-ethylbenzaldehyde). White solid, mp 
101 − 102 °C. 
1H NMR (600 MHz, CD3CN, +50 °C): δ 1.07 (bs, 3 H), 2.07(bs, 3 H), 
2.54 (bs, 2 H), 7.03 − 7.09 (m, 2 H), 7.16 − 7.26 (m, 2 H) 7.36(t, J = 7.6 
Hz, 2 H), 7.43 (t, J = 7.6 Hz, 1 H), 7.54 (t, J = 7.6 Hz, 1 H),7.60 − 7.65 
(m, 4 H), 8.32 (d, J = 7.6 Hz, 2 H). 
13C NMR (150.8 MHz,CD3CN, +50 °C): δ 15.3 (CH3), 16.4 (CH3), 29.8 
(CH2), 122.6 (2 CH), 123.4 (q, J = 275.0 Hz, CF3), 128.1 (CH), 128.5 
(CH), 129.5 (CH), 130.0 (2 CH), 130.1 (CH), 130.8 (CH), 130.9 (2 CH), 
131.0(2 CH), 131.1 (Cq), 134.9 (Cq), 135.3 (CH), 139.3 (Cq), 140.6(Cq), 
144.2 (q, J = 34.4 Hz, C-CF3), 145.7 (Cq), 145.8 (Cq), 148.1(Cq), 150.6 
(Cq), 195.8 (CO). 
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19F NMR (376.3 MHz, CD3CN, +25°C): δ −61.42 (s). HRMS (ESI-TOF-
MS+): m/z: [M + H]+ calcd forC29H23F3N3O: 486.17932; found: 
486.17912. Crystals suitable for X-ray analysis (colorless bricks) were 
obtained by slow evaporation of a hexane/ethyl acetate 4:1 v:v solution. 
(4-(3-Isopropylphenyl)-3-methyl-1-phenyl-6-(trifluoromethyl)-1 H -
pyrazolo[3,4- b ]pyridine-5-yl)(phenyl)methanone (4) 
Yield: 255 mg (51%, relative to m-isopropylbenzaldehyde). White solid, 
mp 119 − 120 ° C. 
1H NMR (600 MHz, CD3CN, +50 °C): δ 1.07(bs, 3 H), 1.11 (bs, 3 H), 
2.07 (s, 3 H), 2.80 (bs, 1 H), 7.05 (d, J = 7.4Hz, 1 H), 7.09 (bs, 1 H), 7.20 
(d, J = 7.4 Hz, 1 H), 7.32 (bs, 1 H), 7.36 (t, J = 7.5 Hz, 2 H), 7.42 (t, J = 
7.5 Hz, 1 H), 7.42 (t, J = 7.5 Hz, 1 H),7.61 (d, J = 7.5 Hz, 2 H), 7.63 (t, J 
= 7.8 Hz, 2 H), 8.32 (d, J = 8.2 Hz, 2 H). 
13C NMR (150.8 MHz, CD3CN, +50 °C): δ 15.2 (CH3),24.4 (CH3), 24.7 
(CH3), 35.3(CH), 118.6 (Cq), 122.6 (CH), 123.4(q, J = 275.2 Hz, CF3), 
128.1 (CH), 128.7 (CH), 128.7 (Cq), 128.8(CH), 129.3 (CH), 129.5 (CH), 
130.0 (CH), 130.9 (CH), 131.0 (CH), 134.8 (Cq), 135.3 (CH), 139.3 
(Cq), 140.6 (Cq), 144.2 (q, J =34.4 Hz, C-CF 3 ), 145.7 (Cq), 148.2 (Cq), 
150.3 (Cq), 150.6 (Cq),195.8 (CO). 
19F NMR (376.3 MHz, CD3CN, +25 °C): δ −61.60 (s). HRMS (ESI-TOF-
MS+): m/z: [M + H]+ calcd for C30H25F3N3O: 500.19497; found: 
500.19449. 
(4-(3-Isopropylphenyl)-3-methyl-1-phenyl-6-(trifluoromethyl)-1 H -
pyrazolo[3,4-b]pyridine-5-yl)(3,5-dimethylphenyl)-methanone (5) 
Yield: 29 mg, 28%, relative to m-isopropylbenzaldehyde). Waxy solid. 
1H NMR (600 MHz, CD3CN, +50 °C): δ 1.00 − 1.18 (bs, 6 H), 2.05 − 
2.08 (bs, 6 H), 2.24 (s, 3 H), 2.82 (bs, 1 H), 7.06 (d, J = 7.6 Hz, 1 H), 
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7.09 (bs, 1 H), 7.18 (s, 1 H), 7.20 − 7.28 (m, 4 H), 7.43 (t, J = 7.5 Hz, 1 
H), 7.64 (t, J = 8.0, 2 H), 8.33 (d, J = 8.2 Hz, 2 H). 
13C NMR (150.8 MHz, CD3CN, +50 °C): δ 15.2 (CH3), 21.6 (CH3), 24.4 
(CH3), 24.6 (CH3), 35.3 (CH), 122.6 (CH), 123.5 (q, J = 275 Hz, CF3), 
128.1 (CH), 128.7 (CH), 128.8 (CH), 129.1 (Cq), 129.2(CH), 129.4 (CH), 
130.9 (CH), 135.0 (Cq), 136.8 (CH), 139.5 (Cq),140.0 (Cq), 140.6 (Cq), 
144.2 (q, J = 35.1 Hz, C-CF3), 145.7 (Cq),148.1 (Cq), 150.2 (Cq), 150.6 
(Cq), 196.0 (CO). 
19F NMR (376.3 MHz, CD3CN,+25 °C): δ −61.60 (s). HRMS (ESI-TOF-
MS+): m/z: [M + H]+calcd for C32H29F3N3O: 528.22627; found: 
528.22702. 
(3-Methyl-4-(1-naphthyl)-1-phenyl-6-(trifluoromethyl)-1H-
pyrazolo[3,4-b]pyridine-5-yl)(phenyl)methanone (6).  
Yield: 131mg (36%, relative to 1-naphthaldehyde). White solid, mp 185 
− 187 ° C. 
1H NMR (600 MHz, CD3CN, +50 °C): δ 1.60 (s, 3 H), 7.21 (bs, 2 H),7.30 
(d, J = 6.5 Hz, 1 H), 7.35 − 7.47 (m, 5 H), 7.50 (t, J = 7.6 Hz, 1 H), 7.55 
(d, J = 7.7 Hz, 2 H), 7.65 (t, J = 7.9 Hz, 2 H), 7.88 (d, J = 8.4 Hz, 1 H), 
7.90 (d, J = 8.4 Hz, 1 H), 8.34 (d, J = 8.4 Hz, 2 H). 
13C NMR (150.8 MHz, CD3CN, +50 °C): δ 14.1 (CH3), 119.7 (CH), 
122.7 (CH), 123.5 (q, J = 275.1 Hz, CF3), 126.2 (CH), 127.4 (CH), 128.0 
(CH), 128.2 (CH), 128.4 (CH), 129.6 (CH), 129.7 (CH), 129.8 (CH), 
129.9 (bs, CH), 130.7 (CH), 130.9 (CH), 131.2 (CH), 132.2, 133.2,134.6, 
135.1 (CH), 138.9, 140.6, 144.8 (q, J = 34.4 Hz, C-CF3), 145.5, 146.2, 
150.6, 195.6 (CO). 
19F NMR (376.3 MHz, CD3CN, +25 °C): δ −61.40 (s). HRMS (ESI-TOF-
MS+): m/z: [M + H]+calcd for C31H21F3N3O 508.16367; found: 
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508.16539. HPLC resolution of the atropisomeric pair: Daicel ChiralPak 
AD-H (5 μm, 250 × 20 mm), 18 mL/min flowrate, 254 nm detection, +25 
°C; eluent: hexane:2-propanol 98:2 v:v; tR 6.10 and 6.83 min. Crystals of 
the racemic mixture suitable for X-ray analysis (colorless sticks) were 
obtained by slow evaporation of a CH3OH/CH2Cl2 3:1 v:v solution. 
 
Study of the intramolecular NO2/CO interaction in 
solution 
Materials 
Compounds 1, 2, 3 were prepared using a known procedure6. Compounds 
4, 5, 6, 7, 8 were prepared starting from 2,3-dibromo-1,4-naphthoquinone 
and 2,5-dibromo-1,4-p-hydroquinone7 by Suzuki coupling.  
1-benzyl-3,4-bis(2-nitrophenyl)-1H-pyrrole-2,5-dione (1) 
In an oven dried round bottom flask under nitrogen atmosphere, 1-
benzyl-3,4-dibromo-1H-pyrrole (1 mmol, 1 eq) and 2-nitrophenylboronic 
acid (3 mmol, 3 eq) were dissolved in 5 ml of dry THF. Cs2CO3 (2.5 eq) 
was added and the reaction mixture was degassed by nitrogen bubbling 
for 5-10 minutes. Pd(OAc)2 (0.05 eq) was added and the reaction was 
heated at 40 °C until complete consumption of the starting material (GC-
MS, 6 hours). The solution was then diluted with water (10 ml) and 
extracted with Et2O (3 x 10 ml). The combined organic layers were dried 
over Na2SO4 and the solvent were evaporated under reduced pressure. 
The crude reaction mixture was purified with semi-preparative HPLC on 
                                                     
6 Ambrogi, M.; Ciogli, A.; Mancinelli, M.; Ranieri, S.; Mazzanti, A., J. Org. 
Chem., 2013, 78, 3709–3719. 
7Yu, D.; Mattern, D. L.Synth. Commun. 1999, 29, 821 – 825. 
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C18 column, to obtain analytically pure samples. (10 μm, 250 x 10.0 mm, 
20 mL/min, ACN/H2O 75:25 v/v).  
1H-NMR (600 MHz, CD3CN, 1.96 ppm, 25 °C): δ 4.79 (s, 2 H), 7.30 - 
7.36 (m, 5 H), 7.35 - 7.42 (m, 2 H), 7.65 (t, J = 7.2 Hz, 2 H), 7.70 (td, J = 
7.9 Hz, 1.5 Hz, 2 H), 8.26 (d, J = 8.2 Hz, 2 H).  
13C-NMR (150.8 MHz, CD3CN, 118.3 ppm, 25 °C): δ 42.7 (CH2), 124.5 
(2 Cq), 126.1 (2 CH), 128.3 (2 CH), 128.7 (CH), 129.7 (2 CH), 132.5 (2 
CH), 133.0 (2 CH), 135.3 (2 CH), 137.4 (2 Cq), 138.3 (2 Cq), 149.6 (Cq), 
169.5 (2Cq). 
HRMS (ESI-Orbitrap) m/z calcd for C23H15N3O6Na+ [M+Na]+: 452.0585, 
found 452.0589. 
1-benzyl-3-(2-nitrophenyl)-4-(o-tolyl)-1H-pyrrole-2,5-dione (2) 
In an oven dried round bottom flask under nitrogen atmosphere, 1-
benzyl-3-bromo-4-(o-tolyl)-1H-pyrrole-2,5-dione (1 eq) and o-
nitrophenylboronic acid (2.0 eq) (1 mmol, 1 eq) were dissolved in 5 ml of 
dry THF. Cs2CO3 (2.5 eq) was added and the reaction mixture was 
degassed by nitrogen bubbling for 5-10 minutes. Pd(OAc)2 (0.05 eq) was 
added and the reaction was heated at 40 °C until complete consumption 
of the starting material. (GC-MS, 6 hours). The solution was then diluted 
with water (10 ml) and extracted with Et2O (3 x 10 ml). The combined 
organic layers were dried over Na2SO4 and the solvent were evaporated 
under reduced pressure. The crude reaction mixture was purified with 
semi-preparative HPLC on C18 column, to obtain analytically pure 
samples. (10 μm, 250 x 10.0 mm, 20 mL/min, ACN/H2O 67:33 v/v).  
1H-NMR (600 MHz, CD2Cl2, 5.33 ppm, 25 °C): δ 2.11 (bs, 3 H), 4.81 (s, 
2 H), 7.08 (d, J = 7.63 Hz, 1 H), 7.15 - 7.29 (bs, 3 H), 7.29-7.42 (m, 6 H), 
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7.52 (t, J = 7.73 Hz, 1 H), 7.58 (t, J = 7.73 Hz, 1 H), 8.17 (d, J = 8.25 Hz, 
1 H).  
13C-NMR (150 MHz, CD2Cl2, 53.4 ppm, 25 °C): δ 19.7 (b, CH3), 42.0 
(CH2), 124.6 (Cq), 125.0 (CH), 125.7 (CH), 127.7 (CH), 128.0 (CH), 
128.6 (CH), 129.8 (CH), 130.1 (CH), 130.7 (CH), 130.8 (CH), 131.5 
(CH), 133.6 (CH), 136.3 (Cq), 137.4 (Cq), 148.4 (Cq),168.5 (CO), 169.8 
(CO). HRMS (ESI-Orbitrap) m/z: calcd for C24H19N2O4+ [M+H]+: 
399.13393, found: 399.13492, C24H18N2O4Na+ 421.1164; found 
421.1168. 
2,3-bis(2-nitrophenyl)naphthalene-1,4-dione (4) 
In an oven dried round bottom flask under nitrogen atmosphere, 2,3-
dibromonaphthalene-1,4-dione (0.5 mmol, 1 eq) and 2-
nitrophenylboronic acid (1.1 mmol, 2.2eq) were dissolved in 5 ml of 1,4-
dioxane. 2 M aqueous solution of K2CO3(1 ml, 4 eq) was added and the 
reaction mixture was degassed by nitrogen bubbling for 5-10 minutes. 
Pd(PPh3)4 (0.025 mmol, 0.05 eq) was added and the reaction was heated 
at 90 °C until complete consumption of the starting material (GC-MS, 6 
hours). The solution was then diluted with water (10 ml) and extracted 
with ethyl acetate (3 x 10 ml). The combined organic layers were dried 
over Na2SO4 and the solvent was evaporated under reduced pressure. The 
crude reaction mixture was purified with silica-gel flash chromatograhy 
eluting with petrol ether/AcOEt mixture (95:5 →7:3) to afford the 
product as a brown solid in 14 % yield. An analytic sample of the 
compound was obtained by semi-preparative HPLC on a Synergy Polar-
RP column (4 μm, 250 x 10.0 mm, 5 mL/min, ACN/H2O 70:30 v/v).  
1H NMR (600 MHz, CDCl3):δ 7.24 (dd, J1 = 7.8 Hz, J2 = 1.2 Hz, 2 H), 
7.44 (dt, J1 = 7.8 Hz, J2 = 1.2 Hz, 2 H), 7.49 (dt, J1 = 7.8 Hz, J2 = 1.2 Hz, 
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2 H), 7.82 (dd, J1 = 6.0 Hz, J2 = 3.6 Hz, 2 H), 8.17 (dd, J1 = 6.0 Hz, J2 = 
3.6 Hz, 2H), 8.20 (dd, J1 = 7.8 Hz, J1 = 1.2 Hz, 2 H).  
13C-NMR (150 MHz, CDCl3): δ 124.3 (2 CH), 127.1 (2 CH), 129.5 (2 
Cq), 130.1 (2 CH), 131.1 (2 CH), 131.8 (2 Cq), 134.0 (2 CH), 134.3 (2 
CH), 143.3 (2 Cq), 148.9 (2 Cq), 182.4 (2 Cq). 
HRMS (ESI-Orbitrap) m/z: calcd for C22H12N2O6 Na+[M+Na]+: 423.0593; 
found 423.0587. 
2-bromo-3-(o-tolyl)naphthalene-1,4-dione and 2,3-di-o-
tolylnaphthalene-1,4-dione 
 
In an oven dried round bottom flask under nitrogen atmosphere, 2,3-
dibromonaphthalene-1,4-dione (0.22 mmol, 1.1 eq) and o-tolylboronic 
acid (0.2 mmol, 1.0 eq) were dissolved in 2 ml of 1,4-dioxane. 2 M 
aqueous solution of K2CO3 (0.4 ml, 4 eq) was added and the reaction 
mixture was degassed by nitrogen bubbling for 5-10 minutes. Pd(PPh3)4 
(0.011 mmol, 0.05 eq) was added and the reaction was heated at 90 °C 
until complete consumption of the starting material (GC-MS, 6 hours). 
The solution was then diluted with water (10 ml) and extracted with 
DCM (3 x 10 ml). The combined organic layers were dried over Na2SO4 
and filtered through a short pad of silica-gel. The volatiles were removed 
under reduced pressure and the crude product was purified by 
semipreparative HPLC on a Luna C18 column (10 μm, 250 x 21.2 mm, 
25 mL/min, ACN/H2O 80:20 v/v) to afford 22 mg of 2-bromo-3-(o-
tolyl)naphthalene-1,4-dione and 14 mg of 2,3-di-o-tolylnaphthalene-1,4-
dione, with 54 % overall yield. 
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2-bromo-3-(o-tolyl)naphthalene-1,4-dione 
1H-NMR (400 MHz, CDCl3):δ 2.19 (s, 3 H), 7.10 (d, J = 7.2 Hz, 1 H), 
7.30 - 7.34 (m, 2 H), 7.37 - 7.41 (m, 1 H), 7.79 - 7.84(m, 2 H), 8.14 - 8.19 
(m, 1 H), 8.24 - 8.29 (m, 1 H).  
13C-NMR (100 MHz, CDCl3): δ 19.7 (CH3), 125.8 (CH), 127.4 (CH), 
127.6 (CH), 127.9 (CH), 129.2 (CH), 130.2 (CH), 131.2 (Cq), 131.7 
(Cq), 134.1 (CH), 134.4 (CH), 134.6 (Cq), 135.1 (Cq), 140.0 (Cq), 151.0 
(Cq), 178.1 (Cq), 181.3 (Cq).  
MS (EI) m/z: 247 (100) [M-Br]+, 219 (30), 189 (45). 
2,3-di-o-tolylnaphthalene-1,4-dione (6) 
1H-NMR (600 MHz, C2D2Cl4) δ 2.07(s, 6Hsyn), 2.24 (s, 6Hanti), 6.75 (d, 
J1 = 7.2 Hz, 2Hanti), 6.99 (dt, J1 = 7.2 Hz, J2 =1.8 Hz, 2Hanti), 7.02 (d, J 
= 7.8 Hz, 2Hsyn), 7.10 (t, J = 7.8 Hz, 2Hsyn), 7.12 (d, J = 7.8 Hz, 2Hsyn), 
7.16-7.21 (m, 4Hanti + 2Hsyn), 7.84-7.87 (m, 2Hanti + 2Hsyn), 8.19-
8.21 (m, 2Hanti + 2Hsyn).  
13C-NMR (150 MHz, C2D2Cl4):δ 20.5 (2CH3), 20.8 (2CH3), 125.2 (2CH), 
125.8 (2CH), 127.0 (2CH), 127.1 (2CH), 128.0 (2CH), 128.7 (2CH), 
128.8 (2CH), 130.0 (2CH), 130.2 (2CH), 130.7 (2CH), 132.2 (2Cq), 
132.3 (2Cq), 132.8 (2Cq), 133.9 (2Cq), 134.4 (2CH), 134.5 (2CH), 136.1 
(2Cq), 136.3 (2Cq), 147.8 (2Cq), 148.1 (2Cq), 184.6 (2Cq), 184.8 (2Cq). 
HRMS-(ESI-Orbitrap) m/z: calcd for C24H18O2Na+[M+Na]+: 361.1204; 
found 361.1193. 
2-(2-nitrophenyl)-3-(o-tolyl)naphthalene-1,4-dione (5) 
In an oven dried round bottom flask under nitrogen atmosphere, 2-bromo-
3-(o-tolyl)naphthalene-1,4-dione (0.2 mmol, 1 eq) and 2-
nitrophenylboronic acid (0.4 mmol, 2.0 eq) were dissolved in 2 ml of 1,4-
dioxane. 2 M aqueous solution of K2CO3 (0.2 ml, 4 eq) was added and 
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the reaction mixture was degassed by nitrogen bubbling for 5-10 minutes. 
Pd(PPh3)4 (0.010 mmol, 0.05 eq) was added and the reaction was heated 
at 90 °C until complete consumption of the starting material (GC-MS, 3 
hours). The solution was then diluted with water (5 ml) and extracted 
with DCM (3 x 5 ml). The combined organic layers were dried over 
Na2SO4 and the solvent were evaporated under reduced pressure. The 
crude reaction mixture was purified with silica-gel flash chromatography 
eluting with petrol ether/AcOEt mixture (9:1 → 8:2) to afford the product 
as a brown solid in 35 % yield. An analytic sample of the compound was 
obtained by recrystallization from n-Hex:i-PrOH:THF 1:1:1 mixture.  
1H-NMR (600 MHz, C2D2Cl4):δ 1.97 (s, 3 Hsyn), 2.31 (s, 3 Hanti), 6.86 
(d, J = 7.2 Hz, 1 Hanti), 6.91 - 6.94 (m, 1 Hanti), 6.97 (t, J = 7.2 Hz, 1 
Hanti), 7.09 (d, J = 7.8 Hz, 2 Hsyn), 7.16 - 7.25 (m, 3 Hsyn + 2 Hanti), 
7.43 - 7.47 (m, 2 Hanti), 7.48 (dd, J1 = 7.8 Hz, J2 = 1.2 Hz, 1 Hsyn), 7.52 
(dt, J1 = 7.8 Hz, J2 = 1.2 Hz, 1 Hsyn), 7.83 - 7.88 (m, 2 Hsyn + 2 Hanti), 
8.11 (dd, J1 = 8.4 Hz, J2 = 1.2 Hz, 1 Hsyn), 8.14 - 8.18 (m, 1 Hsyn + 2 
Hanti), 8.21 - 8.23 (m, 1 Hsyn + 1 Hanti). 
13C-NMR (150 MHz, C2D2Cl4): δ 19.7 (CH3), 20.9 (CH3), 120.6 (Cq), 
124.6 (CH), 124.9 (CH), 125.2 (CH), 126.3, (CH), 127.1 (CH), 127.20 
(CH), 127.23, 127.3 (CH), 128.5 (CH), 129.0 (Cq), 129.1 (CH), 129.3 
(CH), 129.4 (Cq), 130.0 (CH), 130.1 (CH), 130.2 (CH), 130.4 (CH), 
130.7 (CH), 130.9 (CH), 131.9 (Cq), 132.0 (Cq), 132.1 (Cq), 132.3 (Cq), 
132.4 (Cq), 132.9 (CH), 133.5 (CH), 133.6 (Cq), 134.0 (CH), 134.5 
(CH), 134.6 (CH), 134.7 (CH), 134.8 (CH), 136.5 (Cq), 136.7 (Cq), 
145.5 (Cq), 145.72 (Cq), 145.74 (Cq), 146.2 (Cq), 147.8 (Cq), 183.5 
(Cq), 183.7 (Cq), 183.9 (Cq), 184.8 (Cq). HRMS-(ESI-Orbitrap) m/z: 
calcd for C23H15NO4Na+[M+Na]+: 392.0899; found 392.0886. 
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2,5-bis-o-tolylbenzoquinone (8) 
In an oven dried Schlenk tube, under nitrogen atmosphere, 2,5-dibromo-
p-benzoquinone (100 mg, 0.379 mmol, 1 eq) and o-tolylboronic acid (129 
mg, 0.948 mmol, 2.5 eq) were dissolved in 3 ml of dry THF. 2 M 
aqueous solution of K2CO3 (0.75 ml, 4 eq) was added and the reaction 
mixture was degassed by nitrogen bubbling for 5-10 minutes. Pd(PPh3)4 
(0.038 mmol, 0.1 eq) was added and the solution was stirred 6 hours at 60 
°C. The reaction mixture was then diluted with 1 M HCl (5 ml) and 
extracted with ethyl acetate (3 x 5 ml). The combined organic layers were 
dried over Na2SO4 and the solvent was evaporated under reduced 
pressure. The crude reaction mixture was dissolved in 4 ml of MeCN and 
a solution of CAN (1.04 g, 5 eq) in 4 ml of water was added at room 
temperature. The reaction mixture was stirred overnight and then the 
aqueous layer was extracted with DCM (3 x 10 ml), the combined 
organic layers were dried over Na2SO4 and the volatiles were removed 
under reduced pressure. The crude product was purified with silica-gel 
flash chromatography (petrol ether/ethyl acetate 95/5) affording the 
product in 14% yield as a sticky yellow solid. Further purification of the 
product with preparative HPLC (Kinetex C18 5μm, 100 Å, 250 x 21.2 
mm, MeCN/H2O 70/30, 20 ml/min and Chiralpak AD-H 2x25 cm n-
Hex/i-PrOH 90/10, 20 ml/min) provide the product with 95% purity.  
1H-NMR (600 MHz, CDCl3):δ 2.26 (s, 6 H), 6.82 (s, 2 H), 7.18 (dd, J1 = 
7.8 Hz, J2 = 1.2 Hz, 2 H), 7.28 (d, J = 7.8 Hz, 2 H), 7.30 (d, J = 7.8 Hz, 2 
H), 7.37 (dd, J1 = 7.8 Hz, J2 = 1.2 Hz, 2 H).  
13C-NMR (100 MHz, CDCl3): δ 20.5 (2 CH3), 125.8 (2 CH), 129.4(2 
CH), 129.5 (2 CH), 130.5 (2 CH), 132.9 (2 Cq), 134.8 (2 CH), 136.2 (2 
Cq), 148.2 (2 Cq), 186.6 (2 Cq).  
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HRMS-(ESI-Orbitrap) m/z: calcd for C20H16O2Na+ [M+Na]+: 311.1048; 
found 311.1042. 
2,5-dibromo-p-hydroquinone 
According to the procedure described, p-benzoquinone (1 eq) was 
dissolved in dry Et2O (0.2M) at 0 °C, under N2 flow, then bromine (2 eq, 
2 M solution in dry Et2O) was added over 10 minutes. The mixture was 
stirred at room temperature for 15 minutes, returned to the ice bath, and 
treated with concentrated H2SO4 (2 eq). After 30 minutes the mixture was 
poured onto iced water and extracted 3 times with Et2O and the extracted 
organic layer was dried (Na2SO4), filtered and concentrated at reduced 
pressure. The crude mixture of 2,5-dibromo-p-hydroquinone containing a 
small amount of 2,3-dibromo-p-hydroquinone was used without any 
further purification.  
1H-NMR (600 MHz, CD3CN, +25°C): δ 7.10 (s, 1 H), 6.87 (s, 1 H).  
13C-NMR (150.8 MHz, CD3CN, +25°C): δ 105.95 (Cq), 109.71 (Cq), 
116.50 (CH), 120.68 (CH), 148.34 (Cq), 148.98 (Cq). 
2,5-bis-o-nitrophenylbenzoquinone (7)  
The mixture of 2,5-dibromo-phydroquinone and 2,3-dibromo-p-
hydroquinone (1 eq) were dissolved in dry THF (0.067 M), then the o-
nitrophenylboronic acid (4 eq), potassium carbonate (5 eq, 2 M solution) 
and the palladium catalyst Pd(PPh3)4were added. The stirred solution was 
kept at reflux for 2 hours. Et2O and H2O were then added and the 
extracted organic layer was dried (Na2SO4), filtered on silica gel and 
concentrated at reduced pressure. The crude products were purified by 
semi-preparative HPLC on C18 column (60:40 v/v acetonitrile/H2O), to 
obtain a mixture of 2,5-bis-o-nitrophenylhydroquinone and 2,3-bis-o-
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nitrophenyl hydroquinone(about 3%). The oxidation8 to benzoquinone 
was then performed as described. The crude products were then purified 
and separated by semi-preparative HPLC on Synergi-hydro column 
(70:30 v/v acetonitrile/H2O).  
1H-NMR (600 MHz, CD3CN, +25°C): δ 7.03 (s, 1 H), 7.62 (dd, J1 = 7.69 
Hz, J2 = 1.20 Hz, 1 H), 7.77 (dt, J1 = 8.08 Hz, J2 = 1.39 Hz, 1 H), 7.87 
(dt, J1 = 7.67 Hz, J2 = 1.30 Hz, 1 H), 8.22 (dd, J1 = 8.21, J2 = 0.98 Hz, 1 
H).  
13C-NMR (150.8 MHz, CD3CN, +25°C): δ 124.68 (CH), 128.34 (Cq), 
131.34 (CH), 132.00 (CH), 132.26 (CH), 134.56 (CH), 147.20 (Cq), 
148.50 (Cq), 184.98 (Cq).  
HRMS-(ESI-Orbitrap) m/z: calcd for C18H10N2O6Na+[M+Na]+: 373.0431; 
found. 373.042.
                                                     
8Minisci,F.; Citterio,A.; Vismara,E.; Fontana,F.; De Bernardinis, S.; Correale, M. 
J. Org. Chem. 1989, 54, 728 – 731. 
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Long range bonding/non-bonding interactions: study on 
2-arylpyridines 
2-(2-ethylphenyl)-3,5-dimethylpyridine (6) 
1H-NMR (600 MHz, CD2Cl2, 5.32 ppm, +25°C): δ 1.00 (t, J = 7.4 Hz, 3 
H), 2.04 (s, 3 H), 2.35 (s, 3 H), 2.39 (bs, 2 H), 7.09 (d, J = 7.7 Hz, 1 H), 
7.23 (dt, J = 7.0, 2.2 Hz, 1 H), 7.33 (dt, J = 7.8, 1.5 Hz, 1 H), 7.50 (s, 1 H), 
8.30 (s, 1 H). 
13C-NMR (150.8 MHz, CD3CN, 118.69 ppm, +25°C): δ 14.497 (CH3), 
17.086 (CH3), 18.254 (CH3), 25.715 (CH2), 125.499 (CH), 127.908 (CH), 
128.563 (CH), 128.878 (CH), 130.822 (Cq), 131.851 (Cq), 138.144 (CH), 
140.092 (Cq), 142.025 (Cq), 146.737 (CH), 156.556 (Cq). 
1-(2-(3,5-dimethylpyridin-2-yl)phenyl)-N,N-dimethylmethanamine (7) 
1H-NMR (600 MHz, CD2Cl2, 5.32 ppm, +25°C): δ 2.04 (s, 9 H), 2.35 (s, 3 
H), 3.17 (s, 2 H), 7.11 (d, J = 7.1 Hz, 1 H), 7.29 (t, J = 7.1 Hz, 1 H), 7.36 
(t, J = 7.1 Hz, 1 H), 7.39 (s, 1 H), 7.56 (d, J = 7.7 Hz, 1 H), 8.28 (s, 1 H). 
13C-NMR (150.8 MHz, CD2Cl2, 54 ppm, +25°C): δ 18.353 (CH3), 19.382 
(CH3), 45.757 (2 CH3), 61.258 (CH2), 126.957 (CH), 128.121 (CH), 
129.377 (CH), 129.875 (CH), 131.585 (Cq), 132.046 (Cq), 138.131 (Cq), 
138.552 (CH), 141.210 (Cq), 147.262 (CH), 156.978 (CH). 
2-(2-(methoxymethyl)phenyl)-3,5-dimethylpyridine (8) 
1H-NMR (600 MHz, CD2Cl2, 5.32 ppm, +25°C): δ 2.05 (s, 3 H), 2.35 (s, 3 
H), 3.16 (s, 3 H), 4.20 (bs, 2 H), 7.16 (d, J = 8.1 Hz, 1 H), 7.34 (t, J = 7.1 
Hz, 1 H), 7.40 (t, J = 8.1 Hz, 1 H), 7.43 (s, 1 H), 7.53 (d, J = 7.6 Hz, 1 H), 
8.29 (s, 1 H). 
13C-NMR (150.8 MHz, CD3CN, 118.69 ppm, +25°C): δ 17.097 (CH3), 
18.239 (CH3), 57.395 (CH3), 71.483 (CH2), 125.517 (Cq), 127.150 (CH), 
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127.717 (CH), 128.157 (CH), 128.911 (CH), 136.643 (Cq), 138.228 (CH), 
139.825 (Cq), 146.645 (CH), 147.161 (Cq), 155.626 (Cq). 
Dimethyl(2-(methoxymethyl)phenyl)boronate 
2-(methoxymethyl)phenylbromide (1.15 g, 5.7 mmol, 1 eq) was dissolved 
in dry THF (0.2 M), under nitrogen flux and kept at -78°C. At this solution 
n-BuLi (1.6 M in hexane, 5.56 ml, 8.58 mmol, 1.5 eq) was added dropwise 
and kept stirring at -78°C for 1 hour. Keeping the solution at the same 
temperature, trimethylborate (1.78 g, 17.2 mmol, 3 eq) was added 
dropwise and kept stirring for 1 hour. The reaction was kept stirring 
overnight at room temperature, then the 0.2 M solution was used for the 
next synthesis step without any further work up. 
2-(2-methoxymethyl)phenyl)-3-methylpyridine (9) 
A mixture of 3-methyl-2-bromopyridine (0.11 ml, 1 mmol, 1 eq) and 2-
methoxybenzyl-phenylboronic dimethyl ester (0.2 M in THF, 7.5 ml, 1.5 
mmol, 1.5 eq), under nitrogen flux, were dissolved in dry (0.10 M). Then 
potassium carbonate (2 M, 0.69 g, 5 mmol, 5 eq) and the palladium 
catalyst Pd(PPh3)4. The stirred solution was kept at reflux for 2 hours. 
Water was then added and the solution was extracted three times with 
dichloromethane. The organic layer was dried (Na2SO4), filtered on silica 
gel and concentrated at reduced pressure. The crude was then purified by 
silica flash chromatography (7:3 petroleum ether/ethyl acetate), and by 
semi-preparative HPLC on Synergi 4u Hydro RP (80:20 v/v 
acetonitrile/H2O). The clean product was obtained with a 48% yeld. 
1H-NMR (600 MHz, CD2Cl2, 5.22 ppm, +25°C): δ 3.09 (s, 3H), 4.12 (s, 2 
H), 7.08 (d, J = 7.9 Hz, 1 H), 7.11 (q, J1 = 4.8 Hz, J2 = 7.57 Hz, 1 H), 7.26 
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(t, J = 7.5 Hz, 1 H), 7.31 (dt, J1 = 1.24 Hz, J2 = 7.5 Hz), 7.44 (d, J = 7.9 
Hz, 1 H), 7.51 (d, J = 7.9 Hz, 1 H), 8.36 (d, J = 4.33, 1 H). 
13C-NMR (150.8 MHz, CD2Cl2, 53.40 ppm, +25°C): δ 18.19 (CH3), 57.21 
(CH2), 71.08 (CH3), 126.39 (CH), 127.11 (CH), 127.40 (CH), 127.88 
(CH), 131.05 (Cq), 135.72 (CH), 136.95 (CH), 138.86 (Cq), 145.56 (CH), 
157.81 (Cq). 
Dimethyl(2-(fluoromethyl)phenyl)boronate 
2-(fluoromethyl)phenylbromide (1.28 g, 6.8 mmol, 1 eq) was dissolved in 
dry THF (0.2 M), under nitrogen flux and kept at -78°C. At this solution n-
BuLi (1.6M in hexane, 6.34 ml, 10.15 mmol, 1.5eq) was added dropwise 
and kept stirring at -78°C for 1 hour. Keeping the solution at the same 
temperature, trimethylborate (2.3 ml, 20.3mmol, 3eq) was added dropwise 
and kept stirring for 1 hour. The reaction was kept stirring overnight at 
room temperature, then the 0.2 M solution was used for the next synthesis 
step without any further work up. 
2-(2-fluoromethyl)phenyl)-3-methylpyridine (10) 
A mixture of 3-methyl-2-bromopyridine (0.11ml, 1 mmol, 1 eq) 
anddimethyl (2-fluoromethyl)phenyl)boronate(0.2 M in THF, 7.4 ml, 1.5 
mmol, 1.5 eq), under nitrogen flux, were dissolved in dry (0.10 M). Then 
potassium carbonate (2 M, 0.691 g, 5 mmol, 5 eq) and the palladium 
catalyst Pd(PPh3)4. The stirred solution was kept at reflux for 2 hours. 
Waterwas then added and the solution was extracted three times with 
dichloromethane. The organic layer was dried (Na2SO4), filtered on silica 
gel and concentrated at reduced pressure. The crude was then purified by 
silica flash chromatography (7:3 petroleum ether/ethyl acetate), and the 
product was obtained with a 49% yeld. 
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1H-NMR (600 MHz, CD2Cl2, 5.22 ppm, +25°C): δ 2.04 (s, 3 H), 5.11 (d, J 
= 47.3 Hz, 2 H), 7.15 (m, 2 H), 7.36 (m, 2 H), 7.48 (d, J = 7.8 Hz, 1 H), 
7.53 (d, J = 7.8, 1 H), 8.37 (d, J = 4.5, 1 H). 
13C-NMR (600 MHz, CD2Cl2, 53.40 ppm, +25°C): δ 18.99 (CH3), 82.45 
(d, J=164.7 Hz, CH2), 131.83 (Cq), 134.36 (Cq), 134.49 (Cq), 122.55 
(CH), 128.14 (CH), 128.35 (CH), 128.40 (CH), 128.99 (CH), 138.00 (CH), 
146.44 (CH), 157.67 (Cq). 
3,5-diethyl-2-(2-methylphenyl)pyridine (11) 
1H-NMR (600 MHz, CD3CN, 1.96 ppm, +25°C): δ 1.03 (t, J = 7.6 Hz, 3 
H), 1.30 (t, J = 7.6 Hz, 3H), 2.40 (bs, 2 H), 2.70 (q, J = 7.7 Hz, 2H), 7.15 
(d, J = 8.3, 1H), 7.26 (m, 1H), 7.32 (m, 2H), 7.58 (d, J=2.5 Hz, 1H), 8.35 
(d, J=2.5 Hz, 1H). 
13C-NMR (600 MHz, CD3CN, 118.69 ppm, +25°C): δ 14.59 (CH3), 15.28 
(CH3), 19.24 (CH3), 25.47 (CH2), 25.85 (CH2), 125.81 (CH), 128.114 
(CH), 129.25 (CH), 130.38 (CH), 136.07 (CH), 136.37 (Cq), 137.20 (Cq), 
138.60 (Cq), 140.95 (Cq), 146.59 (CH), 156.80 (Cq). 
3,5-diethyl-2-(2-ethylphenyl)pyridine (12) 
1H-NMR (600 MHz, CD2Cl2, 5.32 ppm, +25°C): δ 0.98 (t, J = 7.6 Hz, 3 
H), 1.02 (t, J = 7.7 Hz, 3 H), 1.26 (t, J = 7.7 Hz, 3 H), 2.34 (m, 4 H), 2.66 
(q, J = 8.3 Hz, 2 H), 7.08 (dd, J = 7.7, 0.9 Hz, 1 H), 7.22 (dt, J = 7.4, 1.4 
Hz, 1 H), 7.31 (t, J = 7.0 Hz, 1 H), 7.34 (t, J = 7.7 Hz, 1 H), 7.48 (s, 1 H), 
8.28 (s, 1 H). 
13C-NMR (150.8 MHz, CD3CN, 118.69 ppm, +25°C): δ 14.109 (CH3), 
14.497 (CH3), 14.820 (CH3), 25.078 (CH2), 25.418 (CH2), 25.814 (CH2), 
125.359 (CH), 127.980 (CH), 128.416 (CH), 128.998 (CH), 135.698 (CH), 
190 
 
136.928 (Cq), 138.272 (Cq), 139.821 (Cq), 142.065 (Cq), 145.872 (CH), 
156.230 (Cq). 
1-(2-(3,5-diethylpyridin-2-yl)phenyl)-N,N-dimethylmethanamine (13) 
1H-NMR (600 MHz, CD2Cl2, 5.32 ppm, +25°C): δ 1.08 (t, J = 7.6 Hz, 3 
H), 1.32 (t, J = 7.6 Hz, 3 H), 2.06 (s, 6 H), 2.40 (bs, 2 H), 2.71 (q, J = 7.7 
Hz, 2 H), 3.17 (bs, 2 H), 7.15 (dd, J = 7.5, 1.2 Hz, 1 H), 7.29 (dt, J = 7.2, 
1.3 Hz, 1 H), 7.31 (dt, J = 7.7, 1.2 Hz, 1 H), 7.47 (d, J = 2.2 Hz, 1 H), 7.59 
(dd, J = 8.2, 1.4 Hz, 1 H), 8.32 (d, J = 2.1 Hz, 1 H). 
13C-NMR (150.8 MHz, CD3CN, 118.69 ppm, +25°C): δ 15.386 (CH3), 
16.261 (CH3), 26.399 (CH2), 26.812 (CH2), 46.187 (CH3), 61.998 (CH2), 
127.621 (CH), 128.965 (CH), 130.363 (CH), 130.411 (CH), 136.701 (CH), 
138.409 (Cq), 139.134 (Cq), 139.459 (Cq), 141.879 (Cq), 147.135 (CH), 
157.135 (Cq). 
3,5-diethyl-2-(2-(methoxymethyl)phenyl)pyridine (14) 
1H-NMR (600 MHz, CD2Cl2, 5.32 ppm, +25°C): δ 1.05 (t, J = 7.3 Hz, 3 
H), 1.31 (t, J = 7.9 Hz, 3 H), 2.40 (q, J = 7.7 Hz, 3 H), 2.70 (q, J = 7.7 Hz, 
2 H), 3.19 (s, 3 H), 4.19 (s, 2 H), 7.16 (dd, J = 7.5, 1.1 Hz, 1 H), 7.33 (dd, 
J = 7.5, 1.1 Hz, 1 H), 7.40 (dt, J=7.7, 1.2 Hz, 1 H), 7.47 (d, J = 1.9 Hz, 1 
H), 7.53 (d, J = 7.7 Hz, 1 H), 8.31 (d, J = 2.0 Hz, 1 H). 
13C-NMR (150.8 MHz, CD2Cl2, 54 ppm, +25°C): δ -5.814 (CH3), -5.642 
(CH3), 4.726 (CH2), 5.806 (CH2), 38.367 (CH3), 52.598 (CH2), 108.227 
(CH), 109.267 (Cq), 109.637 (2CH), 111.017 (CH), 117.065 (CH), 
117.164 (Cq), 122.205 (Cq), 122.476 (Cq), 124.354 (CH), 129.264 (Cq). 
2-ethyl-2’-methoxy-1,1’-biphenyl (15) 
A mixture of 2-bromoanisole (0.1 ml, 0.8 mmol, 1 eq) and 2-
ethylphenylboronic acid (0.150 g, 1 mmol, 1.25 eq), under nitrogen flux, 
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were dissolved in a 8:3 mixture of toluene/ethanol (0.15M). Then 
potassium carbonate (1 M, 0.55 g, 4 mmol, 4 eq) and the palladium 
catalyst Pd(PPh3)4. The stirred solution was kept at reflux for 2.5 hours. 
Water was then added and the solution was extracted three times with 
dichloromethane. The organic layer was dried (Na2SO4), filtered on silica 
gel and concentrated at reduced pressure. The crude was then purified by 
semi-preparative HPLC on Luna C18 column (90:10 v/v acetonitrile/H2O). 
Yeld 57%. 
1H-NMR (600 MHz, CD2Cl2, 5.32 ppm, +25°C): δ 0.43 (t, J = 7.6 Hz, 3 
H), 1.81 (bs, 2 H), 3.11 (s, 3 H), 6.33 (d, J = 8.1 Hz, 1 H), 6.37 (dt, J = 7.3, 
0.8 Hz, 1 H), 6.51 (t, J = 8.7, 1.4 Hz, 1 H), 6.58 (m, 1 H), 6.67 (dd, J = 7.0, 
0.8 Hz, 1 H), 6.71 (dt, J = 7.9, 1.7 Hz, 1 H). 
13C-NMR (150.8 MHz, CD2Cl2, 54 ppm, +25°C): δ 4.939 (CH3), 6.194 
(CH3), 35.559 (CH2), 90.830 (CH), 100.496 (CH), 105.412 (CH), 107.360 
(CH), 107.924 (CH), 108.638 (CH), 110.439 (CH), 110.648 (Cq), 111.351 
(CH), 118.310 (Cq), 122.908 (Cq), 136.604 (Cq). 
1-(2-bromophenyl)-N,N-dimethylmethanamine 
A mixture of 2-bromobenzylbromide (1.35 g, 5.4 mmol, 1 eq) and a 
solution 33% (w/w) of dimethylamine (7.40 ml, 54 mmol, 10 eq) was 
dissolved in 2 ml of ethanol. The stirred solution was kept in agitation for 
two hours at 60°C. After this time, 10 ml of water were added and the 
aqueous phase was extracted with dichloromethane (3 x 20 ml). The 
collected organic layers were dryed (Na2SO4), filtered and the crude 
mixture was then washed with n-pentane, collected and concentrated under 
reduced pressure, giving the clean product with 47% yeld. 
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1H-NMR (400 MHz, CDCl3, 7.26 ppm, +25°C): δ 2.29 (s, 3 H), 3.51 (s, 2 
H), 7.10 (dt, J = 7.8, 1.7 Hz, 1 H), 7.27 (dt, J = 7.5, 1.3 Hz, 1 H), 7.41 (dd, 
J = 7.7, 1.7 Hz, 1 H), 7.53 (dd, J = 8.0, 1.2 Hz, 1 H). 
1-(2’-methoxy-[1,1’-biphenyl]-2-yl)-N,N-dimethylmethanamine (16) 
A mixture of 1-(2-bromophenyl)-N,N-dimethylmethanamine (0.250 g, 1.04 
mmol, 1 eq) and2-methoxyphenylboronic acid (0.237 g, 1.56 mmol, 1.5 
eq), under nitrogen flux, were dissolved in a 8:3 mixture of toluene/ethanol 
(0.10M). Then potassium carbonate (2 M, 0.55 g, 4 mmol, 4 eq) and the 
palladium catalyst Pd(OAc)2. The stirred solution was kept at reflux for 2.5 
hours. Water was then added and the solution was extracted three times 
with dichloromethane. The organic layer was dried (Na2SO4), filtered and 
concentrated at reduced pressure. The crude was then purified by a silica 
plug (dichloromethane + triethylamine 0.1 % - 0.5%). The eluted fraction 
contains the desired product in 49 % yeld. 
1H-NMR (600 MHz, CD3CN, 1.96 ppm, +25°C): δ 2.08 (s, 6 H), 3.27 (bs, 
2 H), 3.73 (s, 3 H), 7.03 (dt, J = 7.4, 1.1 Hz, 1 H), 7.06 (dd, J = 8.4, 0.7 
Hz, 1 H), 7.14 (m, 2 H), 7.30 (dt, J = 7.4, 1.3 Hz, 1 H), 7.37 (dt, J = 7.6, 
1.4 Hz, 1 H), 7.40 (dt, J = 7.9, 1.7 Hz, 1 H), 7.62 (dd, J = 7.8, 0.7 Hz, 1 H). 
13C-NMR (150.8 MHz, CD3CN, 118.69 ppm, +25°C): δ 45.802 (CH3), 
56.303 (CH3), 61.728 (CH2), 112.190 (CH), 127.719 (CH), 127.969 (CH), 
128.672 (CH), 130.195 (CH), 130.297 (CH), 131.352 (Cq), 131.495 (CH), 
132.282 (CH), 138.659 (Cq), 140.204 (Cq), 157.975 (Cq). 
2-methoxy-2’-(methoxymethyl)-1,1’-biphenyl (17) 
A mixture of (2’-methoxy-[1,1’-biphenyl]-2-yl)methanol (0.098 g, 0.46 
mmol, 1 eq), potassium t-butoxyde (0.057 g, 0.51 mmol, 1.1 eq) and 
iodomethane (0.126 ml, 2.02 mmol, 4 eq), under nitrogenflux, in dry THF. 
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The reaction was conducted at room temperature until complete 
conversion of the reagent. Then water was added and the aqueous phase 
was washed three times with dichloromethane. The organic phase was 
dried, filtered and concentrated under reduced pressure. The crude was 
then purified by semi-preparative HPLC on Luna C18 column (90:10 v/v 
acetonitrile/H2O). Yeld 50%. 
1H-NMR (600 MHz, C2D2Cl4, 7.26 ppm, +25°C): δ 3.25 (s, 3H), 3.77 (s, 3 
H), 4.27 (bs, 2 H), 6.97 (d, J = 8.4 Hz, 1 H), 7.03 (t, J = 7.5, 1H), 7.18 (dd, 
J = 7.4, 1.7 Hz, 1 H), 7.23 (d, J = 7.2 Hz, 1 H), 7.33 (t, J = 7.2 Hz, 1 H), 
7.38 (t, J = 7.2 Hz, 1 H), 7.53 (d, J = 7.5 Hz, 1 H). 
13C-NMR (150.8 MHz, CD3CN, 118.69 ppm, +25°C): δ 56.357 (CH3), 
58.725 (CH3), 73.143 (CH2), 112.291 (CH), 121.777 (CH), 128.418 (CH), 
128.697 (CH), 128.843 (CH), 130.450 (CH), 130.772 (Cq), 131.512 (CH), 
132.204 (CH), 138.622 (Cq), 139.222 (Cq), 157.960 (Cq). 
2-(fluoromethyl)-2’-methoxy-1,1’- biphenyl (18) 
A mixture of 2-bromoanisole (0.12 ml, 1 mmol, 1 eq) and dimethyl (2-
fluoromethyl)phenyl)boronate (0.2M in THF, 7.5 ml, 1.5 mmol, 1.5 eq), 
under nitrogen flux, were dissolved in dry (0.10M). Then potassium 
carbonate (2M, 0.69 g, 5 mmol, 5 eq) and the palladium catalyst 
Pd(PPh3)4. The stirred solution was kept at reflux for 2 hours. Waterwas 
then added and the solution was extracted three times with 
dichloromethane. The organic layer was dried (Na2SO4), filtered on silica 
gel and concentrated at reduced pressure. The crude was then purified by 
silica flash chromatography (7:3 petroleum ether/ethyl acetate), and the 
product was obtained with a 49 % yeld. 
1H-NMR (600 MHz, C2D2Cl4, 5.59 ppm, 0°C):δ 3.71 (s, 3 H), 5.18 (dq, J1 
= 11.03 Hz, J2 = 48.60 Hz, 106.93 Hz, 2 H), 6.92 (d, J = 8.15 Hz, 1 H), 
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6.99 (t, J = 7.58 Hz, 1 H), 7.14 (dd, J1 = 1.49 Hz, J2 = 7.46 Hz, 1 H), 7.23 
(m, 1 H), 7.53 (m, 3 H), 7.50 (m, 1 H). 
13C-NMR (150.8 MHz, C2D2Cl4, 74.02 ppm, +25°C): δ 55.63 (CH3), 83.11 
(d, J = 163.87 Hz, CH2), 110.91 (CH), 120.82 (CH), 127.60 (CH), 127.67 
(CH), 128.52 (CH), 129.44 (CH), 130.72 (CH), 131.48 (CH), 135.11 (Cq), 
137.46 (Cq), 156.38 (Cq). 
 
